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SUGARY
The introduction to this thesis discusses the occurrence 
and potential carcinogenic hazards of environmental N-nitroso 
compounds. The adaptive response to MNNG, which arises from the 
chronic administration of this N-nitroso compound) is discussed 
with reference to the current knowledge of this response in 
E.coli, mammals and mammalian cells in vitro. Chapter 2 lists the 
materials and methods basic to the cell culture procedures used in 
succeeding chapters.
The experimental work is presented in five parts. In 
Chapter 3, the establishment of the adaptive pre-treatment 
protocol used throughout this study is described.
Chapter 4 describes the effect of adaptive pre-treatment on 
the growth, MNNG-induced cytoxicity and mutation to ouabain 
resistance (Oua1) in CHO-K1 and V79-379A cells. The effect of cell 
synchrony on the MNNG-induced cytotoxicity and mutation to Oua1 in 
CH0-K1 cells is also described.
In Chapter 5 the isolation of cell clones that are either 
resistant or sensitive to the cytotoxic action of MNNG, is 
described. The growth parameters, MNNG-induced cytotoxicity and 
mutation to Oua1 of each clone are determined, and compared to 
those found for adaptively pre-treated clones and their respective 
parental cells.
Chapter 6 describes the ability of cell-free extracts of 
CHO-K1, V79-379A cells, and their MNNG-resistant clones, to 
de-me thy late 06-methylguanine within an alkylated DNA substrate. 
The assay system has been validated using mouse C3H 10T1/2 cells, 
a cell line previously shown to de-me thy late alkylated DNA.
Chapter 7 describes the detection of MNNG-induced sister 
chromatid exchanges (SCE) in CH0-K1, V79-379A and their respective 
MNNG-resistant clones, and investigates the effect of adaptive 
pre-treatment on this parameter.
A summary of findings is presented at the end of each 
experimental chapter. -These are discussed in Chapter 8 in the 
light of current evidence for the existence of an adaptive 
response in mammalian cells.
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Interest in environmental chemical carcinogenesis probably 
began in 1775 when the London surgeon Sir Percival Pott published 
a treatise entitiled "Chirurgical Observations Relative to the 
Cateracts, the Polyps of the Nose, the Cancer of the Scrotum, the 
Different Kinds of Ruptures and the Mortification of the Toes and 
Feet", in which he concluded that the high incidence of 
epithelioma of the scrotum among chimney sweeps, was due to the 
soot to which they were daily exposed. He wrote, "It is a disease 
which always makes its first attack on, and its final appearance 
in the inferior part of the scrotum; where it produces a 
superficial, painful, ragged, ill-looking sore with hard and 
rising edges. The trade call it soot-wart... .the disease, in these 
people, seems to derive its origin from a lodgement of soot in the 
rugae of the scrotum". Sir Potts* observations are historically 
acknowledged as having provided the first evidence for a role of 
environmental agents in the aetiology of cancer. They also 
provided the basis for the first preventative measures against 
environmental cancer when, in 1778, the Danish chimney-sweeps’ 
guild urged its members to bathe daily (Clemmensen, 1951), and by 
1892 a lower scrotal cancer incidence in northern European chimney 
sweeps, relative to that in Ehgland, was noted (Butlin, 1892). The 
same disease was once again noticed among workers in the 
Lancashire cotton spinning industry where it became known as "mule 
spinners cancer"• About this time, occupational skin cancer among 
oil and tar workers was reported by Von Volkemann, (1875) in 
Germany and by Bell, (1876) in Scotland. It was suspected that 
prolonged contact of the spinners with clothes impregnated with
mineral oil used to lubricate their machines was responsible for 
the disease. Some years later, a very potent carcinogenic 
polycyclic hydrocarbon called benz(a)pyrene was identified and 
isolated from crude coal tar (Kennaway, 1955).
Many known carcinogens interact with various components of 
DNA, and in many cases cause damage to the nitrogenous bases. Seme 
chemical carcinogens, such as alkylating agents, are reactive with 
DNA in the native state and do not require prior chemical 
modification in target cells (Singer, 1979). Others, such as 
benz(a)pyrene, are essentially unreactive with DNA. It is known, 
however that benz(a)pyrene, and other polycyclic aromatic 
hydrocarbons are metabolised to phenols and dihydrodiols by the 
mammalian P-450 system (Selkirk et al., 1982). Some of the 
products of this metabolism are electrophilie epoxides and it is 
well established that the ultimate carcinogenic form of 
benz(a)pyrene is an anti diol epoxide which can react with the 
2-amino group of guanine, amongst other sites (Malaveille et al., 
1977; Weinstein et al,, 1976). Thus it was shown that metabolic 
activation can convert relatively weak proximal carcinogens into 
more potent ultimate carcinogens.
The earliest impetus for the study of the interaction of 
chemicals with DNA was probably their potential for use as lethal 
and injurous agents in warfare, but a far more humane stimulus 
came from the field of cancer chemotherapy. This was based on the 
simple idea that damage to DNA can interfere with normal DNA 
synthesis, leading to the replicative arrest of rapidly dividing 
cell populations such as cancer cells. Increasing public awareness 
of environmental mutagens and carcinogens has, in recent years, 
led to an interest in the study of the mechanisms by which
genotoxic chemicals interact with and damage DNA.
The human environment constantly presents threats to our 
genetic material and if it were not for continuous cellular 
monitoring and repair systems, we would soon be living cm a sick 
and barren planet. The study of DNA repair is therefore very 
important in the search for a fuller understanding of the 
mechanisms of human carcinogenesis. One of the most persuasive 
arguments for a role of DNA damage and mutation in the 
pathogenesis of at least one human cancer, steins from the study of 
patients suffering from the hereditary disease Xeroderma 
pigmentosum (XP). Extremely high incidences of skin cancer were 
recorded in patients with XP, and cells isolated from patients by 
Cleaver in 1968, revealed a defect in the excision repair of base 
damage caused by UV irradiation. Skin cancers occuring in patients 
with this disease are probably caused by UV radiation from the 
sun. This was the first indication of a DNA repair defect 
associated with a a human disease. Cleavers * observations also 
provided an impetus to examine the phenotypic resonses to 
DNA-damaging agents of cells from a number of other hereditary 
human diseases, particularly those associated with chromosomal 
abnormalities or with an abnormally raised incidence of neoplasia 
(Arlett and Lehman, 1978; Lehman and Mayne, 1981; Paterson, 1979; 
Setlow, 1978).
The past few decades have witnessed an unparalleled 
expansion of the chemical industry with the concomitant 
development of many new organic chemical products as well as 
enhanced product application e.g. increased usage of agricultural 
pesticides and fertilizers. It is estimated that over 3000 
chemicals are now known to be carcinogenic in experimental animals
and it seems likely that this nunber will increase since 
approximately 700 to 3000 new industrial chemicals are introduced 
per annua into the United States alone (Fishbein, 1979). The 
interest and concern of the general public has understandably 
increased as the list-of known environmental carcinogens expands.
Of the many thousands of chemicals known to man, the 
alkylating agent3 probably represent one of the major classes of 
DNA-damaging agents to which the human species is exposed 
(Fishbein, 1979). They were among the first chemicals to be 
recognised as mutagenic (Auerbach and Robson, 1946). Alkylating 
agents are electrophilic compounds with affinity for nuceophilic 
centres in organic macromolecules (Lawley, 1974; Singer and 
Kusmierek, 1982). They can be either monofunctional or bi- or 
polyfunctional, the former having a single reactive group which 
can covalently interact with single nucleophilic centres in DNA.
The bi functional alkylating agents have two reactive groups 
allowing them to react with molecules either within the same 
strand of DNA (intra-strand cross-links), or with molecules on 
different DNA strands (inter-strand cross-links). Numerous sites 
for alkylation have been identified in all four bases, although 
not all of them have equal reactivity (1.4.2.). Figure 1.1. shows 
normal purine:pyrimidine base pairing and also the sites, within 
these molecules, susceptible to alkylation by alkylating agents. In 
general the ring nitrogens of the bases are more nucleophilic than 
the oxygens, with the N7 position of guanine and N3 position of 
adenine being the most reactive, (Roberts, 1978). Alkylation of 
oxygen in phosphodiester linkages results in the formation of 
phosphotriesters.
Alkylating agents of particular importance are the










Sites susceptible to methylation in DNA and RNA.
Guanine N1, N2, N3, N7, 06.
Adenine N1, N3, N«, N7.
Cytosine N3, N4, 02.
Thymine 02, O4, N3.
Ribose 2 *-CH
Phosphate O.
N-nitroso compounds e.g. nitrosamines and nitrosamides, since they 
possess the property of generating cancer in a wide range of 
animal species. Other compounds possess this ability but no single 
chemical group is as universally carcinogenic as the N-nitroso 
compounds. In a number of studies, about 300 different N-nitroso 
compounds were administered to more than 40 different vertebrate 
species. Almost 90% of the tested compounds induced tumours in one 
species or another (Lijinskyt 1984; Preussman and Stewart, 1984). 
These observations may suggest that humans are also susceptible to 
carcinogenesis by N-nitroso compounds and that exposure entails a 
probable carcinogenic risk.
N-nitroso compounds are formed readily by interaction of a 
secondary or tertiary amino compound with a nitrosating agent. 
Common nitrosating agents include inorganic nitrites, nitrite and 
nitrate esters, nitrogen oxides and other N-nitroso compounds. 
Nitrosamines are produced by the reaction of secondary amines with 
nitrous acid giving a characteristic yellow oil. This feature is 
sometimes used as an analytical test to establish the presence of 
secondary amines in a mixture of primary, secondary and tertiary 
amines.
R2NH + HNO2 = R2N-NO + H2O
HC1
2° amine nitrous nitrosamine
acid
These compounds are found extensively in certain industrial 
environments, in particular the rubber, leather and agricultural 
industries. Di-methylnitrosamine (DMN) (CH3)2N-N0, was once used 
as an industrial solvent but the observation that the incidence of 
liver cirrhosis in exposed workers was higher than other workers,
prompted an investigative study by Magee and Barnes, (1956). Their 
animal experiments showed the induction of liver necrosis in rats, 
rabbits, mice and guinea pigs following a single dose of 15 to 50 
mgkg*1 body weight. Chronic dietary administration of DMN to rats 
at levels of 100 and 200 parts per million (ppm) led to the death 
by liver damage within 95 and 37 days, respectively. Levels of 
50ppm induced no visible liver damage after 110 days, but 
following continued treatment every rat developed liver cancer and 
subsequently died.
N-nitroso compounds are found in foodstuffs containing 
amines and nitrosating agents which have reacted together. One 
class of nitrosating agents, commonly found in the environment, 
are the nitrites. Readily available sources of nitrite occur in 
the form of sodium and potassium nitrate, widely used as 
preservatives in cured meat and fish, bacon, cheese etc. Nitrates 
are reduced to nitrite by bacteria present in the human body e.g. 
nitrate reducing bacteria in the saliva (Tannenbaum et al., 1977). 
The cooking process can catalyse the reduction of nitrates to 
nitrites allowing reaction with amines to form nitrosamines.
Trace amounts of nitrosamines have been detected in samples of 
cooked foods e.g. levels of up to 100 pgkg-1 of DMN have been 
observed consistently in fried bacon (Scanlan, 1975). Injested 
amines may also react with residual nitrites from cured meat or 
fish, to form nitroso compounds in the stomach and bladder. The 
number of N-nitroso compounds which can be formed in vivo, from 
these sources, is very large, and the carcinogenic effects of the 
majority are still unknown (Lijinsky, 1980).
The smoking of tobacco probably represents one of the 
principal human exposures to N-nitroso compounds. It was proposed
that amines contained in tobacco smoke, once swallowed, may be 
nitrosated in the stomach to form carcinogenic nitrosamines whose 
target might be the lung, amongst other organs (Taylor and 
Lijinsky, 1975). The identification of DMN in cigarette smoke in 
1972, confirmed the suspicions that burnt tobacco itself contained 
nitrosamines (Rhodes and Johnson, 1972). The studies of Hecht et 
al., (1978) led to the identification of a number of nitrosamines 
present in tobacco smoke e.g. nitrosonomicotine (NNN), a product 
expected from the nitrosation of the tertiary amine nicotine, and
4- (N-methyl-N-nitrosamino) -1-(3-pyridyl) -1-butanone (NNK) an open 
ring form of NNN.
Cosmetics and toiletries contain nitrosamines such as 
di-ethanolnitrosamine a component of cosmetic emulsifiers, and 
methylethanenitrosamines which eventually become incorporated into 
shampoos. In these forms both compounds may be absorbed through 
the skin (Hecht et al., 1980). Table 1.1. gives examples and 
sources of N-nitroso compounds commonly encountered by man.
The largest group of amines which are of concern to the 
population at large, consists of drugs and medicines. Many 
hundreds of these are secondary or tertiary amines, although only 
a limited number are in common use. They include tranquilisers, 
analgesics and antihistamines, some of which are taken in 
relatively large quantities by many people, for long periods. 
Cimetidine (Tagamet), a widely used and very effective drug for 
the treatment of gastric disorders, has been shown to induce 
stomach tumours after becoming nitrosated in vivo (Jensen and 
Magee, 1981). Many drugs have more than one tertiary nitrogen 
susceptible to nitrosation, and the potential products are 
numerous. The extent to which the products contribute to an









Di -e thy Ini trosamine
Me thy ldodecyIni trosamine
Me thyltetradecy Ini trosamine
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increased cancer risk, associated with use of the drug, is 
difficult to calculate, even though one or all of the products 
have been found carcinogenic in animals (Mergens et al., 1979).
In 1960 considerable interest in nitrosamides was 
stimulated by the finding that N-methyl-N * -nitro-N 
-nitrosoguanidine (MNNG) had a reproducible anti-tunour activity 
against the murine L1210 leukaemia cell line (Green and Greenberg, 
1960). In later, structure-activity studies it was demonstrated 
that the nitroso group of the MNNG molecule was required for its 
anti-tumour activity and that substitution of a chloroethyl group 
for the methyl group enhanced its activity (Hyde et al., 1962). 
Montgomery et al., (1975), evaluated a series of compounds with 
structural similarities to MNNG, assessing their anti-tumour 
activities. One of these, N-methyl-N-nitrosourea (MNU), was found 
to be a very effective anti-tumour agent. This, coupled with the 
fact that MNU crosses the blood-brain barrier in cytotoxic 
concentrations, led to the synthesis of a large nunber of 
nitrosoureas with the aim of producing a clinically effective 
cytotoxic agent. Of the 200 or so nitrosourea analogues synthesised 
by Montgomery, only one specific structural type, i.e.
N-(2-haloethyl) -N-nitrosourea, proved to be superior in its 
anti-tunour action to MNU. Further alterations to the 
2-chloroethyl and the nitrogen group led to the synthesis of 
carmustine (1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)), 
lomustine (1- (2-chloroethyl)-3-cyclohexyl-l-nitrosourea (CCNU)) 
and its methylated derivative semustine (Me-OCNU), compounds used 
extensively as anti-neoplastic agents in cancer chemotherapy (Meyn 
and Murray, 1984). However, as one would expect with N-nitroso 
compounds, there are numerous reports of secondary malignancies,
particularly leukaemias, lymphomas and squamous cell carcinomas 
occuring after a 4 year latent period following the initiation of 
cancer chemotherapy which has included these drugs (Sieber and 
Adamson, 1975). It has been reported that over a period of 10 
years, 5 to 15% of patients given alkylating agents, will develop 
a secondary cancer of some description (Althouse, 1979).
The number and variety of environmental amines available 
for nitrosation is enormous. Human contact with such chemicals is 
likely to be chronic i.e. of the long-period, low-dose type, 
rather than an acute, single high dose exposure. We are 
continuously exposed to N-nitroso compounds in air pollutants, for 
example, which are present in low concentration in the air we 
breathe. Mutagenicity testing strategies, in general, use a single 
large dose of test compound to induce the measurable effect, and 
hence do not account for chronic exposure. In an attempt to 
experimentally simulate chronic environmental exposure to 
DNA-damaging agents, Samson and Cairns, (1977) studied bacterial 
mutagenesis under conditions of constant low-dose alkylating agent 
exposure. The authors used this biological end-point since it has 
been previously demonstrated that there is a high correlation 
between mutagenesis and carcinogenesis i.e. the somatic mutation 
theory of carcinogenesis. The object of their study was to 
determine whether mutation induction occured with the frequency 
and kinetics one would expect from the more usual mutagenesis 
studies that involved the exposure of cell to extremely large 
doses of mutagen for a short period. They compared mutations 
induced during several days of mutagen exposure with those induced 
during several minutes of mutagen exposure. Since alkylating 
agents, particularly N-nitroso compounds, represent one of the
major classes of DNA-damaging agents in the environment these 
workers chose the simple monofunctional methylating agent MNNG as 
their study mutagen. The results were totally unexpected. An 
E.coli population, growing in the presence of a low, non-toxic 
MNNG dose (1 pgml"1), did not continuously accumulate mutant cells 
over a period of three days, since it had become resistant to 
mutation induction during the first 60 minutes of exposure. Ihe 
mutation frequency did not increase any further during the 
remaining 4-7 days of the experiment. Further experimentation 
revealed that exposure of E.coli to sub-lethal levels of MNNG 
induced de novo synthesis of at least two DNA repair enzymes i.e. 
the response was absent when the experiment was performed in the 
presence of chloramphenicol, a protein synthesis inhibitor. These 
enzymes provided protection against the killing and mutagenic 
effects of further alkylation damage, even by very high challenge 
doses of MNNG (Samson and Cairns, 1977). This response was termed 
"The adaptive response to alkylating agents". Its characterisation 
by several laboratories, using a variety of biochemical, bacterial 
and molecular biology techniques, has allowed a fuller 
understanding of alkylation-induced cell death, mutation and the 
mechanisms bacteria can use to avoid these fates (Lindahl et al., 
1982, 1983).
This phenomenon raised a number of questions:
1) Does an analogous repair process exist in mammal ian cells and 
if present, does it protect these cells from mutation and 
cytotoxicity induced by environmentally abundant alkylating 
agents, such as the N-nitroso compounds ?.
2) Could the existence of this response influence the approach 
taken toward the assessment of the mutagenic and carcinogenic
risk of environmental chemicals ?.
3) Since many of the drugs used in cancer chemotherapy are, or are 
metabolised to, alkylating agents, will the appearance of an 
adaptive response during these treatments, often pursued for 
long periods, modify the efficiency of the treatment or result 
in the appearance of iatrogenic diseases ?.
4) Does this response exist in man, and if so how does it help to 
deal with mutagenic insults presented by the environment ?.
The initial work using in vitro mammalian cell cultures, 
indicated the presence of an adaptive response to alkylating 
agents in two cell types i.e. Chinese hamster ovary (CHO) and 
GM637 SV40-transformed normal hunan fibroblasts (Samson and 
Schwartz, 1980). This group used alkylating agent-induced 
cytotoxicity and sister chromatid exchanges as their biological 
end-points. Studies using whole animal systems were also 
promising. Existence of a mammalian adaptive response was 
implicated when administration of a wide variety of N-nitroso 
compounds to rats, was shown to increase the O6-methylguanine 
removal ability of liver extracts (1.4.3.).
A wealth of information about this response has 
subsequently been collected by many authors. Ihey have used many 
different cell types, adaptation protocols and biological 
end-points. However, for an adequate description of the mammalian 
adaptive response, as it currently stands, it is beneficial to 
firstly present the main features of the better defined bacterial 
adaptive response.
1.2. The adaptive response in E.coli.
The work of Samson and Cairns, (1977) had shown that there 
were two main features of this response:
i) the repair system is inducible and ii) since it makes the cells 
less mutable, it is error-free. Schendel and Robins, (1978) ruled 
out the possibility of diminished accessibility of adapted cells' 
DNA to MNNG and it soon became evident that the resistance of 
induced cells could be correlated to a significant reduction of 
06-methylguanine (06MG) in their DNA. This repair process was 
found to be of limited use to the cell since the system became 
saturated at high doses of MNNG. This was explained by the 
discovery that the enzyme which mediated the reduction of 0*MG, is 
apparently expended in the reaction i.e. it is not catalytic in 
the usual sense of the term, and once the induced pool was 
exhausted the adapted cells became as unprotected as the unadapted 
ones (Robins and Cairns, 1979). After enzyme depletion both 0*MS 
and mutations started to accumulate in adapted cells (Schendel and 
Robins, 1978). Karran et al, (1979), showed that the disappearance 
of 06MS from DNA was not accompanied by a corresponding release of 
the alkylated base. This is apparently due to the enzymatic 
transfer of methyl groups, from the methylated base, to a protein 
cysteine residue giving rise to S-methylcysteine in the enzyme 
structure (Olsson and Lindahl, 1980). The same group also 
suggested that the protein carrying the methyl acceptor and the 
methyltransferase activity resided in the same protein molecules 
since electrophoretic separation of the two proteins was not 
possible. The methyl transf erase, therefore, is an enzyme that 
modifies itself in the course of the reaction it catalyses i.e. it
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exhibits 'suicide* enzyme kinetics. Mutagenic adaptation involves 
the induction of this enzyme, called
08 -me thy lguanine-DNA-me thyl transf erase (08MGMT), with up to a 
100-fold increase in the enzyme levels of adapted E.coli (Lindahl,
1982) and a corresponding 6000-fold decrease in mutation rate.
(Cairns et ai., 1981). In each case mutation wets assessed by 
reverse mutation of histidine dependent bacteria {his-) to 
histidine independent bacteria (his*).
08MGMT has been purified to 95% homogeneity (Demple et al., 1983) 
from an E.coli mutant which constitutively expresses the adaptive 
response to alkylation-induced mutation i.e. E.coli adc-1 
(Sedgwick, 1982). Sodium-dodecylsulphate gel electrophoresis of 
the purified protein shows a single polypeptide with a molecular 
weight of approximately 18,000 Daltons (Olsson and Lindahl, 1980).
The active form of this enzyme is also monomeric since 
non-denaturing conditions i.e. velocity sedimentation analysis, 
yields a similar molecular weight. Protease digestion followed by 
amino acid analysis indicates the presence of four (or possibly 
five) cysteine residues per molecule, but only one of these is the 
methyl acceptor (Demple et al., 1983)
Under adaptive conditions, E.coli has demonstrated 
mutagenic resistance to ethylating, propylating and butylating 
agents, as well as against methylating agents. (Schendel, 1981).
It should be noted, however, that adducts larger than methyl 
groups at the O8 position of guanine in the DNA of E.coli can also 
be repaired by a process called excision repair - a topic not 
dealt with in this thesis.
The other inducible enzyme associated with this response, 
i.e. 3-methyladenine-DNA.-glycosylase II (3-MAO), protects adapted
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cells from mutagen-induced cell killing (Eveson and Seeberg, 1982; 
Karran et al., 1982). Jeggo et al., (1978) reasoned that mutagenic 
and lethal adaptation were two distinct pathways, when the 
DNA-polymerase-1 deficient E,coli pol A strains failed to acquire 
lethal resistance whilst exhibiting mutagenic resistance. The 
3-MAG enzyme has been shown to be capable of removing 
3-methyladenine, 3-methylguanine and 7-methylguanine from 
alkylated DNA (Riazuddin and Lindahl, 1978). The constitutively 
expressed 3-methyladenine-DNA-glycosylase I enzyme efficiently 
removes 3-methyladenine but not 7- or 3-methylguanine and since 
7-methylguanine appears to be a relatively inocuous lesion, it was 
proposed that repair of 3-methylguanine is involved adaptation to 
mutagen-induced cell killing, (Karran et al., 1982). These authors 
also showed that in E.coli, under adaptive conditions, glycosylase 
II is present in about 20-fold higher levels than non-adapted 
cells. A comprehensive explanation of general glycosylase-mediated 
repair is given in Friedberg, (1985).
The genetic control of the E.coli adaptive response has 
been studied in detail and is the subject of a number of reviews 
(Cairns et al., 1981; Lindahl et al., 1983; Sedgwick, 1982;
Yarosh et al., 1985) and will not be dealt with here.
It has been reported that E.coli contains 02-me thyl thymine 
-DNA-glycosylase and 04 -methyl thymine-DNA-me thyl transf erase 
enzymes (Ahmed and Laval, 1984), and that these identify with 
3-MAG and 06MGMT respectively (McCarthy et al., 1984). These 
enzymes therefore appear to be able to remove several different 
kinds of lesion, with common structural features, from alkylated 
DNA.
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1.3. The adaptive response in other prafcarvntic celbi.
Bacillus subtil is and Bacillus thurigiensis have both 
exhibited the presence of an adaptive response to MNNG following 
pre-treatment with sub-toxic doses of this mutagen (Boutibones and 
Auffrey, 1987; Hadden et al., 1983). Cell extracts of each strain 
contained me thyl transf erase activity that appeared to be very 
similar to that of the enzyme found in E.coli, In adapted 
B.subtilist enzyme activity increases by an order of magnitude, 
again as a result of de novo protein synthesis following MNNG 
adaptive pre-treatment (Hadden et al., 1983). In contrast, these 
authors failed to show an adaptive response in Haemophilus 
influenzae.
1.4. The adaptive response in mammalian cells.
1.4.1. The mammftl 3-methyladenine-DNA-glycosylase.
Evidence for the existence of a mammalian
3-methyladenine-DNA-glycosylase II enzyme, comparable to the 
bacterial enzyme, is sparse. However, Cathcart and Goldthwait,
(1981) purified an enzyme from rat liver, that exhibited 3-MAG 
activity since it released 3-methyladenine and 7-methylguanine 
from alkylated DNA. Brent, (1979) purified an enzyme from human 
lymphoblasts that had 3-MAG activity and was specific for
3-methyladenine in duplex DNA.
It has been shown that a enzymic activity similar to that 
of 3-MAG is induced in rat liver during the regeneration period 
following partial hepatectomy (Gombar et al., 1981) • There is no 
direct evidence, however, that any of the above enzymes are 
analogous to the 3-methyladenine-DNA-glycosylase II of E.coli.
The increased enzyme activity observed by Gombar et al., (1981)
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may simply reflect the increased proliferation of cells associated 
with liver regeneration.
1.4.2. The mammal i an O6 -me thylguanine-DNA-methvl transf erase
(06MGMT). -
An enzyme activity similar to the 06HGMT of E, coli has been 
found in a large variety of animal and human organs and tissues.
This enzyme is also referred to as 'alkyl acceptor protein' and 
'06-methylguanine-DNA-transmethylase'. Table 1.2. lists the 
various tissues reported to contain this enzyme (mostly in vitro cell 
culture systems) and also the corresponding literature reference.
Numerous methods for quantifying the activity of this enzyme 
exist but the indirect methods, rather than the direct assay 
methods, are the most frequently used. Monitoring the 
disappearance of 06MG from an exogenous alkylated DNA substrate, 
following incubation with tissue extracts or other enzyme 
preparation, is a commonly used assay. Substrates used include 
3H-methylated calf thymus DNA (Brent, 1986; Frosina and Laval,
1987), Micrococcus luteus DNA (Karran et al., 1979; Samson and 
Linn, 1987) or the synthetic polymer poly(dC.dG[3H]06medG)
(Boiteux and Laval, 1985; Foote et al., 1983). 06MG is measured by 
HPLC analysis, gel electrophoresis or by radioimmunoassay. Using 
the synthetic polymer, containing 06MG labelled in the purine 
ring, the in situ conversion of 0*MG to guanine can be followed 
(Boiteux and Laval, 1985; Foote et al., 1983; Fegg et al., 1983).
Direct methods involve the measurement of protein-bound 
radioactivity associated with the methylated (inactivated) enzyme 
(Pegg et al., 1983; Yarosh et al., 1984). Pro tease digestion and 
subsequent amino acid separation allows the amount of
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Table 1.2. Evidence for the presence of OeMGMT in mammalian tissues.
Source tissue. Reference.
Rat liver Den Englese et al., 1986; Margison et al., 1984.
Rat hepatoma Frosina and Laval, 1987; Lefebvre and Laval,
1986.
Rat kidney Foote and Mitra, 1984.
Rat lung Margison et al., 1985.
Mouse liver Bogden et al., 1981.
Mouse prostate Smith and Margison, 1981.
Mongolian gerbil Bambourschke et al., 1983.
Monkey liver Hall et al., 1985.
Human liver Hall et al., 1985; Pegg et al., 1982.
Human lymphocytes Setlow et al., 1982; Waldstein et al., 1982a.
Human skin fibroblasts Karran et al., 1982; Domoradzki et al., 1985; 
Yarosh et al., 1986.
Human brain Gerson et al., 1986.
Human foetal tissues Krokan et al., 1983.
Human placenta Yarosh et al., 1984.
HeLa cells Dolan et al., 1985; Foote and Mitra, 1984; 
Walds tein et al., 1982c.
Chinese hamster lines Foote and Mitra, 1984; Walds tein et al., 1982b; 
Margison et al., 1982.
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S-methylcysteine to be measured (Craddock et al., 1982)
The 06MGMT enzyme has been partially purified from regenerating 
rat liver (Pegg et al., 1983) and human placenta (Yarosh et al. ,
1984). The structural and kinetic properties of this enzyme are 
similar to those described for the E.coli 0®MGMT enzyme described 
in 1.2. The protein is monomeric with an estimated molecular 
weight of between 20,000 and 22,000 Daltons (Harris et al., 1983;
Pegg et al., 1983), which is close to the value of 18,000 quoted 
for E.coli (Olsson and Lindahl, 1980). There is a stoichiometric 
relationship between the amount of methyl groups removed from DNA 
and the amount of enzyme molecule used. In a similar fashion to 
the E.coli enzyme, a methyl group of 06MG, in alkylated DNA, is 
transfered to a cysteine residue on the enzyme itself. This 
results in the generation of a guanine residue and 
S-methylcysteine followed by total protein inactivation (Bogden et 
al., 1981; Craddock et al., 1982; Pegg et al., 1983; Walds tein,
1982a). The stoichiometric nature of the alkyl transfer reaction 
has allowed an approximate calculation of the number of alkyl 
acceptor sites per cell. Harris et al., (1983) estimated 10,000 to
25.000 molecules per cell in Raji human lymphoma cells, whilst 
Foote et al., (1983) found 100,000 in HeLa 0CL2 cells. Walds tein, 
(1982c) demonstrated a 3-fold increase in enzyme levels (to over
300.000 molecules per cell) after adaptive pre-treatment of the 
same HeLa cell line. In fully adapted E.coli cells, with a genome 
of 3x10® base pairs, there are approximately 3000 0®MGMr molecules 
per cell i.e. 1 protein molecule per 1x10s base pairs (Lindahl,
1982). HeLa CCL2 cells, under the same optimal adaptive conditions 
however, were shown to contain approximately 100 times as much 
enzyme , and with an approximate genome of 6x10® base pairs, a
r
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ratio of 1 protein molecule to 2xl04 base pairs is seen. There 
appears to be a 20-fold difference between bacteria and mamoalian 
cells, under adaptive conditions, in the efficiency of this repair 
process. Under non-adaptive conditions, however, the repair 
potential of each is similar if the DNA content is again taken 
into account i.e. 1 protein molecule per 1.5x10s base pairs, in 
E,coli and 1 protein molecule per 6xl04 base pairs, in HeLa cells.
Laval and Laval, (1984) reported an increase in the 06MGMT 
activity of rat hepatoma H« cells, following a single exposure to 
MNNG, MMS or EM3. MNNG pre-treatment caused an initial decrease in 
the enzyme level but de novo protein synthesis reversed this, 
resulting in a 3-fold increase over the constitutive enzyme level 
after 48 hours. MMS and EMS did not cause this initial decrease 
leading the authors to conclude that pre-treatment caused the 
measured induction rather than enzyme disequilibrium caused by 
re-synthesis. Durrant et al., (1981), using V79 cells reported no 
increase in the ability to deme thy late 0*MG following a single 
non-toxic dose of MNU.
Studies utilising in vitro mammalian cell cultures have 
revealed two opposite phenotypic characteristics with regard to 
their ability to repair alkylation damage. The Mer* phenotype is 
assigned to cells which express me thyl transf erase activity (methyl 
excision repair proficient) and the Her* phenotype to 
transferase-deficient cells (Day et al., 1980; Foote et al., 1983; 
Goth-Goldstein and Hughes, 1987a; Yagi et al., 1984). This 
phenomenon was first observed by Day et al., (1980) who defined 
this phenotype as the competence of cells to support the growth of 
MNNG-treated adenovirus 5. Mer~ cells are deficient in the ability 
to reactivate this virus but are able to reactivate UV irradiated
viruses. Cells of this phenotype also show a greater sensitivity 
to the cytotoxic effects of methylating agents compared to Her* 
cells (Day et al., 1980). The Mer phenotype appears to correlate 
with a phenotype designated Mex, which distinguishes cells that 
effect removal of 0*M5 from their DNA (Mex*), from those that do 
not (Mex') (Sklar and Strauss, 1983). The distinction between Mer* 
and Mer' (or Mex* and Mex') cells is not always clear and 
intermediate degrees of removal ability have been reported (Day et 
al,, 1980; Yarosh et al., 1983).
The observation that the ability to remove 0®M3 always 
correlated with resistance to MNNG, seemed to indicate that 0*MQ 
is a lethal lesion (Domoradzki et al., 1984). The HeLa MR cell 
variant (Mer~), which is hypersensitive to alkylation killing and 
mutagenesis, was found to repair 06MG with much lower efficiency 
than the Mer* HeLa CGL2 cell line (Baker et al., 1979; Foote et 
al., 1983). A recent study, however, showed that HeLa Mer' cells 
that have survived a highly toxic dose of MNNQ, regain Mer* 
resistance to the cytotoxic effects of MNNQ but without 
simultaneously acquiring tha ability to repair OeMQ 
(Goth-Goldstein and Hughes, 1987a). Scudiero et al., (1984) 
suggested that the two characteristics coomonly associated with 
the Mer* phenotype i.e. 06MQ repair and resistance to MNNQ, can be 
separated and the latter defined by the Rem phenotype. The Rem 
phenotye originated from the observation that some Mer* tumour 
cell strains show intermediate sensitivity to the cytotxic effects 
of MNNQ, between that of Mer* and Mer* lines. They termed these 
strains Mer* Rem~, defining the Rem phenotye by ’resistance to 
MNNG-produced cell killing’. An example of a cell line which 
corresponds to this phenotype is the human lung carcinoma line
A549, described by Yagi et al., (1984), which was found to possess 
the ability to repair 06MG lesions but was sensitive to 
MNNG-produced cell killing. In contrast, mouse mamnary tumour line 
341 lacks the ability to repair 06MG but was relatively more 
resistant to MNNQ than other Mer' lines and is therefore an 
example of a Mer* Rem* phenotype. A list of over 80 cell lines 
investigated for the Mer*/Mer” phenotype, is given in Frosina and 
Abbondandolo, (1985). The Mer designation is essentially erroneous 
since the 06MGMT protein does not actually repair methylation 
damage via an excision process. A more correct designation of this 
phenotype could be MDR, representing methylation damage repair.
1.4.3. Animal studies.
Margison et al. f (1984) have reviewed the results of a 
great nunber of studies which have been carried out on rodents, 
assessing the indueibility of the 0*MQ repair system by low doses 
of alkylating agents. The tabulated evidence was conflicting e.g. 
inducible enzyme acivity was found in rat liver but not in other 
rat tissues, and this activity was induced by a wide variety of 
N-nitroso compounds but not by directly acting alkylating agents 
such as MNU and MMS (Table 1.2. )• The enhancement of 0*MQ repair, 
as seen in rat liver, was not reproducible in other rodent models. 
The increase in 0*MQ repair capacity, however, was not exclusive 
to alkylating agents since it was found that non-alkylating, 
hepa to toxic agents e.g. 2-acetylaminofluorine (AAF), ionising 
radiation and even partial hepa tec tomy or unilateral nephrectomy 
could also stimulate 06MG repair (Cooper et al., 1982; Margison et 
sd.t 1985; Pegg and Weist, 1983).
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Table 1.3. The inducibility of 06MGMT in whole animal systems.
Tissue. Inducing
agent.
Increase in 06MS 
repair capacity.
Reference.
Rat liver DMN + Margison et al., 1985.
DMH + Bedell et al.t 1982.
DEN + Margison et al., 1980.
DPN, DBN + Margison, 1982.
AAF + Cooper et al., 1982.
AFBi + Chu et al., 1981.
MNU - Margison et al., 1980.
MMS * O'Connor and Margison, 
1981.
Rat lung DMN - Margison et al., 1985.
Rat kidney DMN - Margison et al., 1980.
Mouse DMN - Lindamood et al., 1984.
Chinese hamster DMN - Smith and Margison, 1981.
Syrian hamster DMN - Margison et al., 1985.
Mongolian gerbil DMN — Bambourschke et al., 1983.
Abbreviations: DMN = dimethylnitrosamine; DM! = 1-2-dime thylhydrazine; 
DEN = diethylnitrosamine; DPN, DBN = dipropyl- and dibutylnitrosamine; 
AAF = 2-acetylaminof luor ine; AFBi = af la toxin Bi; MNU =
N-methyl-N-nitrosourea; = methylmethanesulphonate.
1.4.4. Mutation and related effects.
1.4.4.1. Mutation.
To live and to multiply, organisms depend on the 
information encoded in their genes (the units of inheritance). The 
material of inheritance of all living organisms, with the exception 
of some viruses, is carried by deoxyribonucleic acid (DNA). The 
normal DNA molecule is a linear macromolecule consisting of a 
pair of polynucleotide strands coiled around each other in the 
form of a double helix. The two strands are held together by 
hydrogen bonds between pairs of purine (adenine (A) and guanine 
(G)) and pyrimidine (cytosine (C) an thymine (T)) bases. Base 
pairing is subject to a number of physical and chemical 
constraints allowing A to bond only with T, and G only with C 
(Figure 1.1.). The AT and GC base pairs therefore enforce 
complementarity between opposite strands of the duplex. In order 
to make identical copies of itself for eventual distribution to 
daughter cells, the two DNA strands separate to allow pairing with 
incoming complementary mono-deoxyribonucleotides. Each strand 
serves as a template for the formation of a new daughter strand by 
normal AT and GC base pairing. The replicated region of DNA 
consists of two duplexes, each having a parental strand paired 
with a newly-synthesised daughter strand. The process of 
replication is therefore semi-conservative, since each strand of 
the parental duplex is conserved as a partner to each of the 
daughter strands.
The order of bases on each template strand constitutes a 
genetic message which contains all the information necessary to 
determine the specific structure and function of that cell. In a 
complex process involving messenger RNA, ribosomes and transfer
RNA, the genetic message is translated to yield a specific 
polypeptide chain (Watson, 1976). Each amino acid component of a 
particular polypeptide is specified by a triplet of successive 
bases (a codon) in the DNA. A linear sequence of codons, which 
code for a polypeptide, is called a gene.
A gene mutation is a heritable alteration in the sequence 
or number of bases in DNA. Mutation may occur spontaneously or may 
be induced by physical or chemical agents. Gene mutation can occur 
by base substitution i.e. one base is substituted by another, or 
by deletion or addition of one or more bases from one or more 
codons. Mutations due to substituions are known as base-pair 
substituions and those due to additions or deletions as frameshift 
mutations.
Base-pair substitution mutations occur when an incorrect 
base is inserted, e.g. fay pairing with an alkylated natural base, 
which then pairs with its natural partner during DNA replication. 
In this way a new pair of incorrect bases cure inserted into DNA. 
This results in the alteration of an amino acid within the 
polypeptide gene product. When a frameshift mutation occurs, 
however, the defect in the newly-synthesised polypeptide may be 
positioned at a site crucial to the integrity of the protein e.g. 
at a folding point or active site of an enzyme. Frameshift 
mutations are usually expressed as decreases in function rather 
than by total loss, and can often be identified by this property. 
Gene mutations affecting dispensible, enzymatic functions, can be 
detected if the resultant mutant cell has a phenotypic trait which 
allows it to be distinguished from normal (wild-type) cells.
Gene mutations are classified as being either ’forward9 
(wild type to mutant) or reverse (mutant to wild type). Reverse
mutation is generally studied in mutant cells containing known 
base-pair substitutions or frameshift mutations. Normal functional 
activity can be restored to these cells by a new substitution) a 
second addition or deletion close to the original change. A 
reverse mutation, therefore, requires a highly specific-type of 
DNA interaction. The best known, i.e. the most widely used, test 
measuring reverse mutation, is the Ames test. Ames et al., (1973), 
devised a simple test for the screening of environmental chemicals 
for mutagenicity, based on the reversion of histidine requiring 
Salmonella typhimurium bacteria to prototrophy (growth factor 
independence) i.e. his- to hist.
Forward mutations may arise from substituions, additions or 
deletions of the bases of a gene. These can be detected when there 
is a change in an enzyme function resulting in auxotrophy (growth 
factor dependence), or in resistance to various chemical or 
physical agents. Genetic markers, based on forward mutations to 
drug resistance, are employed in mammalian cell mutation assays. 
The most cotnnonly used markers are resistance to the 
anti metabolite 6-thioguanine (TG) (Bradley et al., 1981; Hsie et 
al., 1981), which detects both frameshift and base-pair 
substitutions, and resistance to the steroid compound ouabain 
(Baker et al., 1974; Cole and Arlett, 1976), which detects only 
base-pair substitutions. The biochemical basis of the resistance 
to the cytotoxic actions of the purine analogue 6-thioguanine 
(TG) is well established and, has been extensively reviewed by 
Caskey and Kruh, (1979). Briefly, TG is converted into the 
nucleoside 5 *-monophosphate, thioguanosine monophosphate, by the 
enzyme hypoxanthine-guanine-phosphoribosyl-transferase 
(E.C.2.4.2.8), abbrieviated as HGPRT, present in the purine
salvage pathway. After further phosphorylation this can then be 
incorporated into nucleic acids in place of guanine. Although 
sufficiently similar to guanine, to be metabolised in an identical 
manner, TG is sufficiently dissimilar to functionally alter the 
DNA and RNA into which it is incorporated and thus causes cell 
death. Resistance to TG arises, therefore, by a deficiency or 
inactivity of the HGPRT enzyme, induced by a mutagen or another 
process, leading to the inability of the cells to metabolise this 
exogenous purine (Hsie et al., 1975). The biochemical basis 
underlying cellular resistance to ouabain, is discussed later in
4.2.
Chromosomal mutations, usually referred to as chromosomal 
aberrations, are much less delicate than gene mutations and are 
recognised as morphological alterations in the gross structure of 
chromosomes. In eukaryotic cells, many of the aberrations are 
observable by microscopic examination of fixed and stained 
metaphase cells. Aberrations include deletions, duplications and 
inversions of sections within chromosomes, and exchanges (or 
translocations) of sections between chromosomes. The more subtle 
changes are easily seen if the chromosomes are stained in special 
ways e.g. G-banding. Mutagen-induced sister chromatid exchanges 
(SCE) can be visualised by the FPG technique (Perry and Wolff, 
1974) described in Chapter 7.
Numerical chromosome aberrations i.e. genomic mutations, 
involve changes in the number of chromosomes in the genome (ploidy 
changes). Such changes can result in polyploid genomes, where the 
normal diploid (euploid) genome is doubled or trebled. Loss or 
gain of a single chromosome is known as aneuploidy and may occur 
as a result of non-disjunction during cell division. Addition or
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deletion of a single chromosome results in conditions called 
trisomy and monosomy, respectively.
1.4.4.2. N-methyl-N1 -nitro-N-nitrosoguanidine (MNNG).
As previously mentioned, alkylating agents represent the 
largest class of mutagens present in the human environment 
(Fishbein et al., 1979). Chemicals comprising a large proportion 
of this class are the N-nitroso compounds. Therefore to investigate 
the effect of long-term exposure of cells to N-nitroso compounds, 
and consequently the possible induction of the adaptive response, 
the simple monofunctional alkylating agent MNNG was chosen as a 
representative compound of this group. MNNG was the mutagen used 
by Samson and Cairns, (1977) in their initial studies into 
the adaptive response of E.coli. It has been used subsequently in 
in vitro studies into the mammalian adaptive response (Frosina and 
Laval, 1987; Lefebvre and Laval, 1986; Samson and Schwartz, 1980). 
One other reason for the choice of this mutagen was the fact that 
it does not need an energy-requiring cellular metabolic process to 
produce a reactive metabolite (metabolic activation) (Singer,
1979). This characteristic was attractive since it simplified the 
experimental aspects of mutagen dose administration, particularly 
during adaptive pre-treatment (Chapters 3 to 7).
MNNG is capable of inducing gene mutations in bacteria, 
yeast and mammalian cells (Auerbach, 1976; Kao and Puck, 1968; 
O’Neill et al., 1977). It also induces structural and numerical 
chromosome aberrations in mammalian cells (Kao and Puck, 1969) and 
is a potent carcinogen (McCann et al., 1975). MNNG is a 
monofunctional alkylating agent which is able to donate a single 
methyl group to nucleophilic sites within a biological
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Most N-nitroso compounds, including MNNG, exert their 
biological effects via a highly reactive carbonium ion i.e. an ion 
in which one carbon atom has three bonds and possesses a positive 
charge. MNNG requires a thiol or primary amine to displace its 
carbonium ion i.e. the methyl diazonium ion (Lawley and Thatcher, 
1970). This ion preferentially reacts with weakly nucleophilic 
centres in DNA and RNA, such as oxygen atoms, over strongly 
nucleophilic centres such as nitrogen atoms (Grisham and Smith, 
1984). Figure 1.2. shows the position of DNA and RNA atoms 
susceptible to methylation by MNNG and also a suggested schematic 
respresentation of some possible chemical reactions of this 
compound with cellular constituents (Grisham and Smith, 1984). 
Besides methylating DNA and RNA, MNNG can cause carbamoylation of 
cellular proteins via the N-nitroguanido moiety (McKay, 1948) and 
has been shown to inactivate DNA polymerase by carbamoylation 
(Drahovsky and Wacker, 1975). Guanidation has been suggested as the 
cause of methylation induced malfunction of other enzymes (Kann 
et al., 1974), including DNA repair enzymes.
Alkylation of DNA can produce potentially miscoding
3 1
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(mutagenic) lesions and potentially lethal lesions. 06alkylG and
04-alkyIT probably represent the most important DNA lesions with 
respect to the induction of gene mutations, and cancer, by simple 
alkylating agents such as MNNG (Fox and Carlton, 1984; Lawley, 
1974; Singer and Kusmierek, 1982). These alkylated bases almost 
certainly undergo mispairing with thymine and guanine, 
respectively, to generate GC to AT and AT to GC base-pair 
transitions (Drake and Baltz, 1976; Murray, 1987). Alkylation at 
the N7 and N3 position of guanine and the N3 of adenine have been 
correlated with the lethality of MNNG (Karran et al., 1982;
Lawley, 1974). Some potential MNNG-induced alkylations, which are 
likely to lead to mispairing events, are shown in Figure 1.3. MNNG 
may also induce mutation indirectly by a misrepair mechanism, 
which occurs when a pre-rautational lesion interrupts daughter 
strand elongation during DNA replication (Drake and Baltz, 1976). 
The gap produced in the daughter strand becomes a substrate for an 
enzymic, error-prone post-replication DNA repair mechanism 
(Heidelberger, 1975; Hart et al., 1978). When these gaps are 
filled either base-pair substitutions or frameshift mutations can 
be generated.
1.4.3. Mutagenic adaptation.
The results of experimental work to establish whether 
mammalian cells in culture possess a mutagenic adaptive response, 
analogous to that found in E.coli, have so far been conflicting. 
The interpretation of results obtained from a range of mutagenic 
end-points and the use of different adaptive pre-treatment 
protocols, is further complicated by the use of a wide variety of 
cell types. Mutagenic end-points so far used to assess the effect
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Abbreviations: 06MG = 06-methylguanine; 04MT = 04-methylthymine;
3MG = N3-methylguanine; 7MG = N7-methylguanine;
3HA = N3-methyladenine; G = guanine; C = cytosine;
\
T = thymine.
of mutagen adaptive pre-treatment on cells are SCE induction) 
forward mutation to 6-thioguanine resistance (HGPRT* to HGPRT“) or 
ouabain resistance (OuaB), reverse mutation to HAT resistance 
(hypcocanthine, aminopterin and thymidine resistance , HQPRT" to 
HGPRT+), induced chrcmosome aberrations and micronuclei induction.
The first indication that mammalian cells possess a 
mutagenic adaptive pathway was shown by Samson and Schwartz,
(1980) who reported that MNNG pre-treatment caused a decrease in 
SCE and cell killing in CHO cells, on subsequent challenge with 
MNNG or MNU. SCE were also decreased in the SV40-transformed 
human cell line, GM637. Further to this work many authors reported 
results which suggest the presence or absence of a mutagenic 
adaptive resonse in cultured cells. Evidence contradicting the SCE 
findings of Samson and Schwartz has not yet been put forward for 
CHO cells, but a single MNU pre-treatment of V79 cells did not 
alter the MNU-induced SCE (Fax et al., 1982b). Kaina, (1982), 
using V79-C10 cells, reported that a substantial decrease in the 
frequency of MNNG or MNU induced 6-thioguanine resistant mutants 
was caused by pre-treatments with single low doses of the same 
agents. Reduction in MNNG-induced killing was reported in the H« 
rat hepatoma line following pre-treatment with multiple, non-toxic 
doses of MNNG (Laval, 1986; Laval and Laval, 1984). The same 
pre-treatment protocol caused a marked increase in the ability of 
these cells to remove 06MG from their DNA. Schwartz and Samson, 
(1983), using the pre-treatment schedule that had previously 
lowered the induced SCE frequency, showed a lack of mutagenic 
adaptation in CHO cells. Further negative evidence was produced by 
Durrant et al., (1981), who demonstrated no change in the MNU 
induced mutation to 6-thioguanine resistance in V79 cells
following a single pre-treatment dose of MNU. Both observations 
were later confirmed by Frosina et al., (1984) who subjected cells 
to 49 different pre-treatment protocols and a variety of 
pre-treatment and challenge mutagens. Fox et al. , (1982a) reported 
no change in the MNU-induced mutation to ouabain resistance of V79 
cells pre-treated with a single dose of the same mutagen. The same 
group later reported a decrease in MNNG or hMS-induced mutation to 
HAT* of HGFRT" V79 cells, pre-treated with a single dose of either 
MNNG or MMS (Fox and Carlton, 1984). Since V79 cells have been 
shown to lack the 06MGMT enzyme (Foote et al., 1983; Foote and 
Mitra, 1984), the authors did not interpret their results in terms 
of the induction of this enzyme, but instead suggested that if
04-methylthymine was responsible for the mutational event, then 
adaptive re-synthesis of an enzyme specific for this lesion could 
be induced so explaining the reduction in mutation frequency.
Reduction in the induction of chromosome aberrations and 
cytotoxicity were found by Kaina, (1982) who, in a later 
publication, showed induced aberrations were reduced to a maxiimm 
of 50% less than control values following MNNG or MNU 
pre-treatments (Kaina, 1983a).
Karran et al., (1982) were unable to show adaptation to 
MNU-induced micronuclei formation and cytotoxicity in GM730 normal 
human fibroblasts after MNNG pre-treatment.
1.5. of the present study.
Following the discovery and characterisation of the 
bacterial adaptive response, a number of questions were raised 
concerning the existence of a similar response in mammalian cells 
(1.1.). The data currently available for in vitro cultures are not
sufficient to answer these questions* Far from answering them, two 
more pertinent questions have been raised during the course of 
these studies; i) are the discrepancies reported due to different 
experimental protocols used, and 2) are the contrasting results 
due to the different cell types used ?.
A nixnber of workers have stressed the importance of the 
inductive schedule (Durrant et al., 1981; Karran et al., 1982; 
Laval and Laval, 1984). However, even when the same schedule had 
been used, contrasting results were still obtained (Frosina et 
al., 1984; Kaina, 1982). Laval and Laval, (1984) suggested that 
pre-treatment for a long period (8 doses over a 48 hour period) 
was necessary for the induction of an adaptive response but the 
results of Kaina, (1982, 1983a, b), who induced adaptation 
following a single mutagen dose, suggested otherwise.
The diverse origins of cell lines like Chinese hamster CHO 
and V79 cells, rat H4 hepatoma cells and human tumour lines may be 
explanation enough for the contrasting results. However, when the 
same cell line was used in three different laboratories (Fox et 
al., 1982a; Frosina et al., 1984; Kaina, 1982, 1983a, b) 
conflicting results were again obtained. Baker et al., 1979 
reported that HeLa cell clones differ in sensitivity to 
monofunctional alkylating agents and offered a possible 
explanation for the inter-cell line discrepancies i.e. some 
sub-clones of some cell lines have lost the ability to remove 06MGr 
from their DMA __
The overall aim of this project, therefore, was to compare 
the adaptive response in V79 and CHO cells subjected to adaptive 
protocols which had previously been shown to induce this response 
in each line. In this way differences in cell line and adaptive
pre-treatment protocol could be ruled out as a reason for the lack 
of an observed response. Further to the suggestion of Baker et 
al., (1979), cell clones that are either sensitive or resistant to 
the cytotoxic action of MNNG would be isolated, for both cell 
lines, and the effect of adaptive pre-treatment on these cell 
lines assessed. The techniques employed throughout this project 
would be those previously used to define the mammalian response 
and included MNNG-induced cytotoxicity, mutation to ouabain 
resistance, SCE and the OeMG de-methylation ability of cell-free 
extracts. Correlation of these factors, therefore, should assist 
the fuller understanding of the adaptive response in 
these mammalian cells.
The widespread use of both CHO and V79 cell lines in the 
mutagenicity testing of industrial, pharmaceutical and 
manufacturing compounds (Venitt and Parry, 1984), also influenced 
the choice of cell lines for the present studies.
Note in proof.
Since this introduction was written a significant review 
concerning the nature of the E.coli 06MGMT enzyme has been 
reported by Lindahl, (1987). The protein was found to contain two 
functional activities which could be physically separated after 
treatment with low concentrations of trypsin. The C-terminal half 
of the protein serves to repair 0*MG residues in DMA and accounts 
for the anti-mutagenic effect of the adaptive response. The 
N-terminal half of the protein can also abstract an alkyl group 
from modified DNA but does so from phosphotriester lesions. The 
intact enzyme has a molecular weight of 39,000 Daltons with the 
C-terminal half having a weight of 19,000 Daltons.
Lindahl, T. (1987), Br. J. Cancer. 56. 91-95.
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CHAPTER 2. MATERIALS AND METHODS.
2.1. Eguiment.
Laminar flow hood* During the course of this work two 
different flow hoods were used for all aseptic manipulations.
(i) 2m, horizontal displacement type (Fell Clean Air (1971) Ltd., 
Newhaven, Sussex.).
(ii) 1.3m, vertical displacement type, Class II biological safety 
cabinet, Microflow model no. 20229 (MDH Ltd, Andover, Hampshire).
The surfaces of hoods were washed with 70% ethanol before 
and after use.
Incubator.
LEEC PF2 anhydric incubator with forced air circulation 
(Laboratory and Electrical Engineering Company, Nottingham). The 
thermostatic controls were adjusted to maintain a temperature of 
37.5±1°C.
Centrifuges.
(i) Beckman bench centrifuge model No. TJ-6 (Beckman Industrial 
Estate Mervue, Galway, Ireland. )•
(ii) MSE Micro Centaur (MSE Scientific Instruments, Crawley,
Sussex.)•
Adjustable replicating pipettes.
Pipette Effective Volune range
Gilson Pipetman P20 2-20 pi
Gilson Pipetman P200 20-200 pi
Gilson Pipetman P1000 200-1000 pi
Gilson Pipetman P5000 1000-5000 pi
Pipettes with disposable polypropylene tips were obtained from
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Anachem Ltd., Luton, Beds. Pipettes were periodically checked to 
ensure accurate and reproducible sample delivery. A gravimetric 
method was used in which 10 replicates of a set volume of water at 
20°C were each weighed on an analytical balance.
Liquid nitrogen freezers.
Two types of storage unit were used to house the 2 ml 
polypropylene ampoules containing the stock cultures.
(i) Union Carbide model No. LR-33-10 (Union Carbide UK, Ltd., 
Cleveland.), in which the ampoules are held in the liquid N2 
refrigerant or in its overlying vapour.
(ii) Union Carbide model No. LR-40, in which the ampoules are shelved in 
the vapour phase of the liquid N2.
Freezing unit.
Union Carbide BF-6 biological freezer, a plug-type device, 
designed for use with the LR-33-10 freezer. This unit is capable 
of cooling up to eight 2 ml ampoules, to below -70°C, at a cooling 
rate of between 0.5°C and 7°C min"1.
Haemocytometer.
Standard double grid improved Neubauer-type blood cell 
haemocytometer, with coverslips (Fisons Ltd., Loughborough,
Leics.)•
Microscopes.
(i) For examination of growing cell cultures under phase
contrast an inverted biological microscope Wild M40 (Wild 
Heerberg Ltd. ,Heerberg, Switzerland) was used. This
instrument fitted with appropriate condensers and xlO and 
x20 objectives gives magnifications of xl87 and x375 
respectively.
(ii) For haemocytometer and other cytological preparations an 
Amplival microscope with mf basic body and 35nm camera 
attachment (Carl Zeiss Jena, CZ Scientific Instruments Ltd, 
Borham Wood, Herts), was used. With fitted condenser and 
both plain and phase-ringed plane field objectives (xl6, x40 
and xlOO), this instrument allows transmitted light and 
phase-contrast microscopy at magnifications of x256, x640 
and xl600.
(iii) Binocular dissecting microscope. Standard microscope model 
(C.Baker Ltd., London), which allows magnification at x20.
Disposable Cell Culture Plasticware.
Tissue culture (T/C) grade disposable plasticware was 
obtained pre-sterilised from Sterilin Ltd., Feltham, England.
Items used: 25cm2 and 75cm2 T/C flasks, lOQom x 16mm T/C tubes 
with screw caps, 50mm x 13mm and 9Oran x 16mm T/C petri dishes with 
triple vents.
2 ml polypropylene screw-capped ampoules, for liquid N2 
cell storage, and 30ml universal containers with caps were 
obtained pre-sterilized from Sterilin Ltd.
Glassware.
100ml and 500ml bottles for the storage of solutions and 
media were obtained with caps from Flow Laboratories Ltd., 
Rickmansworth, Herts.
150ml and 500ml soda glass ’medical* flat bottles and caps,
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and general laboratory glassware were obtained from Fisons Ltd.
2.2. Cell Lines.
(i) CH0-K1: a L-proline requiring Chinese hamster cell line 
~ (Kao and Puck, 1968) were isolated and characterised by
R. S. Dewdney (1982). Genetic heterogeneity is markedly reduced 
in cell populations derived from single, cloned cells (Ham 
and Puck, 1962). These cells were used in experiments between 
passages 30 and 40.
(ii) CHO-K1S: an MNNG-sensitive sub-clone of CHO-K1, isolated 
as described in 5.3.2.
(iii) CH0-K1R: an MNNG-resistant sub-clone of CH0-K1, isolated 
as described in 5.3.1.
(iv) V79-379A: a sub-clone of V79-1, male Chinese Hamster lung
fibroblasts (Ford and Yerganian, 1958), were obtained from
Flow Labs Ltd. These were obtained at an unknown passage 
number and so were arbitrarily designated at passage 2 , and 
were used between passage 2 and 12 in experiments.
(v) V79-379A/S: an MNNG sensitive sub-clone of V79-379A, 
isolated as described in 5.3.2.
(vi) V79-379A/R: an MNNG resistant sub-clone of V79-379A
isolated as described in 5.3.1.
(vii) C3H 10T1/2 : mouse embryo fibroblasts originated in Charles
Heidelbergers laboratories in Los Angeles (Reznikoff et al., 
1973), were kindly provided by Dr.T.Meyer (Shell Research, 
Sittingboume, Kent). Cells were received at passage 10 and 
used in experiments between passages 10 and 2 0.
Paul, (1975) outlined the problem of cellular cross
-contamination whilst maintaining more than one cell line within a
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laboratory. Great care was therefore taken to maintain the purity 
of the cultures throughout these studies by avoiding simultaneous 
handling of different cell lines, and by sequestration of media 
for use with individual cell lines.
2.3 Cell Culture Materials.
2.3.1. Water.
Double glass distilled water (DDH2O) was used in the 
preparation of all solutions and media. This was produced by a 
6kW, 4.5 litre hr-1 bi-distillation Fi-stream still, model 2903 
(Fisons Ltd.) fitted with a Fi-stream pre-deioniser (Fisons Ltd). 
DDH2O was sterilised by autoclaving at 121°C for 15 minutes in 
100ml and 500ml volumes. Sterile distilled water produced in this 
way has a pH of 4.5.
2.3.2. Balanced salt solution.
Dulbecco's phosphate buffered saline was routinely used, 
either with or without added calcium or magnesium ions. Solutions 
were designated either PBS or PBS(A) respectively.
Composition: (Dulbecco and Vogt, 1954)
Component gl"1 DDH2O
NaCl 8
KC1 0.2 PBS(A) PBS




Sterile PBS (A) was prepared by dissolving one Dulbecco A
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tablet (Qxoid Ltd,London) in 100ml of freshly prepared DDH2O and 
autoclaving for 15 minutes at 121°C* PBS was prepared by the 
aseptic addition of 0.5ml Dulbecco B solution (Oxoid Ltd.) to 100 
ml of sterile FBS(A). Both PBS and PBS(A) were stored at room 
temperature, for a maximum of one month.
2.3.3. Trypsin solution.
Trypsin (tryptic activity 1:250*) was obtained as a 2.5% w/v 
solution in Hanks balanced salt solution without calcium, 
magnesium or phenol red in pre-sterilised 100ml unit quantities 
from Flow Labs Ltd. This was aseptically diluted to working 
strengths of 0.025% w/v plus 0.02% w/v EDTA (Sigma) or 0.1% w/v 
plus 0.02% w/v EDTA, with PBS (A). (Working strengths quoted relate 
to CHD/V79 cell lines and the C3H IOTV2 cell line respectively).
All solutions were stored at -20°C in approximately 16ml volumes 
in plastic universals and used within one month. Prior to use the 
solutions were thawed in a 37°C water bath.
(* 1:250 : one part of trypsin will convert 250 parts of casein to 
peptides, peptones and amino acids under the conditions of the US 
National Formulary assay for pancreatin (Vol 14, 1975)).
2.3.4. Additives for Cell Culture Media.
(•i) Antibiotic solution: Penicillin (5000 IU ml"1) and
streptomycin (5000 pgml"1) was obtained as a sterile solution from 
Flow Labs Ltd in 100ml unit quantities. This was sub-divided into 
15ml volumes and stored *. in plastic universals at -20°C for 
a maximum of one year.
(ii) L-glutamine: was obtained as a sterile 200mM solution in
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100ml quantities from Flow Labs. Ltd. This was sub-divided into 
15ml volumes and stored in plastic universals at -20°C for a 
maxi mum of one year.
(iii) L-proline: a lOOmM solution was prepared from chromatographically 
homogenous L-proline (cell culture tested, Sigma chemicals Ltd., 
Poole, Dorset) in DDH2O, and sterilised by'membrane filtration. 
15ml volumes of this solution were stored in plastic universals at 
-20°C for a maximum of one year.
(iv) Ethylene diamine tetra acetic acid (EDTA, versene): a 2% w/v 
solution of EDTA (Sigma Chemicals) was prepared in DDH2O and 
sterilised by membrane filtration. 15ml volumes of this solution 
were stored in plastic universals at -20°C for a maximum of six 
months.
(v) Sodium bicarbonate: was obtained as a sterile 7.5X w/v 
NaHOC>3 solution in 100ml quantities from Flow Labs Ltd. This 
solution was stored at room temperature for a maximum of one year.
(vi) Hypoxanthine (6-hydroxypurine): 81.6mg of hypoxanthine,
(minimum assay 99%, BDH Chemicals), were dissolved in 50ml of 
boiling DDH2O, made alkaline with 2 drops of concentrated 
ammonium hydroxide solution and made up to a final volume of 
1 litre with DCH2O. The final solution (0.6mM) was filter 
sterilised, divided into 100ml volumes and stored at 4°C 
protected from light.
All solutions stored at -20°C were thawed in a water bath
at 37°C immediately prior to use.
2.3.5. Media.
(i) Hams F10 medium: was obtained from Flow Labs Ltd. as a sterile 
lOx liquid concentrate containing phenol red but lacking 
L-glutamine and NaHOOa. The concentrate was received in 500ml 
units and split into 100ml aliquots and stored at 4°C for a 
maximum of one year. 500ml volumes of single strength media were 
aseptically prepared from the lOx concentrate plus the media 








NaHOOa (7.5% w/v) 8ml
Cnee prepared the medium was stored in 100ml volumes at 4°C and 
used within four weeks.
(ii) Hams F10 medium lacking hypoxanthine, thymidine and NaH003: 
was obtained in powder form from Flow Labs Ltd. and stored at 4°C 
in a vacuum desicator. Powder to prepare one litre of single 
strength medium was added to approximately 900ml of freshly 
colected DDH2O at room temperature. The powder was allowed to 






NaH003 ( 7.5% w/v) 16ml
The medium was made up to 1 litre with DDH2O, rendered slightly 
acidic by bubbling OO2 through it, then sterilised by positive 
pressure membrane filtration (2.5.1.)* The sterilised medium was 
stored in 100ml volumes at 4°C and used within four weeks.
Note: Storage conditions and maximum storage times for cell 
culture materials above were those recommended in the Flow 
Laboratories catalogue.
2.3.6. Sera.
For the Chinese Hamster cell lines studied the culture 
medium was supplemented with 5% foetal calf serum (PCS), whereas 
the mouse C3H IOTV2 line was grown in medium supplemented with 
10% PCS. To achieve levels of 5% or 10% either 5.3ml or 11.1 ml, 
of FCS, respectively, added to 100ml of medium immediately prior 
to use.
During the course of these studies PCS from two different 
batches was used. Both serum lots were obtained from Sera TAha 
Ltd., Crawley, Sussex, and selected for the ability, as a media 
supplement, to support clonal growth. Assessment of serum 
suitability, involved dilution plating of small numbers of CHO-K1 
cells (2.6.7.) into T/C petri-dishes containing media supplemented
47
with different batches of test serum. Following 7 days incubation 
the colonies formed were stained, scored and a batch comparison 
made on the basis of relative colony size and plating 
efficiencies. Using these criteria, two batches were chosen from a 
total of six test batches supplied by Sera Labs Ltd.
Batch 1 : Sera Labs batch number 301110
Batch 2 : Sera Labs batch number 404010
Both serum batches were obtained filter sterilised, frozen 
in 500ml bottles which were allowed to thaw at 4°C, then 
sub-divided into 100ml volumes. These were stored frozen at -20°C 
for a maximum of 18 months. As required, 100ml volumes were 
withdrawn from stock and allowed to thaw at 4°C. Once thawed the 
serum was stored at 4°C and used within four weeks.
2.3.7. Cryoprotectants and Solvents.
(i) Glycerol, AnalaR grade (Fisons Ltd) was stored at room 
temperature, protected from moisture. Prior to use as a 
cryoprotectant, 2-3ml volumes were sealed in glass powder 
ampoules and sterilised in a hot air oven 160°C for one hour.
(ii) Dimethyl sulphoxide (DMSO), grade 1 (Sigma) was obtained in
100ml quantities and stored in tightly capped bottles at room 
temperature. DMSO was filter sterilised through 0.2 pm Millex-FG 
filter units.
(iii) Acetone, hplc grade (Fisons Ltd) was stored at room 
temperature, protected from moisture.
2.3.8. Biological Stains.
(i) Methylene blue (BDH Chemicals) was prepared as a 0.5% w/v
solution in 50% v/v methanol. It was used to stain mammalian cell
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colonies attached to T/C plates.
(ii) Giemsa stain, Improved R66 solution (Hopkin and Williams, 
Chadwell Heath, Essex.), was used as a 5% w/v solution in 
Sorensens buffer pH=6 .8 , for the differential staining of sister 
chromatids. —
2.4. Mutagen and Mutation Selecting Agent.
2.4.1. N-roethyl-N*-nitro-N-nitrosoguanidine (MNNG).
This was obtained in crystalline form (Sigma) and stored in 
. a desiccator at -20°C. Stock solutions of 1 mgml" 1 (6 .8mM) 
(solubility limit 4 mgml”1 (27mM)), were prepared by dissolving 
the solid in a small volume of acetone, not exceeding 0.5X v/v of 
the final volume, then making up to the required amount with 
DDH2O. 10ml aliquots were sterilised by passage through 0.2 pm 
Millex-GS filter units. This solution was stored at -20°C, in 
darkness. Immediately before use stock solutions were thawed in a 
37°C water bath and dilutied with sterile DEH2O.
2.4.2. Ouabain. (G-strophanthin).
This was obtained as ouabain octahydrate crystals (Sigma) and 
stored at room temperature. Stock solutions were made at lOmM in 
culture medium by dissolving at 50°C, protected from light.
Solutions were sterilised by membrane filtration, stored in the 
incubator at 37°C and used within 48 hours. 1ml of the stock 
solution was added to each selection plate with 9ml medium to give 
a final concentration of lmM.
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2.5. General Methods.
2.5.1. Sterilisation by Membrane Filtration.
Heat-labile liquids, solutions and media were sterilised by
membrane filtration.
(i) Small volumes were filtered through autoclave-sterilsed 25mm 
Swinnex units (Millipore UK Ltd., London), fitted with 0.2 pm 
pore size Sartorius membrane filter discs, (V.A.Howe and Co.
Ltd., London.).
(ii) Small volumes of hazardous solutions were filtered from 
luerlocked syringes through disposable Millex-GS units 
(Millipore), fitted with membrane filters of 0.2 pm pore size.
(iii) Non-aqueous solvents, e.g. DMSO, incompatible with cellulose 
nitrate filters, were filtered through disposable Millex-PG units 
(Millipore), fitted with Fluoropore hydrophobic membrane filters 
made of polytetrafluoroethylene (PTFE).
(iv) Large volumes of solutions and media i.e. greater than 
250ml, were filtered from a positive pressure apparatus 
SM16616/80 (Sartorius GmbH, Gottingen, FRG.), through an 
autoclave-sterilised 47mm Swinnex unit fitted with an AP25 
pre-filter (Millipore) and a 90mm, 0.2 pm pore size membrane 
filter enclosed in a sterile Sartorius filtration tripod 
unit type SM16260. Filtration under positive pressure rather 
than negative pressure was preferentially used as it 
prevents frothing and reduces the loss of CO2 from 
bicarbonate containing media.
2.5.2. Recycling of Glassware.
Immediately after use all glassware was rinsed with tap water,
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and} except for pipettes, processed as follows.
(i) Soaked in a hand-hot 2% v/v solution of RBS25 detergent (Fisons Ltd.) 
for 30 minutes.
(ii) Thoroughly cleaned, using China brush on all surfaces,in running 
water.
(iii) Rinsed in three changes of tap water, being left for 30 minutes 
in the last rinse.
(iv) Rinsed in three changes of distilled water, again leaving for 
30 minutes in the last rinse.
(v) Finally, all articles were rinsed and left for at least 30
minutes in a large volume of freshly collected glass distilled water.
(vi) After drying in a hot air oven at 160°C, all items were 
foil-capped and sterilised in a hot air oven at 160°C for a 
minimum of one hour. Graduated glass pipettes were rinsed in 
a pipette washer with tap water, for at least 30 minutes, 
and then rinsed as above, from (iii). After drying in a hot 
air oven, pipettes were put into metal canisters and 
sterilised at 160°C for a minimum of one hour.
2.5.3. Recycling of Tins. Bottle Cans and other Non-glass items.
Immediately after use these were rinsed with tap water and 
cleaned by boiling in three changes of single distilled water.
After this they were rinsed as for glassware (from 2.5.2 (iii)).
After drying in a warm oven at 55°C, all items were sealed in 
autoclave bags (DRG Hospital Supplies, Bristol) and sterilised by 
autoclaving at 121°C for 15 minutes.
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2.5.4. Siliconising of Pasteur Pipettes.
Pasteur pipettes were siliconised by a double rinse with a 
2% w/v solution of dimethylchlorosilane in 1 ,1 ,1-trichloroethane 
(BDH Chemicals, Poole, Dorset.). After drying in a hot air oven at 
160°C they were immersed in a large volume of freshly collected 
distilled water for a minimum of 30 minutes to remove any trace 'of 
hydrochloric acid formed in the treatment. After drying the now 
siliconised pipettes were put into metal canisters and sterilised 
in a hot air oven at 160°C for a minimum of one hour.
2.5.5. Gases and Gassing procedures.
(i) Cylinders of N2 , CO2 and 5% CO2 in air mixture (5% OO2 and 
20% O2 in N2) were all obtained from British Oxygen 
Company, Bristol. CO2 and 5% OO2 in air mixture were piped 
to each work station from a central holding reservoir.
(ii) Gas flowmeter, floating needle type, 0.1-1.0 lmin”1
(Rotameter Manufacturing Co. Ltd., Croydon) calibrated for use with 
CO2.
(iii) Incubation boxes, rigid clear plastic boxes, 3.25 litre 
volumes (A. Gallenkamp and Co. Ltd., London.).
(iv) Gas-tight tape, British standard vinyl tape, 2.5cm wide (Intech Tapes 
Ltd., Manchester).
The cell culture media used contain a bicarbonate pH buffer 
system. When sodium bicarbonate dissociates CO2 is released into 
the atmosphere with a resultant increase in alkalinity. It is 
possible to control this reaction by artificially supplying carbon 
dioxide to the atmosphere and preventing the gas from leaving the 
liquid, thus reducing the hydroxyl ion concentration. To achieve 
this, all gas-tight culture flasks were charged with a 5% CO2 in
air mixture, introduced at a low flow rate through a sterilised 
Pasteur pipette plugged with non-absorbent cotton wool. Cell 
culture dishes were placed in incubation boxes which were flushed 
with 150ml of CO2 from a metered supply, again through a plugged 
Pasteur pipette. The boxes were then sealed with gas-tight tape. 
When only a few plates were put into a particular box an open 50ml 
beaker of sterile water was included to prevent excessive 
evaporation of the culture medium.
2.6. Cell Culture Methods.
2.6.1. Maintenance of Cell lines.
The Chinese hamster lines used in these studies are all 
capable of growth attached to glass surfaces. Stock cultures were 
routinely maintained in Hams F10 medium in sterile 150ml clear, 
soda-glass ’medical* flat bottles at 37°C. Cultures of mouse C3H 
10T1/2 cells were maintained in 75cm2 T/C plastic flasks 
(Sterilin) as their ability to attach and grow on glass was poor. 
Under these conditions cells grew as a monolayer on the bottom of 
each horizontally placed vessel.
Cultures were not allowed to reach a point were cells were 
released from a confluent monolayer, since this can lead to an 
increased heterogeneity within the cell population. The routine 
sub-culture protocol, designed to keep cells in a state of 
exponential growth (4.3.1), never allowed the culture to reach 
complete confluence (2.6.4).
2.6.2. Preparation of Cell Suspensions from Monolayer Cultures.
The essential procedure in the maintenance of cells in
culture is sub-culture, a process involving the transfer of cells
from one culture vessel to another* For monolayer cultures 
attached to glass a suspension of cells must first be obtained. 
Once in suspension, cells can also be greatly diluted and plated 
allowing colonies to arise from single cells, a procedure 
fundamental to many experiments.
Prior to sub-culturing, cells in glass bottles were 
examined by naked eye. For routine sub-culture the medium was 
required to be clear, with no floating cellular debris, and not 
unduly acidic or basic as indicated by the phenol red component
(orange through red to purple; acid to alkali). Cellular growth of
more than 5OX confluency was acceptable for experimental use.
Where cultures were grown in plastic T/C flasks examination of 
cell growth under phase contrast microscope was possible. For 
these cultures cells had to have a normal appearance i.e. either 
epithelioid or fibroblastoid, depending on the cell type, with no 
refractile granules in the cytoplasm. If a particular culture
failed to fulfil these requirements it was discarded.
The medium was removed from the culture and the monolayer 
rinsed with 5ml trypsin solution (2.3.3.). This was discarded and 
replaced with 1ml of fresh trypsin solution. The culture was 
incubated for either 5 min (CHO-K1 and C3H IOTV2 cells) or 3 min 
(V79-379A cells) at 37°C and then agitated to release the cells 
from the monolayer. The cell suspension was aspirated with a 
sterile Pasteur pipette, added to 5ml of serum-containing medium 
in a T/C tube, and sedimented by centrifugation. Although the Ca2 + 
and Mg2* present in culture medium and serum provide some 
protection against the deleterious effects of the enzyme, 
re-suspension of the cells in typsin-free medium reduces its 
carry-over into fresh cultures.
The same method was used for the preparartion of cell 
suspensions for all cell lines employed during this study, 
although the composition of trypsin solution was varied (2.3.3.).
2.6.3. Determination of Cell Density.
This was achieved by haemocytometer count, a method which 
also allows the visual examination of the cells prior to 
experimentation. Cells were thoroughly mixed before a small volume 
was withdrawn from just below the surface of the suspension, and 
introduced into the haemocytometer chamber. Each chamber is 
divided into nine large squares by triple white lines. The four 
corner squares cure divided into 16 squares. A total count was 
performed on eight large squares of the haemocytometer grid, (i.e. 
double chambered haemocytometer, 2 .1 .), under a phase contrast 
microscope. If cell clumping was observed, the count was 
disregarded, and the suspension aspirated to break up the clumps 
and a new sample taken. If the cell density was greater than 150 
per large square, at which point counting becomes impeded by 
crowding, the suspension was further diluted and a repeat count 
was made. Conversely, if a very low cell density (<25 per large 
square) was observed, the cells were concentrated by 
centrifugation (1000 rpm for 5 min, Beckman TJ-6 ) and resampled.
The large squares each have an area of Iran2. When the 
coverslip is pressed down over the grid , so that interference 
patterns appear, the depth of the chamber is 0.Iran. The total 
volume over each large square is therefore:
1 x 1 x 0.1 = 0 .Iran3 = 0 .0001cm3 = 10~4 ml
Hence total cell count per ml i.e. cell density, is given by:




Cells were sub-cultured, at low inoculation densities, at 
least three times a week to maintain cultures in a state of active 










Aliquots of counted cell suspensions were added to 15ml 
volumes of culture medium, pre-warmed to 37.5°C, in standard 150ml 
'medical1 flat bottles and the cells evenly distributed by gentle 
agitation. Culture bottles were then purged with 5% 002 in air for 
10-15 secs, capped tightly and returned to the incubator. Bottles were 
incubated flat to present the maximum surface area for growth. 
Photo-products, cytotoxic to mammalian cells, are known to be formed 
from certain media components (Wang et al., 1974), therefore cultures 
were incubated in the dark. When a culture was required for use 3 
days later 2x1 0s cells were inoculated, and for use 2 days later,
5x10s cells were inoculated.
2.6.5. Cell Storage.
Cells were routinely stored frozen in liquid N2 , or its 
overlying vapour, in the presence of a cryoprotectant. Either 5%
DMSO v/v or 8% v/v glycerol were used as cryoprotectants. No
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differences to the subsequent recovery of cells was observed with 
either compound.
Cells for storage were required to be in an actively growing 
state and hence a cell suspension was prepared from a culture 
ready for routine sub-culture. The cell density was determined and 
the suspension adjusted to a final cell density of 5xl05 cell ml"1 
in medium containing the required volume of cryoprotectant. After 
thorough mixing, 1ml volumes were immediately distributed into 2ml 
screw-capped polypropylene ampoules. Batches of 8 ampoules were 
cooled at 1°C min"1 in the freezing unit of an LR-33-10 liquid N2 
freezer, to below -70°C, and then rapidly transfered to a liquid 
N2 freezer for long term storage. A few days after every freezing 
operation a single ampoule was removed from storage. If the cells 
could be recovered to normal growth the freezing procedure was 
considered to be successful.
2.6.6. Recovery of Cells from Storage.
After removal of ampoules from the liquid N2 refrigerator, 
the contents were rapidly thawed at 37°C in a water bath and the 
ampoule swabbed with 70% ethanol. The cells were transfered 
aseptically by sterile Pasteur pipette to 14ml of pre-warmed culture 
medium and evenly distributed by gentle agitation. The culture bottle 
was purged with 5% CO2 in air and incubated at 37.5°C. After 2-3 hours 
the cells had usually attached to the glass surface and within 2-3 
days had grown sufficiently to be passaged and subsequently handled 
as a routine stock culture.
2.6.7. Dilution Plating.
The plating of a small number of single cells into T/C
petri dishes, and their subsequent growth into macroscopic 
colonies, was fundamental to most experiments performed. This 
single-cell plating technique allows the determination of the 
plating (cloning) efficiency i.e. the proportion of individual 
cells in a given population capable of indefinite reproduction, 
and also the isolation of clonal populations (5.3.2.).
Although the dilution plating procedure varies with the 
nature of the particular experiment the following protocol is the 
basis for all the dilution plating procedures. 4.9ml aliquots of 
culture medium in 5Oran T/C peri dishes were equilibrated at 37.5°C 
in a humidified 5% CO2 in air atmosphere, in plastic incubation 
boxes. Attachment of cells can occur rapidly at 37.5°C (Ham and 
Puck, 1963) therefore to prevent cell loss, all other media and 
solution were used at room temperature. A cell suspension was 
prepared and the density determined. The counted cell suspension 
was serially diluted to a final cell density of 103 to 2xl0 4 
viable cells ml"1 (dependent on the number of cells to be plated 
in a 0.1ml volume). For each step of the dilution procedure 0.5ml 
of the cell suspension was diluted with 4.5ml medium without PCS 
in a T/C tube then whirlimixed for 2 seconds. Mammalian cells tend 
to settle rapidly from suspension because of their large size and 
therefore to maintain a homogeneous cell suspension the dilution 
procedure was performed as quickly as possible and with frequent 
mixing. Replicate 0.1ml volumes of the final dilution were added 
to the equilibrated T/C dishes and the cells evenly distributed by 
gentle circular agitation. Inoculated dishes were replaced in the 
incubation boxes and with a 5% CO2 in air atmosphere. The boxes 
were sealed with gas-tight tape and incubated in darkness at 
37.5°C for 7-8 days. During incubation the dishes were left
undisturbed to prevent the formation of erroneous satellite 
colonies.
2.6.8. Staining.
To determine the plating efficiency of the cells, the 
medium was carefully poured fcxn the plates and then each flooded 
wtih 5% methylene blue in 50% v/v methanol. After 30 minutes the 
dishes were rinsed under running tap water and allowed to dry. 
Stained colonies were scored by naked eye against a white 
background, with aggregates containing 50 or more cells qualifying 
as a surviving colony. Colonies of marginal size were examined 
under a binocular dissecting microscope to confirm that they 
fulfilled this criterion. For all experiments, plates were coded 
and randomised prior to counting i.e. scored ’blind*.
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CHAPTER 3. DETERMINATION OF AN ADAPTIVE PRE-TREATMENT PROTOCOL.
3.1. Introduction.
As reported in Chapter 1.4. a large variety of cell types 
have been used to characterise the mamnalian adaptive response, 
each study having an unique combination of adaptive pre-treatment 
dose and pre-treatment protocol. It was important, therefore, to 
establish a sub-lethal MNNG concentration and a pre-treatment 
protocol applicable to both CHO-K1 and V79-379A cell lines prior 
to the commencement of this study. Frosina et al.t (1984) used a 
total of 49 protocol combinations and a number of mutagen 
concentrations during their work with V79 cells. For this study, 
however, two protocols were used which have previously been 
reported to be effective in the induction of an adaptive response, 
during work with V79 (Kaina, 1982) and CHO (Samson and Schwartz, 
1980) cell lines, respectively.
In the following sections experiments to determine a 
sub-lethal MNNG concentration for each cell line are outlined. Two 
different adaptive pre-treatment schedules are reported. The 
effect of adaptive pre-treatment is assessed by the change in the 
MNNG dose-responses of the cells.
3.2. Toxic reponse tests to MNNG.
One of the major aspects of the bacterial adaptive 
response, (1 .2 .), is the enchancement of cell survival, to further 
mutagen challenge, following adaptive pre-treatment. It was 
necessary therefore to determine the dose responses (survival or 
kill curves) to MNNG for each cell line studied. The results 
obtained from this work would serve two purposes namely, (a) as a 
reference for comparison against the dose-responses observed in 
future adaptive experiments and (b) as an indication of mutagen 
doses likely to yield meaningful results in the mutational and 
sister chromatid exchange analyses detailed in chapters 4 and 7. 
For a given mammalian cell line the dose range over which a 
mutagenic agent produces lethality is usually that over which it 
produces significant mutation and sister chromatid exchanges (Kao 
and Puck, 1969; Carver et al., 1979; Latt et al., 1975).
Survival curves for MNNG-induced cytotoxicty were therefore 
constructed for both CHO-Kl and V79-379A cell lines.
3.2.1. The cytotoxic action of MNNG on CHO-Kl cells.
5x105 CHO-Kl cells were inoculated into 150 ml culture 
bottles containing 15 ml Hams F10 + 5% FCS, gassed with 5% CO2 in 
air and incubated (2.6.4.). After two days growth, a cell 
suspension was prepared (2 .6 .2 .) and the cell density determined 
(2.6.3. )• Aliquots of this cell suspension were serially diluted 
to final cell densities of 103 - 8xl04 cell ml*1 (2.6.7.). 
Depending on the expected lethality, replicate 0.1 ml volumes of 
these suspension were dispensed into 50mm T/C dishes containing 
4.9 ml Hams F10 + 5% FCS to give 100-8000 cells/plate. At each 
MNNG dose level triplicate petri-dishes were seeded. Initially the
number of cells per plate per dose level was calculated from 
previous reports using this cell line (Wilson, 1985). For example, 
if there was an expected cell survival of IX, following a known 
MNNG dose administration, 6000 cells were seeded into each plate 
anticipating a final colony count of approximately 60 colonies per 
plate. During all survival estimations a final colony count of 
between 40 and 140 colonies per plate were aimed for, although 
this was not always achieved since control plating efficiencies 
ranged from 0.70 to 0.95. Using the data of Table 3.1. to 
illustrate this point, a IX survival resulted from a dose 
administration of 0.2 pgml” 1 MNNG, but, since the control plating 
efficiency in this particular experiment was 0.87, a mean count of 
52 colonies per plate was observed rather than the 60 colonies, 
theoretically possible. Differences of control plating 
efficiencies may result from differences in culture condition 
between experiments e.g. slight differences in pH, gaseous 
atmosphere, length of time in culture etc.. When the likely 
cytotoxicity is uncertain, cells were plated at more than one 
density. The inoculated plates were incubated for 3 hours to allow 
cells to attach to the plates and also recover from 
trypsinisation. The test concentration of mutagen in vehicle was 
added in a 50 pi aliquot. After 2 hours mutagen exposure the 
medium was replaced with pre-warmed, fresh Hama F10 + 5X FCS. The 
plates were re-incubated and left undisturbed for 7 days, then 
stained and scored 'blind* (2.6.8.). Percentage survival was 
calculated as:
Ri = Yi / Yo x 100
where;
Ri = Percentage cell survival.




Cells plated Colonies/plate Mean Plating
efficiency
% Survival
0 100 87,90,89 87 0.87 100
0.02 200 50,44,62 52 0.26 30
0.03 500 55,63,62 60 0.12 14
0.04 1000 63,68,58 63 0.063 7.2
0.1 2000 52,56,60 56 0.028 3.2
0.2 6000 46,57,53 52 0.0087 1.0
0.3 8000 30,37,35 34 0.0042 0.48
0)
to
Yi = The plating efficiency after treatment i (mutagen).
Yo = The plating efficiency after treatment o (vehicle). 
Plating efficiency = Ratio of colonies formed to cells inoculated.
Data for the dose-response curve is presented numerically 
on Table 3.1. and graphically in Fig.3.1. as a plot of percentage 
survival) on a log scale, against MNNG dose. This curve is 
bi-phasic showing an immediate exponential reducton in cell 
survival with mutagen doses up to 0.05 pgml”1 MNNG. At MNNG 
concentrations between 0.05 pgml-1 and 0.3 pgml"1 there is a 
further exponential reduction in cell survival but the rate of 
reduction is slower. Extrapolation of the latter portion of this 
curve shows an intercept with the y-axis at a value of 6% 
survival, which represents the percentage of the resistant cell 
sub-population.
The D37 value, defined as the dose required to kill 63% of 
the cell population (37% survival) is considered to be a valid 
measure of cytotoxic potency (Carver et al., 1979). Estimation of 
a D37 value from Figure 3.1. would be unsatisfactory since this 
respresents the results of a single experiment. For a more 
accurate measure of the D37 value of MNNG on CHO-Kl cells, and as 
a demonstration of the reproducibility of this technique, six 
dose-survivor curves were constructed. For each dose level 
triplicate plates were seeded with CHO-Kl cells resulting in a 
total of 18 survival determinations. These data are presented 
graphically in Figure 3.2. which shows a plot of the mean 
percentage survival ± standard error, plotted on a log scale, 
against MNNG concentration. From this figure the inflection point 
of the curve can be calculated as 0.05 pgml"1 MNNG at a survival 











Figure 3.1. Dose-response curve for CHO-Kl cells grown in Haas 










Figure 3.2. Reproducibility of the dose-response curve for
CHO-Kl cells grown in Hams F10 + 5% FCS, treated 
with MNNG. In this and subsequent plots each point 
is the mean value from n replicate experiments ± 
the standard error i.e. in this instance n=6 ± S.E.
exponential portions. The D37 value was calculated from this 
Figure and was found to be 0.021 pgml-1 MNNG. This value is 
comparable to those obtained by Dewdney (1982) (0.035 pgml"1) and 
Wilson, (1985) (0.021 pgml*1), during their studies on CHO-Kl 
cells. Barranco and Humphrey, (1971) working on CHO cells, 
reported a similar bi-phasic response to MNNG, but with the 
inflection point arising at 3% survival and at a dose level of
0.5 pgml-1. This value, and the entire survivor curve, differ by a 
factor of 10 from the data shown in Figs.3.1. and 3.2. The CHO-Kl 
cells used in this study are considerably more sensitive to the 
cytotoxic effects of MNNG than are their parental strain CHO, a 
fact confirmed by Dewdney, (1982) and Wilson, (1985).
3.2.2. The cytotoxic action of MNNG on V79-379A cells.
Dose-response curves for V79-379A cells treated were 
constructed using single plated cells. In preliminary studies by 
Wilson, (1985), MNNG concentrations used by other workers on 
V79 cells (Roberts et al., 1971, Lankas et al*, 1977), were used 
but were found to be far too toxic towards V79-379A cells so the 
doses were reduced by a factor of 10. The MNNG concentrations 
eventually employed were identical to those used to produce the 
the CHO-Kl dose-survivor curve i.e. 0-0.3 ligml-1.
The experimental protocol for V79-379A cells followed that 
used above for the determination of the CHO-Kl dose-response 
curve. (3.2.1.)
Survival data, obtained from six independent experiments, 
are shown in Figure 3.3. These are presented as mean percentage 
survival ± standard error, plotted on a log scale, against MNNG 




Figure 3.3. Reproducibility of the dose-response curve for
V79-379A cells grown in Hams F10 + 5% FCS, treated 
with MNNG. (n=6 ± S.E.)
determined as 0.012 pgml"1. As for CHO-Kl the V79-379A curve is 
bi-phasic but in contrast to the CHO-Kl curve, the inflection in 
the V79-379A curve occurs at an MNNG dose of 0.1 pgml*1 and a 
survival level of 2%.
3.3. Determination of a sub-lethal concentration of WNG for the 
adaptive pre-treatment of CHO-Kl and V79-379A cells.
Before any adaptation experiments could be undertaken it 
was necessary to determine the adaptation dose. Essentially this 
dose has to be sub-lethal and sub-clastogenic i.e. causes no 
cytotoxicity or alteration to the chromosomal integrity, Kaina, 
(1982).
3.3.1. Toxic response tests on CHO-Kl and V79-379A cells exposed
to MNNG concentrations in the range 0-0.02 ugml*1.
CHO-Kl and V79-379A cultures were set up in two 150 ml 
culture bottles containing 15 ml Hams F10 + 5% FCS, gassed with 5% 
CO2 in air and incubated (2.6.4.). After 46-48 hours a cell 
suspension was prepared for each cell line, counted and serially 
diluted to a density of 103 cell ml*1. To 4.9 ml of pre-warmed 
Hams F10 + 5% PCS in 50 ran T/C dishes. 0.1 ml aliquots were 
dispersed and agitated to distribute the cells evenly. After 3 
hours incubation in a 5% CO2 in air atmosphere, the cells were 
exposed to the mutagen in 50 pi vehicle, the control plates 
receiving vehicle alone. Triplicate plates were set up for each 
dose. The cells were incubated for a further 2 hours when the 
medium was replaced with 5 ml of pre-warmed Hams F10 + 5% FCS. 
After 7 days incubation the medium was poured away and the 
colonies stained and scored.
The results of these experiments are presented as dose 
response plots in Figure 3.4. (a) and (b). Although the profiles 
are slightly different for the two lines, the critical or 
threshold MNNG concentration seems to be similar in both instances
i.e. 0.01 pgml”1, the point at which a decrease in cell survival 
begins. Therefore it was decided from this evidence that the 
adaptive pre-treatment dose, to be used in future experiments on 
both cell lines, would be 0.01 ugml*1.
Fig.3.4. (a) and (b) also show that there is an initial 
shoulder to the dose-response curve for each cell line, a feature 
that was not apparent in Figs.3.2. and 3.3.
3.4. Determination of an adaptive pre-treatment protocol for CHO-Kl 
and V79-379A cells.
The criteria governing the choice of an adaptation 
pre-treatment protocol were; a) the protocol should previously 
have been shown to produce an adaptive effect in one or both cell 
lines, and b) the chosen protocol must show an effect in both 
CHO-Kl and V79-379A cell lines used in this study.
3.4.1. The effect of a single sub-lethal MNNG dose followed by MNNG 
challenge 6 hours later (Protocol 1) : toxic resooses of 
CHO-Kl and V79-379A cells.
The protocol used by Kaina, (1982) was followed. This 
involved the seeding of cells into T/C dishes and immediately 
treating them with a single adaptation dose of 0.01 pgml-1 MNNG. 
MNNG challenge was administered after 6 hours incubation producing 
a dose-response curve.











Figure 3.4. Dose-response curves for CHO-Kl cells, (a), and V79-379A cells, (b), grown in Hams F10 + 5% 
FCS, treated with MNNG in the dose range 0-0.2 pgml-1 . (n=3 ± S.E.)
cultures were set up by inoculationg 5xl05 cells into two 150 ml 
culture bottles containing 15ml Hams F10 + 5% FCS, gassed with 5% 
002 in air and incubated at 37°C. After 46-48 hours growth a cell 
suspension was prepared for each cell line, counted and serially 
diluted to densities between 103 and 8xl04 cells ml"1. Depending 
on the expected cytotoxicity (3.2.1. and 3.2.2.) 100-8000 cells 
were plated into 50 mm T/C petri dishes containing pre-warmed Hams 
F10 + 5% FCS. Immediately after seeding the adaptive MNNG dose 
(0.01 pgrnl'1) was administered to each plate. Following a 6 hour 
incubation period, in a 5% 002 in air atmosphere, the medium was 
poured off and the plates rinsed with pre-warmed PBS (2.3.2.) 
and replaced with 5ml fresh pre-warmed Hams F10 + 5% FCS. Mutagen 
challenge doses up to 0.3 jigml-1 were now added and the cells 
incubated for 2 hours before another medium change was carried 
out. After 7 days incubation the cells were stained and scored 
'blind* (Fig.3.5.). Control cells were exposed to the same 
procedure substituting vehicle for the pre-treatment dose.
The effect of this type of pre-treatment on both CHO-Kl and 
V79-379A cells is presented in Fig. 3.6. (a) and (b) respectively. 
The results of three independent experiments are shown.
CHO-Kl cells exhibited no significant change in the dose 
response curve when pre-treated and control cells were compared. 
The D37 values were 0.06 |igml~1 in both instances. This value is 
higher than that of 0.021 jigml-1 observed in 3.2.1. for CHO-Kl 
cells. V79-379A cells, however, show a 2-fold enhancement of 
survival after pre-treatment on comparison of the D37 values for 
treated (0.021 pgml-1) and untreated control cells (0.011 pgml"1). 
This agrees with the findings of Kaina, (1982) who worked on 
V79-C10 cells and also found a 2-fold increase in cell survival on
Diagrammatic representation of adaptation protocols 1 and 2. 
Protocol 1 (Kaina. 1982).
a-d
f








Protocol 2 (Samson and Schwartz. 1980),
f~48 -36 -24 -12 ft
t t  i t t t  t t i
a-d C
3,- farg , 2 hrs h
ell
seed
I tc-^ d m-c
7 days H Cytotoxicity 
data.
a-d * MNNG adaptive dose (0.01 pg ml*1), 











0 0.1 0.2 0.3
100
0.2
0 0.1 0.2 0.3
MNNG Ugfcl-1 MNNG Mgml-*
Figure 3.6. Dooc response curves for CHO-Kl cells (a) and V79-379A cells (b), grown in Haas F10 + 
5X FCS, after pre-treataent with a single 0.01 ugal"1 MNNG dose followed by MNNG 
treataent 6 hours later (Protocol 1). Cfcen and closed syabols represent pre-treated 
cells and control cells respectively. (n=3 t S.E.)
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challenge after a single pre-treatment dose.
3.4.2. The effect of eight single sub-lethal MNNG doses at six-hourly.
intervals for 48 hours, followed by MNNG challenge 
~ (Protocol 2): toxic responses of CHO-Kl and V79-379A cells.
This protocol followed that used by Samson and Schwartz,
(1980).
Two days prior to the experiment CHO-Kl and V79-379A 
cultures were set up by inoculating 5x10s cells into two 150 ml 
culture bottles containing 15 ml Hams F10 + 5% FCS, incubation at 
37.5°C in a 5% 002 in air atmosphere. After 46-48 hours growth a 
cell suspension was prepared and the cell density determined.
Eight culture bottles were now set up each containing 15 ml Hams 
F10 + 5% FCS. To four of these, 2x105 CHO-Kl cells were 
inoculated. To the other four, 2x105 V79-379A cells were added.
Within each set of four bottles two received 50 pi vehicle (H2O) 
and two received the MNNG adaptive dose (0.01 pgml"1). This dose 
was designated to be at time t=-48 (Fig. 3.5.). After 6 hours the 
medium in each bottle was replaced by 15 ml fresh Hams F10 + 5%
FCS containing either vehicle or the MNNG adaptive dose of 0.01 
pgml-1. The bottles were gassed with 5% CO2 in air and incubated 
for a further 6 hours. The procedure of media replacement and MNNG 
administration was repeated every 6 hour until a total of 8 
pre-treatment doses had been given i.e. at t=-6. Six hours after 
the final dose (t=0) cell suspensions were prepared, the cells 
counted and serially diluted to cell densities between 103 and 
8xl04 cells ml-1. 0.1 ml aliquots of cells were distributed into 
50 mm T/C dishes containing 4.9 ml pre-warmed Hams F10 + 5% FCS to 
give between 100 and 8000 cells/plate. The expected cytotoxicity
of pre-treated cells was uncertain so for each challenge dose a 
range of cell densities were prepared. After 3 hours incubation 
the cells were exposed to MNNG challenge doses (up to 0.3 pgml-1) 
and left a further 2 hours before a change of medium was performed 
for each plate. The cells were allowed to grow in the incubator 
for 7-9 days (see 4.3.2.), stained and scored *blind*.
The results of three independent experiments for both 
CHO-Kl and V79-379A cells are presented in Figs. 3.7. and 3.8. 
respectively, presented as mean percentage survival, plotted on a 
log scale, against MNNG concentration. It is observed that at 
each challenge dose pre-treated cells, in both lines, survived 
better than control cells. CHO-Kl cells exhibited a 3-fold 
difference in D37 value over control (0.014 to 0.042 pgml”1) and 
V79-379A cells a 6.8-fold difference in the D37 value compared to 
control (0.012 to 0.082 ngml-1). For both cell lines the bi-phasic 
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Figure 3.7. Dose-response curves for CHO-Kl cells grown in 
Hams F10 + 5% PCS, pre-treated with a 0.01 
Mgml"1 MNNG dose every six hours for 48 hours 
(Protocol 2), then treated with MNNG. Open and 
closed symbols represent pre-treated cells and 
control cells respectively. (n=3 ± S.E.)
MNNG ugal-1
Figure 3.8. Dose-response curves for V79-379A cells grown 
in Hams F10 + 5% FCS, pre-treated with a 0.01 
ligml-1 MNNG dose every six hours for 48 hours 
(Protocol 2), then treated with MNNG. (n=3 ± 
S.E.). Open and closed symbols represent 
pre-treated and control cells respectively.
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3.5. Conclusions.
From the results reported in this chapter the following can
be concluded:
1) MNNG, in the range 0.02 to 0.3 pgml-1, is cytotoxic to both 
CHO-Kl and V79-379A cells in a bi-phasic, dose-dependent fashion 
(3.2.1. and 3.2.2.). D37 values derived are 0.021 pgml"1 and 
0.012 pgml”1 respectively.
2) Below 0.01 pgml-1 MNNG is non-toxic (sub-lethal) to both cell lines.
3) CHO-Kl cells pre-treated by protocol 1 exhibited no change in 
survival when compared to untreated cells (3.4.1.).
4) V79-379A cells pre-treated by protocol 1, however, exhibited a 
2-fold enhancement of survival over untreated cells on comparison 
of the D37 values, i.e. 0.021 pgml-1 to 0.011 pgml"1.
5) Adaptive pre-treatment by protocol 2 resulted in a 3-fold 
enhancement of survival of CHO-Kl over control cells. D37 values 
for pre-treated and untreated controls were 0.042 and 0.014 pgml"1 
respectively.
6) Adaptive pre-treatment by protocol 2 resulted in a 6.8-fold, 
enhancement of survival of V79-379A over control cells. D37 
values were 0.082 and 0.012 pgml*1 for pre-treated and control 
respectively.
7) From these data it is apparent that protocol 1 i.e. a single 
pre-treatment dose, does not fulfil the two criteria outlined 
in 3.4.. Therefore it was decided that the pre-treatment 
protocol to be used in all future adaptation experiments would 
be that of Samson and Schwartz, (1980) using multiple 
pre-treatment doses and set out diagraranatically in Fig.3.5. as 
protocol 2.
These conclusions will be discussed in chapter 8.
CHAPTER 4. TOE EFFECT OF ADAPTIVE PRE-TREATMENT CH CHO-Kl AND
V79-379A ram JR.
4.1. Introduction.
Previous studies into the mamnalian adaptive response have 
revealed that mutagen pre-treatment enhanced survival, but did notr 
always reduce mutation frequencies on subsequent challenge. Two 
independent groups, Durrant et al., (1981) and Frosina et al., 
(1984), both working with V79 cells, observed an increased 
survival without the accompanying mutagenic adaptation. However, 
Kaina, (1982) and Laval and Laval, (1984), working on V79 and rat 
H« lines respectively, reported the presence of both lethal and 
mutagenic adaptation. In each case the mutation frequencies were 
measured by the induction of resistance to the purine analogue 
6-thioguanine. It was important, therefore, to determine whether 
the enhanced cell survival observed in both CHO-Kl and V79-379A 
cells (3.4.2.) was accompanied by a similar enhancement of the 
mutagenic response. Since 0®-methyl-guanine is considered to be 
the most important pre-mutagenic lesion induced in DNA by 
methylating agents, (Chapter 1), an assay system which detects 
potential base-substitution mutations of this type was necessary.
It was decided to assay mutations at the Na+/K+ ATPase locus using 
CHO and V79/ouabain assay systems instead of the relatively 
lengthy and expensive HGPRT, (6-thioguanine resistance), system 
used previously.
The effects of pre-treatment on the growth parameters of 
the two cell lines were also investigated.
Since the sensitivity of CHO cells to MNNG fluctuates 
throughout the cell cycle, (Barranco and Humphrey, 1971), a 
change in cell cycle distribution may alter the responses of the
overall population. Therefore CHO-Kl cells were synchronised and 
the effect of subsequent MNNG challenge) on the induced 
cytotoxicity and mutation to OuaK, compared to the values obtained 
for asynchronous control and asynchronous pre-treated cells.
4.2. Mutation to Qua1.
The active sodium and potassium ion transport system in 
mammalian cells is associated with the Na*-K*-Mg2+-activated 
ATPase (Na*/K+ATPase)(E.C.3.6.1.3) located in the plasma membrane 
(Baker et al., 1974). Resistance to the steroid compound ouabain 
(Qua), involves this enzyme. Ouabain binds to the alpha sub-unit 
of this enzyme specifically inhibiting its action and is 
ultimately cytotoxic. Resistance is probably the result of 
base-pair substitutuion occuring at only limited sites within the 
Na*/K*ATPase locus that affect the affinity (binding) of ouabain 
without destroying enzyme activity. Clones of both established and 
primary lines have been obtained, by single-step selection in 
Oua-containing culture medium, which have greatly increased 
resistance to Oua cytotoxicity when compared with wild-type cells 
(Arlett, 1977; Baker et sd,f 1974; Davies and Parry, 1974; Cole 
and Arlett, 1976).
A number of observations have confirmed that the occurence 
of ouabain resistance (Oua*) reflects a mutant genotype:
a) The ouabain resistance phenotype is stable , being reproducible 
after long intervals of growth in the absence of the selecting 
drug (Baker et al., 1974).
b) Luria-Delbruck fluctuation analyses indicate that Oua* cells 
arise randomly in wild-type (WT) populations of both mouse 
L-cells and CHO cells, as expected of spontaneous mutations
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(Baker et al,, 1974).
c) Treatment of WT cell populations with EMS and other mutagens 
causes a substantial increase in the frequency of Oua1 cells 
(Cole and Arlett, 1976; Davies and Parry, 1974; Gupta and 
Siminovitch, 1980).
d) Hybrids of Oua1 and ouabain-sensitive (Oaas) WT CHO cells show 
intermediate resistance between that of the two parental cell 
strains, establishing that Oua1 is a co-dominant trait (Baker 
et al,, 1974).
The nature of the mutations responsible for Oua1 are 
suggested by the classes of mutagens most effective at inducing 
Oua1 mutants. EMS and UV, agents capable of inducing base-pair 
substitutions, are effective inducers of such mutations (Baker et 
al,, 1974; Arlett, 1977). Oua1 cannot be induced by either ionizing 
radiation or the frameshift mutagen ICR 191, (Bradley et al,,
1981), indicating that some Na*/K+ATPase activity is vital for 
cell survival, and frameshift or other inactivating mutations 
which eliminate enzyme activity, result in cell death. Mutations 
to Oua1 are therefore likely to arise from base-pair substitutions 
resulting in a single amino acid or subtle configuration 
alteration in the relevant gene product, be it Na*/K*ATPase itself 
or some adjacent membrane component.
4.2.1. Th6 MNNG-induced mutation of CHO-Kl cells to Qua1.
Two days prior to the experiment duplicate cultures of 
CHO-Kl cells were set up by inoculating 5x105 cells into 150ml 
culture bottles each containing 15ml Hams F10 + 5% FCS. After 
gassing with 5% 002 in air and incubating for 46-48 hours at 
37.5°C, cell suspensions for each cell line were prepared and the
cell desity determined. These suspensions were used to inoculate 
2x10s cells into 90mn T/C dishes, (five for each mutagen dose i.e. 
1x10® cells in total) each containing Hams F10 + 5% FCS to 10ml 
(selection plates). Further dilution of these suspensions allowed 
survival plates to be set up in parallel as outlined in 3.2.1. For 
each mutagen dose level three petri-dishes were seeded with 
between 100 and 8000 cells per plate, dependent on the anticipated 
cytotoxicity. After 3 hours incubation, MNNG was added to both 
survival and selection plates in 50 ill of vehicle. Control plates 
received vehicle only i.e. DDH2O. After a 2 hour mutagen treatment 
the culture medium in the was replaced with fresh, pre-warmed Hams 
F10 + 5% FCS and the plates re-incubated. Following a further 46 
hour incubation, (mutant expression time. Fig.4.1), the medium in 
the selection plates was replaced with 9ml of Hams F10 + 5% FCS in 
conjunction with 1 ml of lOmM stock ouabain solution (2.4.2.) i.e. 
lmM final Oia concentration. The plates were incubated, stained, 
coded and scored ’blind’ after 7 days (survival plates) or 8 days 
(selection plates). A diagram summarising this experimental 
protocol is given in Fig.4.1. The optimum conditions for 
induction and detection of OuaB mutants, in the CHOK1 cell line, 
were validated by Dewdney, (1982). This system was also used on 
both CHO-Kl and V79-379A cells by Wilson, (1985) who showed that 
the optimum mutant expression time was between 47 and 49 hours 
before mutant selection.
Data obtained from experiments of this type can be 
expressed as mutation frequencies. These are calculated as the 
number of mutants, selected for by the selection medium, following 
mutagen treatment and expression, per 10® surviving cells. The 
observed mutation frequency is calculated as follows
Figure 4.1. Diagrammatic representation of the protocol used to assess the MNNG-induced 
mutation to Oua* of CHO-Kl and V79-379A cells.
MUTATION EXPRESSION TIME- MUTANT SELECTION TIME— |







c-d : MNNG challenge doses (0.02-0.3 ugml"1)
m-c : Medium change
OUA : Mutant selection medium - Hams F10 + 5% FCS + ImM ouabain.
Mutagenicity data
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Observed mutation frequency =
__________ Total number of mutants scored x 106___________
Total number of cells plated x Plating efficiency of cells 
into selection plates* in parallel survival plates.
 Equation 4.1.
Table 4.1. presents cytotoxicity and mutation data 
obtained, for CH0-K1 cells, from a single experiment. This 
illustrates typical plate counts and each step in the calculation 
of the observed mutation frequency.
Computation of results.
Mutation frequencies (M.F.), in these studies, cure 
expressed as mutants per 106 surviving cells. Using the data 
of Table 4.1., for an MNNG dose of 0.2 tigml”1, and working through 
using equation 4.1., the MNNG mutation frequency to OuaB can be 
calculated.
Medium_______Cells/plate Colonies/plate Mean Total mutants
Non-selective 4x10* 58,40,58 52
Selective 2xl05 6,8,7,7,0 - 32
Plating efficiency = 52/4000 = 0.013
M.F. per survivor = 32 x (10*) = 2462 mutants per
(5x2xl05) x 0.013 10* survivors.
The data presented in Table 4.1. is shown in Fig.4.2. as a
plot of induced mutation frequency to OuaR (0ua*/106 survivors),
plotted on a log scale, against MNNQ concentration. CHO-K1 cells
exhibit a dose-dependent increase in mutation frequency when
subjected to increasing concentrations of MNNG over the range 0.02
Table 4.1. Data illustrating the survival and mutation to Qua8 of CH0-K1 cells grown in Hams
F10 + 5% PCS. treated with MNNG. 
Survival data.
Dose MNNG jigm!-1 Cells plated Colonies/plate Mean Plating efficiency X Survival
0 100 113,127,90 110 1.10 100
0.02 200 80,75,88 81 0.405 37
0.04 500 56,44,47 49 0.098 8.9
0.1 2000 65,70,70 68 0.034 3.1
0.2 4000 74,89,83 82 0.0205 1.86
0.3 6000 48,64,59 57 0.0095 0.86
Mutation data.
Dose MNNG pgml"1 Mutant colonies/plate Total mutants P.E. of survivors Mutants/106 survivors
0 0,0,0,1,0 1 1.10 0.91
0.02 3*3,4,9,4 23 0.405 57
0.04 12,3,6,8,4 33 0.098 337
0.1 6,6,6,6,4 28 0.034 824
0.2 10,16,12,17,8 63 0.0205 3073
0.3 12,10,8,13,14 57 0.0095 4515
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Figure 4.2. The dose-response curve of the MNNG-induced 
mutation frequency to Oja* of CH0-R1 cells 





















Figure 4.3. Reproducibility of the dose-response curve of 
the MNNG-induced mutation frequency to Oja* of 
CHO-K1 cells grown in Hams F10 + 5% PCS. (n=6 ± 
S.E.)
pgml"1 to 0.3 pgml"1. The response is curvilinear and hyperbolic. 
The reproducibility of this assay technique was demonstrated by 
performing six independent experiments the results of which are 
shown in Fig.4.3. expressed as mutation frequency, plotted on a 
log scale, against MNNG concentration.
4.2.2. The MNNG-induced mutation of V79-379A cells to Qua1.
Dose-response curves of induced mutation to OuaB for 
V79-379A cells were constructed using single plated cells. The 
experimental protocol for these cells followed that used above for 
determination of the CHO-Kl dose-response curve. The results of 
six independent experiments are shown in Fig .4.4. presented as 
mutation frequency, plotted on a log scale, against MNNG 
concentration.
Cells that are OuaK, occur spontaneously with frequencies 
in the range <1-8 mutants/106 survivors (Arlett et al., 1975;
Lankas et al., 1977; Lever and Seegmuller, 1976) and have been 
induced by a wide variety of chemical mutagens with frequencies 
in the range 5-4000 mutants/106 survivors (Arlett, 1975; Bradley 
et al., 1981; Davies and Parry, 1974; Maleveille et al., 1977). The 
results presented in Figs 4.2, 4.3. and 4.4. fall within these 
ranges. The spontaneous (control) mutation frequencies in these 
figures have not been plotted but were determined as 1.12x10"6 and 
0.97x10"6 for CHO-Kl and V79-379A cells respectively
An alternative method of expressing the effect of MNNG on 
the mutation frequencies of either CHO-Kl or V79-379A cells, is to 
plot mutation against percentage survival, both on log scales. 
Munson and Goodhead, (1977) reported a linear relationship between 
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Figure 4.4. Reproducibility of the dose-response curve of 
the MNNG-induced mutation frequency to CXia* of 
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Figure 4.5. The relationship between MNNG-induced mutation frequency to Qua* and percentage survival of 
CHO-Kl cells, (a), and V79-379A cells, (b), grown in Hams F10 ♦ 5% PCS. CD
O
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(1979) later used this method to compare the cytotoxic and 
mutagenic potencies of a number of different mutagens. Fig.4.5. 
shows this relationship to be linear for both CHO-Kl and V79-379A 
cells where the data used to present Figs.4.3. and 4.4. are 
plotted as cell survival against mutation frequencies) both on 
log scales.
4.2.3. The effect of adaptive pre-treatment on the MNNG induced
mutation to Qua8 in CHO-Kl and V79-379A cells.
Adaptive pre-treatment of both cell lines was administered 
as previously described in 3.4.2. and as shown diagrammatically in 
Fig.4.14. At time zero (t=0) selection and survival plates were set 
up and the protocol described in 4.2.1. followed through. Care was 
taken to keep the control and pre-treated cells separated to avoid 
cross-contamination«
The effect of adaptive pre-treatment on the MNNG-induced 
mutation to OuaK is shown in Figs.4.6. and 4.7. for CHO-Kl and 
V79-379A cells respectively. Each data point is comprised of three 
experiments and is expressed as mean mutation frequency i standard 
error. Control values are also plotted for comparative purposes. 
Pre-treatment has reduced the MNNG-induced mutation to OuaK when 
compared to control at each mutagen dose level for both cell 
lines. Howevert background mutation frequencies in pre-treated 
cell is much higher than in control cells i.e. 30x10“* vs 
0.91x10“* for CHO-Kl cells and 30x10“* vs 0.97x10"* for V79-379A 
cells.
The data plotted in Figs.4.6. and 4.7. for pre-treated 
cells shows the M.F. with this background mutation subtracted thus 
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Figure 4.6. The effect of adaptive pre-treatment, by 
Protocol 2, on the dose-response curve of 
MNNG-induced mutation frequency to Oua1, of 
CHO-Kl cells grown in Hams F10 ♦ 5% PCS. 
Open and closed symbols represent 
pre-treated cells and control cells 
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Figure 4.7. The effect of adaptive pre-treatment, by 
Protocol 2 1 on the dose-response curve of 
MNNG-induced mutation frequency to 0uaB, in 
V79-379A cells grown in Hams F10 ♦ 5% PCS. 
Open and closed symbols represent 
pre-treated cells and control cells 
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Figure 4.8. The effect of adaptive pre-treatment, by Protocol 2, on the relationship between MNNG-induced
mutation frequency to OuaK and percentage survival of CHO-Kl cells, (a), and V79-379A cells, (b) 
grown in Hams F10 + 5% PCS. Open and closed symbols represent pre-treated cells and control 
cells respectively.
the ’pre-treatment plus challenge-induced’ mutation to OuaB. 
Elevation of control mutation frequencies was also observed by 
Schwartz and Samson, (1983) when they pre-treated CHO cells with 
MNNG and then determined the induced mutation to 6-thioguanine 
resistance. If the subtraction of background is not performed, 
however, there still remains a substantial decrease in the 
mutation frequencies of pre-treated cells over control e.g. for a 
challenge dose of 0.2 pgml"1 values are 3073 vs 380 (8-fold) and 
2014 vs 260 (7.7-fold) for CHO-Kl and V79-379A cells respectively 
(Figs.4.6. and 4.7.). Therefore frcm these data it is apparent 
that after pre-treatment with MNNG both CHO-Kl and V79-379A cells 
yield lower mutation frequencies to OuaB, on a dose basis, 
compared to those of un-treated control cells (Figs.4.3. and 
4.4.). However analysis of the mutation data at equicytotoxic 
doses, (Durrant et al., 1981; Friedman and Huberman, 1980; Ishida 
and Takahashi, 1987), revealed these cells to be as equally 
mutable as their respective control cells (Figure 4.8.).
4.3. The effect of adaptive tre-treatynt. m  the growth 
parameters of CHO-Kl and V79-379A 
One of the most favourable characteristics of Chinese 
hamster cell lines, making them very useful to these studies, is 
their ability to grow in a consistent and reproducible fashion. It 
was therefore important to establish the growth parameters of both 
CHO-Kl and V79-379A cell lines and the effect adaptive 
pre-treatment had on these parameters.
4.3.1. Determination of the growth parameters of CHO-Kl and
V79-379A cells.
Inocula of 2x105 cells were sub-cultured into a number of 
25cm2 T/C flasks each containing 5ml Hams F10 + 5% PCS, gassed 
with 5% 002 in air and incubated at 37«5°C. At intervals a flask 
was removed from the incubator and the total cell number 
determined* The medium was withdrawn and placed in a 10ml 
graduated round-bottomed centrifuge tube (MSE Scientific 
Instruments)* The cell monolayer was then rinsed with two 1ml 
portions of trypsin solution (2*3.3.), adding each rinse in turn 
to the centrifuge tube. The cells were detached from the flask by 
incubating with a further 1ml trypsin solution. After the 
appropriate incubation time (2.6.2.) the flasks were removed from 
the incubator, gently tapped on the heel of the hand to dislodge 
the cells and the resultant cell suspension transfered to the 
centrifuge tube. The flask was then rinsed with two 1ml portions 
of PBS to remove the residual cells. Complete removal was 
confirmed by examination of the flasks using phase-contrast 
microscopy. Cell losses due to adherence were minimised by the use 
of a single siliconised Pasteur pipette for all the above 
transferences (2.5.4.). Cells were concentrated by centrifugticn 
(1500 rpm for 5 min) and resuspended in 0.5ml of the supernatant. 
The suspension was adjusted to an expected density of 
2.5xl0s-1.5xl06 cells ml*1 with PBS and the final volume noted.
The cell density was determined by haemocytometer count and the 
total cell nunber calculated.
Both CHO-Kl and V79-379A cell lines exhibit ’classical* 
growth kinetics, growth being conventionally divided into three 
distinct phases:
i) Lag phase : this is the time following sub-culture and
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seeding where there is little evidence of 
an increase in cell number. It is a period 
during which the cell replaces elements of 
the glycocalyx lost during trypsinisation, 
attaches to the substrate, and spreads out 
(Freshney, 1983).
ii) Log phase : this is the period where cell numbers
increase exponentially. It follows the lag 
phase and is also known as the exponential 
growth phase.
iii) Stationary phase : towards the end of the log phase the
culture becomes confluent i.e. all the 
available growth surface is occupied and 
the cells are in contact with neighbouring 
cells. Hence a reduction in cell growth 
rate follows (Freshney, 1983).
Growth curves are constructed by plotting the total number 
of cells in each flask, cm a log scale, against the time elapsed 
from seeding, having incubated the cells at 37.5°C in a 5X 002 in 
air atmosphere. Figures 4.9. and 4.10. show typical growth curves 
of CHO-Kl and V79-379A cells respectively. From such curves two 
useful parameters can be obtained namely the lag time, the time 
taken for growth to commence, and the population doubling time 
(T). The latter is the time taken for the culture to increase its 
numbers two-fold during the log or exponential growth phase and is 
the inverse of k, the exponential growth rate constant. This 
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Figure 4.10. Growth curve of V79-379A cells grown in Hams 
F10 + 5% PCS.
Table 4.2. Growth parameters of CHO-Kl and V79-379A cells. 
ffrewn In ftoma F1Q + 5X PCS.
Cell line Lag time k value T r
(hrs) (hr-M (hrs)
CHO-Kl 6 0.069 14.4 0.99
V79-379A 6 0.088 11.4 0.98
k = Exponential growth rate constant. 
T = Population doubling tine, 
r * Correlation coefficient.
which is established by measuring the transit of a population of 
cells through the cycle until they return to the same point in 
that cycle. During the exponential or log phase of growth, an 
initial population of No cells will, after a time t minutes, be 
increased to Nt cells according to the following equation 
Nt = No 2kt
or in its logarithmic form: LogNt = LogNo + k.t.Log2
where:
No = cell number at time 0 Nt = cell number at time t 
k = exponential growth rate constant.
The growth parameters for both CHO-Kl and V79-379A cells 
are shown on Table 4.2. along with the correlation and regression 
values calculated from the log phase of each cell line. The values 
of slope and r (correlation coefficient) were calculated using a 
BBC Master microcomputer running the INSTAT statistical package 
(Reading University), which included a correlation and regression 
program. The values of T for both lines, i.e. 14.4 hours for 
CHO-Kl and 12.3 hours for V79-379A cells (Table 4.3.), are in good 
agreement with the literature values of 10 to 16 hours reported 
for various CHO and V79 cell lines. (Bradley et al., 1981; Hsie et 
al., 1981; Kao and Puck, 1974.).
4.3.2. The effect of adaptive ore-treatment on the growth 
parameters of CHO-Kl and V79-379A cells.
To determine the effect of adaptive pre-treatment on the 
growth parameters of these cell lines, cultures were set up and 
pre-treated with repeated doses of mutagen as detailed in 3.4.2. 
and Fig.4.14. At t=0 the cells were dispersed by trypsinisation and 
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Figure 4.11. The effect of adaptive pre-treatment, by Protocol 2, on the growth curves of CHO-Kl cells,
(a), and V79-379A cells, (b). A regression line for untreated control cells (..... ) is
included to illustrate the relative growth rates of pre-treated cells (-----) and control
cells.
Table 4.3. The effect of adaptive pre-treatment. by Protocol 2. on the
growth parameters of CHO-Kl and V79-379A cells, grown in Hams 
FlO ± 5% PCS.











14 0.043 23.3 0.99




6 0.081 12.3 0.99
k = Exponential growth rate constant 
T = Population doubling time, 
r = Correlation coefficient.
number of flasks and growth curves for each cell line were 
constructed as described in 4.3.1.
The effects of adaptive pre-treatment are shown in 
Fig.4.11. and also on Table 4.3. Pre-treatment has increased the 
doubling time of CHO-Kl cells by 8.9 hours from 14.4 hours to 23.3 
hours, whereas the doubling time of V79-379A cells was increased 
only slightly from 11.4 to 12.3 hours. Fig 4.11.a, illustrates the 
effect of pre-treatment on CHO-Kl cells by comparing regression 
lines for control and pre-treated cells. Tobey an Crissman, (1975) 
showed CHO cells to ave an increased population doubling time 
following mutagen treatment whilst Roberts and Ward, (1973) 
reported an increase in theis parameter in MNU-treated cultures of 
V79 cells.
The lag time of CHO-Kl cells was increased by 8 hours over 
the control value of 6 hours following adaptive pre-treatment, 
whereas that of V79-379A cells was identical to the lag time of 
untreated control cells.
A simmary of the pre-treatment protocol and the 
determination of growth, cytotoxicity and mutation in both CHO-Kl 
and V79-379A is shown in Fig.4.14.
4.4. The effect of cell synchrony on the WNG-induoed cytotoxicity 
and ■itAtiqn to Qua1 of CHO-Kl cells.
Barranco and Humphrey, (1971) reported that the 
sensitivity of CHO cells to MNNG fluctuates through the cell 
cycle. It would seem likely, therefore, that a treatment causing a 
change in cell cycle distribution may generate an apparent change 
in the MNNG sensitivity of the whole population. MNNG has been 
shown to delay the progression of the cell cycle of Chinese
105
hamster lines (Barranco and Humphrey, 1971; Roberts and Ward,
1973) which is ultimately seen as an increase in the lag time of 
the growth curve. It was decided, therefore, to determine the 
MNNG-induced cytotoxicity and mutation to OuaB for a population of 
synchronised CHO-Kl cells to establish whether the adaptive 
pre-treatment protocol used had induced synchrony within the 
population. The results were compared to the responses of 
asynchronous cultures (3.2.1. and 4.2.1.) and to those of 
pre-treated asynchronous cultures (3.4.2. and 4.2.3.). Since 
adaptive pre-treatment affected the lag time of CHO-Kl cells, but 
not V79-379A cells, only the former were used in these 
experiments.
4.4.1. Synchrony of CHO-Kl cells.
Synchrony was achieved using the protocol of Zwanenburg, 
(1983), who made use of the fact that CHO cells round up and become 
less firmly attached to the growing surface when they enter 
mitosis. The mitotic cells can be shaken off the monolayer, 
collected and concentrated by centrifugation. The advantages of 
this ’shake-off’ method over other techniques is that there is no 
need for the addition of chemicals to enrich the initially 
randomly-growing population, with cells in a specific stage of the 
cell cycle e.g. the addition of an excess of thymidine to obtain 
cells at the beginning of S-phase (Barranco and Humphrey, 1971).
Two days prior to the experiment four CHO-Kl cultures were 
initiated by inoculating 5x10s cells into 150ml culture bottles 
each containing 15ml Hams F10 + 5% PCS. After 48 hours growth at 
37.5°C, in a 5X 002 in air atmosphere, the medium was removed from 
the cultures and replaced with 10ml of fresh, pre-warmed Hams F10
1 0 6
+ 5% PCS. The bottles were then shaken gently to remove dead cells 
and loosely attached interphase cells. The medium was removed and 
again replaced with 10ml fresh media. After 30 minutes the first 
'shake-off’ was performed by gentle circular agitation, the cells 
being collected by centrifugation of the removed media at lOOOrpm 
for 5 min. A further 10ml medium were added to each culture bottle 
and re-incubated for 1 hour. The cells collected were kept on ice, 
in medium lacking PCS, until needed. This prevented the cells from 
progressing through the cell cycle. This procedure was repeated 
twice again i.e. a total of three ’shake-offs’, the cells were 
pooled and used immediately following the last collection.
4.4.2. The effect of synchrony on the MNNG-induced cytotoxicity
and mutation to Qua1 in CHO-Kl cells.
Two days prior to the experiment, cultures of CHO-Kl cells 
were set up in four 150ml culture bottles each containing 15ml 
Hams F10 + 5% PCS, gassed with OO2 in air and incubated at 37.5°C. 
After 48 hours growth, cells were synchronised and collected by 
the method of Zwanenburg, (1983) (4.4.1.). Following cell density 
determination of each population, dilutions were carried out as 
required, to set up selection and survival plates. After 7 days 
incubation at 37°C in a 5X 002 in air atmosphere, the plates were 
stained, randomised and scored 'blind'. The results of both 
survival and mutation to Oua* for pre-treated and control 
synchronous cells are shown in Fig.4.12. Also included in this 
Figure, for comparative purposes, are the dose-response curves of 
unsynchronised control cells and pre-treated unsynchronised 
control cells, as previously plotted in Figs.3.7., 4.3. and 4.6.
Fig.4.12.a. shows survival profiles similar to those seen for
0.2
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Figure 4*12. The effect of cell synchrony on the WING dose-response curves of survival and induced
nutation frequency to (Xia*, for CHO-Kl cells grown in Hams F10 ♦ 5% PCS. ( • ) = control; 























The effect of cell synchrony on the 
Relationship between induced nutation 
frequency to (X»B and percentage survival, of 
CHO-Kl cells grown in Haas F10 ♦ 5% PCS. Open 
and closed symbols represent synchronised 
cells and control cells respectively.
Figure 4.14. Summary of adaptation pre-treatment Protocol 2
80 hours . Growth Curve
7 days Cytotoxicity data,-48 -36 r24 -1 2 3 hrs , 2 hrs
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a-d : MNNG adaptive dose (0.01 pgml-1).
c-d : MNNG challenge doses (0.02-0.3 pgml*1).
m-c : Medium change
QUA : Mutant selection medium - Hams F10 + 5% PCS ♦ lmM ouabain.
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asynchronous cells (Fig.3.7.) but different to those seen for 
pre-treated unsynchronised cells. From this Figure a Da7 value of 
0.028 iigml-1 MNNG for synchronised CH0-K1 cells is derived. This 
value is 1.33-fold greater than that of unsynchronised cells i.e. 
0.021 jigml-1 MNNG, but is 1.5-fold less than the Ds7 value of 
0.042 Mgml"1, derived for adaptively pre-treated CH0-K1 cells 
Synchronised CHO-K1 cells exhibit similar nutation 
frequencies to unsynchronised cells, both on a dose basis and on an 
equicytotoxic basis (Figs.4.12.b. and 4.13.).
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4.5. Conclusions.
Fran the results reported in this chapter the following can
be concluded.
1) MNNG, in the range 0.02-0.3 jigml"1 induced mutation at the 
Na+/K*ATPase locus in a reproducible and dose-dependent fashion 
for both CHO-K1 and V79-379A cell lines (Figs.4.2., 4.3. and
4.4.).
2) The spontaneous (vehicle control) mutation frequencies were low 
and in the order of 1x10"6.
3) Adaptive pre-treatment resulted in a reduced MNNG-induced mutation to 
OuaE, on a dose basis, for both CHO-K1 and V79-379A cell lines 
(Figs.4.6. and 4.7.). However, when the data was analysed at
equicytotoxic doses the pre-treated cells were found to be as 
equally mutable as untreated cells (Fig.4.8.).
4) The spontaneous (vehicle control) mutation frequencies of 
pre-treated cells were higher than control cells in the order 
of 3x10"5.
5) The growth of CH0-K1 and V79-379A cells can be defined 
according to two parameters i.e. lag time and population doubling 
time. For CH0-K1 the values are 6 hours and 14.4 hours 
respectively, and for V79-379A cells are 6 hours and 11.4 hours 
(Table 4.2).
6) Adaptive pre-treatment of V79-379A cells did not alter the lag time 
but slightly increased the population doubling time from 11.4 hours 
to 12.3 hours (Table 4.3.).
7) Adaptive pre-treatment of CH0-K1 cells increased the lag time
by 8 hours, from 6 to 14 hours, and also increased the population 
doubling time by 8.9 hours from 14.4 hours to 23.3 hours
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(Table 4.3.).
8) Synchronised CHO-K1 cells exhibit a D37 value of 0*028 pgml"1 
MNNG, which is 1.33-fold greater than the D37 value for 
unsynchronised cells (0.021 pgml"1) and 1.5-fold less than the 
D37 value for unsynchronised pre-treated cells (0.042 pgml"1). 
the induced mutation to OuaR was not significantly altered by 
synchrony.
These conclusions are discussed in Chapter 8.
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CHAPTER 5. THE ISOLATION AND CHARACTERISATION OF CHO-K1 AND
V79-379A CLONES SENSITIVE CR RESISTANT TO THE CYTOTOXIC 
EFFECTS OF MNNG.
5.1. Introduction.
CHO-K1 and V79-379A cells exposed to MNNG exhibit a 
dose-dependent cell killing which is seen to be bi-phasic (3.2.1. 
and 3.2.2.). This could indicate the presence of at least two cell 
sub-populations each with different sensitivites to MNNG. It is 
suggested, therefore, that MNNG pre-treatment of both cell lines 
may enrich the overall population with the more resistant 
sub-population. This will result in an enhanced survival (reduced 
kill) to subsequent mutagen challenge, a theory also proposed by 
Goth-Goldstein, (1987), in a recent publication. A number of 
authors, using various cell lines, have isolated clones that have 
survived high doses of mutagen and which are subsequently more 
resistant to mutagen challenge (Baker et al., 1979; Friedman and 
Hubennan, 1980; Goth-Goldstein, 1987a; Goth-Goldstein and Hughes, 
1987a; Goldmacher et al., 1986; Ishida and Takahashi, 1987). These 
clones are probably representative of the mutagen resistant 
sub-population of the chosen cell line.
It was proposed, therefore, to isolate the two 
sub-populations evident from the dose-response curves of both 
CHO-K1 and V79-379A cells (Fig.3.2. and 3.3.), determine the 
growth parameters, MNNG-induced cytotoxicity and mutation to OuaR 
and compare the results to the values obtained from their 
respective parental lines. The effects of pre-treatment on these 
variants was determined and compared to those observed with the 
parental control and pre-treated cells.
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5.2. Materials.
Hie isolation of sensitive and resistant sub-populations 
required a number of special materials not listed in Chapter 2: 
Glass selection cylinder: (5mn internal diameter x 8nm external 
diameter x 10mm high) with flame-rounded edges* prepared from a 
length of Pyrex glass tubing. Sterilised by dry heat at 160°C for 
1 hour.
Silicone grease; (Edwards High Vacuum Ltd.* Crawley Sussex.), 
dry heat sterilised at 160°C for 1 hour.
Polyester mesh: 17pm Polymer mesh (PES 17/6. Plastok Associates 
Ltd, Birkenhead). Mesh circles were cut using an 85mm template. 
Notches were made on the edge of each disc to facilitate matching 
of replicas.
Glass balls; 4.5 to 5.5mm diameter (EDH chemicals Ltd.* Poole* 
Dorset).
Preparation of mat^ials for replica plating:
Systematic preparation of polyester discs and glass balls was 
essential for consistent results. Following initial use* both 
polyester discs and glass balls may be re-cycled and used 
repeatedly;
Initial preparation of glass balls: the glass balls were subjected 
to an overnight soak in 10% v/v nitric acid was followed by a 
thorough wash in running water (2 hours). A 2 hour soak in sodium 
hypochlorite solution (12% available chlorine), diluted 1/50 in 
water* was followed by a thorough wash in running water. The glass 
balls were then boiled in detergent (2% RBS 25. Chemical 
concentrates Ltd., London) for 5 minutes. The glass balls were 
washed for several hours in running water and then rinsed with
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four changes of distilled water and drained well. They were placed 
in a beaker, covered with foil and sterilised for 1 hour at 160°C. 
Re-cycling of glass balls: after removal from the culture medium 
the glass balls were soaked for two hours in detergent, washed for 
two hours in running water then rinsed with four changes of 
distilled water. After dry heat sterilisation the balls were ready 
for re-use.
Polyester: initial preparation and re-cycling. A batch of 
polyester discs was soaked in dilute bleach for 30 minutes, washed 
in running water for two hours and boiled in detergent for 5 
minutes. The discs were washed overnight in running water, rinsed 
with four changes of distilled water and drained well. 
Sterilisation was performed by placing each disc between a 
filter-paper 'sandwich* within a well fitting autoclave bag. It 
was important to keep the mesh discs flat throughout the 
sterilisation procedure to maintain their structural integrity.
The sealed bags were then placed within an autoclave and 
sterilised at 121°C for 15 minutes.
5.3. Cell isolation procedures.
5.3.1. Isolation of MNNG resistant clones CHO-K1R and V79-379AR 
by ring cloning.
Isolation of MNNG resistant clones of both cell lines was 
carried out by following the ring cloning technique of Kao and 
Puck, (1974).
48 hour cultures of either CH0-K1 or V79-379A were 
trypsinised and the cell densities of each suspension determined. 
Suspensions were diluted to a density of 2xl04 cells ml-1 and 0.1 
ml aliquots of this suspension were transfered to a number of 90mm
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T/C petri dishes each containing 10ml of Hams F10 + 5% PCS.
Following three hours incubation, at 37.5°C in a 5X 002 in air 
atmosphere, 0.3 pgml-1 MNNG was added and the plates re-incubated 
for two hours. After this time the medium was replaced with fresh, 
pre-warmed Hams F10 + 5% PCS and the plates re-incubated for seven 
days. At this dose level there should be an approximate survival 
rate of IX i.e. about 20 colonies per plate (Figs.3.2. and 3.3.)•
The location of each colony was marked with a glass marker on the 
underside of the plate. Each colony was examined under an inverted 
microscope (2.1.) and a colony which was sufficiently isolated 
from other cells was chosen for clone isolation for each cell 
line. The medium in the plates was removed and a glass selection 
cylinder placed directly over the centre of each colony. The 
cylinder was caused to adhere to the bottom surface of the plate 
by application of a thin layer of silicone grease to the bottom 
edge and then pressed firmly to the plate, making a seal with the 
plastic. Both the cylinder and grease had been previously sterilised 
by dry heat (5.2. )• The cylinder was rinsed with a few drops of 
trypsin solution and the wash discarded. Cells were dispersed by 
adding a few drops of trypsin and incubating for 5 minutes at 
37.5°C. the cells were suspended by gentle aspiration with a 
Pasteur pipette and transfered to 25cm2 T/C flasks containing 5ml 
Hams F10 + 5% PCS . MNNG at 0.3 pgml*1 was added and the cells 
allowed to grow to 75% confluence i.e. about 7-9 days. After this 
time the cells were dispersed and the cell density determined. The 
cells were once more plated out but this time only 500 per plate 
were seeded since the cells were assumed to be more resistant to 
the lethal effects of MNNG. After 3 hours incubation 0.3 pgml**1 
MNNG was added to each plate and the cells allowed to grow for 7-9
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days. Resistant colonies of each cell line were once again 
isolated and allowed to grow in 25cm2 T/C flasks each containing 
5ml Hams F10 + 5% PCS plus 0.3 pgml"1 MNNG. After 7-9 days growth 
the cells were dispersed, counted and sub-cultured into medium 
lacking MNNG. Once 75% confluence was reached the cells were 
prepared for strorage over liquid nitrogen (2.6.5. )• The double 
cloning procedure for resistant mutants was recommended by 
Thompson, (1978). The isolated MNNG-resistant clones from each 
cell line were designated as CHD-K1R and V79-379AR (R = survivors 
of a 0.3 pgml*1 MNNG dose).
5.3.2. Isolation of MNNG-sensitive clones CHO-K1S and V79-379AS 
bv replica plating on polyester mesh discs.
Isolation of MNNG-resistant clones is carried out by 
removing surviving colonies from a culture subjected to a specific 
mutagen dose. Isolation of MNNG-sensitive clones is, however, a 
more difficult process. Since the clones sought are specifically 
those with an increased sensitivity to MNNG the only technique 
available for distinguishing these cells is one that kills them. 
One solution to this problem is to use the technique of replica 
plating. Coranonly used with bacteria and yeasts this technique has 
been less easily applied to mammalian cells. Replica plating 
involves the inoculation of low densities of cells into 
petri-dishes, allowing single cell growth, the resultant colonies 
being copied onto a suitable material. After mutagen treatment, 
the most sensitive colonies can be identified and isolated from 
the corresponding position on the untreated replica. Esko and 
Raetz, (1978), initially used filter paper discs for replica 
plating of CHO cells but found this technique unsuitable for other
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cell lines. In a later publication Raetz et al., (1982) reported a 
more efficient method of replica plating using polyester mesh 
discs to produce high quality replicas of CHO cells and even 
relatively non-adherent myeloma and hybridotna cell lines.
The method of Raetz et al., (1982) was therefore used to 
isolate MNNG-sensitive clones from the CHO-K1 and V79-379A cell 
lines.
The procedure for both cell lines was identical. Two days 
prior to the experiment cultures were set up by inoculating 5xl05 
cells into 150ml culture bottles each containing 15ml of Hams F10 
+ 5% PCS, gassed with CO2 in air and then incubated at 37.5°C.
After 46-48 hours growth the cells were dispersed with trypsin, 
the cell density determined and the suspensions serially diluted 
to a density of lxlO3 cells ml*1. 0.1ml aliquots of these 
suspensions were transfered into a nunber of 90mm T/C petri dishes 
each containing 10ml of Hams F10 + 5% PCS. The cells were evenly 
distributed by circular agitation and then incubated for 3 days. 
After this time four 85mm polyester discs were overlayed onto the 
partially developed colonies. The disc notches were aligned prior 
to overlaying and the position marked on the underside of each 
petri dish. The discs were weighed down with a single layer of 
sterile glass balls to ensure close contact between colonies and 
discs. CHO-K1 and V79-379A grow normally in monolayers, but given 
a physical matrix to adhere to, will grow vertically (Raetz et al., 
1982). After 3 days growth the medium and glass balls were tipped 
from the culture dishes and 5ml pre-warmed FBS(A) was added. The 
now floating discs were separated and transfered to 90mm T/C 
dishes containing 10ml of pre-warmed Hams F10 + 5% PCS. To two of 
the replica containing dishes 0.02 pgml*1 MNNG was added. Care was
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taken not to use the top replica for the mutagen treatment since 
incomplete transfer of all colonies, to this disc, was sometimes 
observed. Plates were re-incubated for 3 days after which the 
treated replicas and one of the master copies were stained. The 
stained discs were compared and the position of absent colonies on 
the MNNG-treated discs scored on the control master disc. Once 
identified the corresponding live colony on the unstained master 
plate was located and isolated by ring cloning (5.3.1. )• The 
isolated colonies were grown in 25cm2 T/C flasks containing 5ml 
Hams F10 + 5% PCS, at 37.5°C in a 5% CO2 in air atmosphere, until 
75% confluence was reached, after which the cells were 
sub-cultured in preparation for later cell storage over liquid 
nitrogen (2.6.5.).
Plates 5.1. and 5.2. show the master, replica and mutagen 
treated replicas of CHO-K1 and V79-379A cells respecively. A few 
colonies have failed to transfer along the edges of some discs 
because the mesh was unevenly cut. The colony isolated from the 
unstained master disc (not shown) is indicated on the stained 
master discs. According to the dose-response curves shown in Figs
3.2. and 3.3. a dose level of 0.02 pgnil"1 MNNG should result in an 
approximate 60X kill. This does not seem to hold true for the 
partially developed colonies found on each disc. Therefore only 
the colonies that had completely disappeared were selected.
Replica 2 of Plate 5.1., however, shows the colonies to be less 
dense than the corresponding untreated replica possibly indicating 
a cytotoxic effect of MNNG but without complete killing of the 
colony.
The MNNG-sensitive clones derived from each cell line were 
designated CHO-K1S and V79-379AS (S = colonies most sensitive to
MASTER PLATE REPLICA 1 REPLICA 2
+ WNG
Plate 5.1. Isolation of the MNNG-sensitive clone CHO-K1S by replica plating on polyester mesh 
discs. The colony missing from replica 2, following a dose of 0.02 pgml-1 MNNG, was 




MASTER PLATE REPLICA 1
REPLICA 2 
+ MNG
Isolation of the MNNG-sensitive clone V79—379AS by replica plating on polyester mesh 
discs. The colony missing from replica 2, following a dose of 0.02 pgml'1 MNNG, was 
isolated from the corresponding position on a master replica disc.
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an MNNG dose of 0.02 pgml"1).
5.4. The effect of adaptive pre-treatment on the MNNG-induced 
cytotoxicity of the sensitive and resistant cell varimta.
5.4.1. Toxic response tests : single plated CH0-K1S. CH0-K1R.
V79-379AS and V79-379AR cells.
After isolation of each cell variant it was first necessary 
to establish if the selection procedures had been effective. Therefore 
MNNG dose-response curves were constructed for each variant line.
Two days prior to the experiments cultures of each cell 
line were started by inoculating 5x10s cells into 150ml culture 
bottles each containing 15ml of Hams F10 + 5% PCS, gassed with 5%
002 in air and incubared at 37.5°C. After 46-48 hours growth cell 
suspensions were obtained and the cell density determined. The 
suspensions were serially diluted to densities between lxlO3 and 
8xl04 cell ml’1, 0.1ml aliquots of each suspension were transfered 
to 50nm T/C petri dishes containing 4.9ml of pre-warmed Hams F10 +
5% PCS, to give between 100 and 8000 cells/plate, depending on the 
expected cytotoxicity. After 3 hours incubation the cells were 
exposed to MNNG at concentrations in the range 0.02 to 0.3 pgml*1. 
Following a 2 hour exposure the medium was replaced with 5ml 
fresh, pre-warmed Hams F10 + 5% PCS and the cells re-incubated for 
7 days, stained, coded and scored 'blind*.
MNNG-induced dose-response curves for each cloned line are 
shown in Figs.5.1. and 5.2. The values for CHO-K1S and V79-379AS 
are expressed as the mean survival ± standard error, of three 
independent experiments, plotted on a log scale against MNNG 
concentration. The values presented for CHO-K1R and V79-379AR 
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Figure S.l. Dose-response curve for CH0-K1S (▲) and CHO-K1R 
cells (▼) grown in Hams F10 + 5% FCS, treated 
with MNNG ( A  , n=3 ± S.E.; ▼  , n=4 ± S.E.). The
dose-response of CHO-K1 cells (---- ) has been














Figure S.2. Dose-response curve for V79-379AS cells ( x ) and 
V79-379AR cells (♦ ) grown in Hams F10 *1* 5% PCS, 
treated with MNNG ( x , n=3 ± S.E.; ♦ , n=4 ± 
S.E.). The dose-response curve of V79-379A cells
(---- ) has been included for comparative
purposes.
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experiments. Hie parental dose-survivor curves are also shown in 
Figs.5.1. and 5.2., for comparative purposes,and are represented 
by single broken lines derived from the data presented in 
Figs.3.2. and 3.3.
The MNNG-sensitive cell clones CHO-K1S and V79-379AS 
exhibited cell killing identical to the parental lines up to a dose 
level of 0.05 pgml'1. Above this level the cells appear to be 
much more sensitive to MNNG than their respective parental lines.
03 7 values for parental and sensitive cell are shown below in 
Table 5.1.
Table 5.1. A comparison of the relative sensitivities of different 
cell types to MNNG, as measured by the D 37 values.







This suggests that the replica plating procedure was 
successful resulting in the isolation of a cell line more 
MNNG-sensitive than the parental line.
1 2 6
Resistant cell variants CH0-K1R and V79-379AR were found 
to be 5.2 and 5.7 fold more resistant to the cytotoxic action of 
MNNG when compared to their respectrive parental lines shown above 
in Table 5.1.
Both lines were maintained in the absence of MNNG for two 
months without a loss of MNNG resistance.
Resistant clones previously isolated by other workers, have 
shown between 3.3 and 40 fold greater resistances to mutagen 
challenge by the selecting mutagen, when compared to their 
parental lines (Friedman and Huberman, 1980; Goldmacher et al., 
1986; Goth-Goldstein, 1987; Ishida and Takahashi, 1987).
5.4.2. The effect of adaptive pre-treatment on the MNNG-induced 
cytotoxicity of CHO-K1R and V79-379AR cells.
Cultures of each cell line were set up and pre-treated as 
previously described (3.4.2.). Construction of MNNG dose-response 
curves for CHO-K1S and V79-379AS cells was attempted many times 
with little success. Colonies were not visible even after 11 days 
incubation, an observation probably explained by the results 
reported in 5.5.2.
It was possible, however, to construct MNNG dose-response 
curves for both CH0-K1R and V79-379AR lines following adaptive 
pre-treatment (Fig.5.3.). CHO-KIR cells exhibited no change 
following adaptive pre-treatment with control and pre-treated D37 
values of 0.11 pgml*1. In contrast, pre-treated V79-379AR cells 
showed a higher D37 value than that of control untreated V79-379AR 
cells i.e. 0.13 and 0.07 pgml'1 respectively. Furthermore survival 
of pre-treated cells is seen to be an exponential function of 











5.3. The effect of adaptive pre-treatment, by Protocol 2, on the doee-response curves of CH0-K1R cells, 
(a), and V79-379AR cells, (b), grown in Hams F10 ♦ 5% PCS. Open and closed symbols represent 




5,5. Hie effect of adaptive nre-treatment on the growth 
of the isolated clones.
5.5.1. Determination of the growth parameters of CH0-K1S. CHO-K1R.
V79-379AS and V79-379AR cells.
Growth curves for the above cells were constructed as 
described in 4.3.1. and are shown in Figures 5.4. and 5.5. The 
growth parameters derived from these data are shown on Table 5.2.
CHO-K1S cells show growth parameters that are identical to 
the parental cell line both having a population doubling times of 
14.4 hours and lag times of 6 hours (Tables 4.2. and 5.2.)•
V79-379AS cells exhibit the same lag time (6 hours) as their 
parental cells but have a population doubling time of 14.4 hours 
compared to 11.4 hours (Tables 4.2. and 5.2.). However, this value 
of T lies within the previously reported range of 10-16 hours for 
V79 cells (Bradley et al., 1981; Hsie et al., 1981; Kao and Puck,
1974) and is therfore considered to be no different to control.
CHO-K1R cells exhibited increased lag and population 
doubling times compared to parental cells (Tables 4.2. and 5.2. )•
These values are similar to those seen for parental cells 
following adaptive pre-treatment where both lag and doubling times 
are increased (Table 4.3.). This suggests that adaptive 
pre-treatment may have enriched the parental population with 
resistant cells so mimicing the resistant clone selection 
procedure. This theory, however, may not hold true for V79-379A 
cells since resistant cells show increased lag and doubling 
times, over parental, but pre-treated parental cells show no 
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Tahle S.2. Growth parameters of CHO-K1S. CHQ-K1R. V79-379AS 
and V79-379AR cells grown in H«n« F10 + 5% PCS*







CH0-K1S 6 0.0695 14.4 0.97
CHO-K1R 17.5 0.0382 26.1 0.99
V79-379AS 6 0.0679 14.7 0.99
V79-379AR 11.5 0.0409 24.4 0.98
k = Exponential growth rate constant. 
T » Population doubling time, 
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Figure 5.6. The effect of adaptive pre-treatment, by Protocol 
2, on the growth of CHOK1S grown in Hams F10 ♦
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Figure 5.7. The effect of adaptive pre-treatment, by Protocol 
2 on the growth of V79-379AS cells in Hams F10 + 
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Figure5 . The effect of adaptive pre-treatment, by Protocol 2, on the growth of CHO-K1R cells, (a), and 
V79-379AR cells, (b), grown in Hams F10 + 5% PCS. Open and closed symbols represented 
pre-treated and control cells respectively.
Table 5.3. The effect of adaptive pre-treatment, by Protocol 2
on the growth parameters of CHQ-K1S. CHO-K1R. V79-379AS 
and V79-379AR cells grown in Hama F10 + 5% PCS.







CHOK1S 6 0.0695 14.4 0.97
CHO-K1S 
+ ADA
10 0.00922 108.5 0.99
CHO-K1R 17.5 0.0382 26.1 0.99
CH0-K1R 
+ ADA
18 0.0386 25.9 0.99
V79-379AS 6 0.0679 14.7 0.99
V79-379AS 
4 ADA
6 0.0146 68.4 0.98
V79-379AR 11.5 0.0409 24.4 0.98
V79-379AR 
+ ADA
11.5 0.0409 24.4 0.99
k = Exponential growth rate constant. T = Population doubling time. 




5.5.2. The effect of adaptive MNNG pre-treatment on the growth 
paramaters of CHO-K1S. CH0-K1R. V79-379AS and V79-379AR 
cells.
To determine the effect of adaptive pre-treatment on the 
growth parameters of these cell lines, cultures were set up and 
pre-treated with repeated dcses of MNNG as detailed in 3.4.2. and 
Fig.4.14. At t=0 the cells were dispersed with trypsin and the 
cell density determined. 2x10s cells of each cell line were 
inoculated into a number of 25cm2 T/C flasks containing 5ml of 
Hams F10 + 5% PCS. Growth curves for each cell line, with or 
without adaptive pre-treatment, were constructed as described in
4.3.2. and the results are presented in Figs.5.6., 5.7 and 5.8., 
and also on Table 5.3.
Following adaptive pre-treatment the population doubling 
times of both MNNG-sensitive cell lines were much greater than 
untreated cells with CH0-K1S cells having a doubling time of 108.5 
hours and V79-379AS a value of 68.4 hours (Table 5.3.)• Untreated 
cells had T values of 14.4 and 14.7 hours respectively (Table 
4.2).
5.6. The IHC-inducfld ■ri-Atifln to Qua1 of the isolated Hwwltive 
or resistant clones.
5.6.1. Determination of the induced mutation to Qua* of CHO-KIS. 
CH0-K1R. V79-379AS and V79-379AR cells.
Two days prior to the experiment, duplicate cultures of 
each cell line were set up by inoculating 5x10s cells into 150ml 
culture bottles each containing 15ml Hams F10 + 5% PCS. The 
cultures were gassed with 5% OO2 in air and incubated at
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37.5°C. After 46-48 hours growth the cells were dispersed with 
trypsin and the cell density determined* These suspensions were 
used to inoculate 2x10s cells into 90mn T/C petri dishes (five 
dishes per mutagen treatment i.e. lxlO6 cells in total) containing 
Hams F10 + 5% PCS to 10ml (selection plates). Further dilution of 
the initial suspension allowed survival plates to be set up in 
parallel as outlined in 3.2*1. and 3.2.2. Following a 3 hour 
incubation, MNNG doses in the range 0.02 to 0.3 pgml"1 were added 
to both survival and selection plates. After 2 hours mutagen 
treatment the culture medium was replaced with fresh, pre-warmed 
Hams F10 + 5% PCS and the plates re-incubated. Following a further 
46 hour incubation, (mutant expression time, Fig.4.1.), the medium 
in the selection plates was replaced with 9ml Hams F10 *1* 5% PCS 
plus 1ml of stock ouabain solution (2.4.2.). All plates were 
incubated and then stained, coded and scored 'blind* after 7 days 
(survival plates) and 8 days (selection plates). The results of 
these experiments are illustrated as a plot of induced mutants per 
10® survivors, on a log scale, against percentage survival, on a 
log scale, in Fig.5.9.
At each MNNG dose level CHO-K1S and V79-379AS cells show a 
greater number of induced mutants than those of their respective 
parental lines. When mutation is considered as a function of cell 
survival, however, the these sensitive clones appear to be as 
equally mutable as their parental lines (Fig.5.9.). CHOK1R and 
V79-379AR cells show the opposite i.e. a decreased number of 
mutants at all MNNG dose levels, but again these cells are seen to 
be as equally mutable as the parental lines when plotted as a 
























X Survival X Survival
Figure 5,9, The relationship between the MNNG-induced mutation frequency to OuaK and percentage survival 
of CH0-K1 ( • ), CH0-K1S (▲ ), CH0-K1R ( T ), V79-379A ( ■ ), V79-379AS ( x ) and V79-379AR cells 
(+) grown in Hams F10 + 5X PCS. 138
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5.6.2. The effect of adaptive pre-treatment on the MNNG-induced
mutation to OuaR of CHO-K1R and V79-379AR cells.
It was shown in 4.4.1. that adaptive pre-treatment severely 
retarded the growth of CH0-K1S and V79-379AS cells. Therefore it 
was decided to determine the effect of pretreatment on the 
MNNG-induced mutation to Oua* in the resistant clones CH0-K1R and 
V79-379AR only.
Two days prior to the experiment, duplicate cultures of 
each cell line were started by inoculating 5x105 cells into 150ml 
culture bottles each containing 15ml Hams F10 + 5% PCS. The 
cultures were gassed with 5% 002 in air and incubated at 37.5°C. 
After 46-48 hours growth the cells were dispersed with trypsin and 
the cell density determined. Adaptive pre-treatment was performed 
as detailed in 3.4.2. At t=0 selection and survival plates were 
set up and the procedure outlined in 5.6.1. followed through. 
Adaptive pre-treatment appears to have little effect on the 
induced mutation frequencies of either CHO-K1R or V79-379AR cells 
when compared to the values obtained for untreated resistant cells 
or those of their respective parental cells (Fig.5.10.). The 
spontaneous mutation frequencies to OuaR are not altered by 
pre-treatment as previously observed following adaptive 

























% Survival X Survival
Figure 5.10. The effect of adaptive pre-treatment, by protocol 2, on the relationship between
MNNG-induced mutation frequency to Oia* and percentage survival of CH0-K1R cells and 
V79-379AR cells grown in Hams F10 + 5% PCS. (( •  ) = CHO-K1; ( ▼) = CH0-K1R; (V) = CHO-K1R 







From the results reported in this chapter the following
can be concluded:
1) It was possible to separate two discrete sub-populations of 
both CH0-K1 and V79-379A cells by virtue of their differing 
sensitivities to MNNG.
2) Cells surviving MNNG doses of 0.3 pgml-1 were isolated by ring 
cloning and were found to have a greater resistance to
MNNG-induced cell killing than their respective parental line 
(Figs.5.1. and 5.2.). CH0-K1R and V79-379AR cells had D37 
values of 0.11 and 0.07 pgml-1 respectively (5.4.1.). These 
values are 5.2 and 5.7 fold greater than their respective 
parental lines (Table 5.1.).
3) MNNG-induced dose-survivor curves of the derived MNNG-sensitive 
clones CHO-K1S and V79-379AS were identical to the parental 
survival up to a dose level of 0.05 pgml-1, beyond which the 
cells exhibited a much greater MNNG-sensitivity (Figs.5.1. and
5.2.).
4) Survival of CHO-K1R cells was seen to be an exponential 
function of MNNG dose which was unaffected by adaptive 
pre-treatment (Fig.5.3.). The slightly bi-phasic nature of the 
V79-379AR dose-response curve was altered to a simple 
exponential decrease in cell survival by, with increase in MNNG 
dose, adaptive pre-treatment (Fig.5.3.). An increase in D37 
value to 0.13 pgml-1 compared to 0.07 pgml-1 for untreated 
V79-379AR cells was seen.
5) CHO-K1R and V79-379AR cells exhibited population doubling 
times of 26.1 and 24.4 hours with lag times of 17.5 and 11.5 
hours respectively (Fig.5.5.; Table 5.2.). These parameters
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were unaffected by adaptive pre-treatment (Fig.5.8.; Table 5.3.).
6) CHO-K1S and V79-379AS cells exhibited population doubling 
times of 14.4 and 14.7 hours respectively. Both had lag times 
of 6 hours (Fig.5.4.; Table 5.2.). These parameters are 
comparable to those of parental cells (Table 4.2.). Population 
doubling times (T) are dramatically increased following adaptive 
pre-treatment. T for CHO-K1S was increased by 94.1 hours, from 
14.4 to 108.5 hours. For V79-379AR, T was increased by 53.7 
hours, from 14.7 to 68.4 hours (Figs.5.6. and 5.7.; Table
5.3.). The lag time of CHO-K1S was increased by 4 hours, from 6 
to 10 hours, following pre-treatment. The lag of V79-379AS 
cells was unchanged at 6 hours, following pre-treatment (Table
5.3.).
7) CHO-K1S and V79-379AS cells exhibited induced mutation 
frequencies to OuaB that were higher, on a dose basis, than 
those of parental cells but when analysed at equicytotoxic 
doses these cells were seen to be as equally mutable as their 
respective parental cell lines (Fig.5.9.).
8) CH0-K1R and V79-379AR cells showed MNNG-induced mutation 
frequencies to Ouas that were lower, on a dose basis, than 
those of parental cells. Again, analysis of the data at 
equi cytotoxic doses revealed these cells to be as equally 
mutable as their respective parental cell lines (Fig.5.9.)• 
Mutation frequencies of each resistant line were unaltered by 
adaptive pre-treatment (Table.5.10.). Spontaneous (vehicle 
control) mutation frequencies remained low following 
pre-treatment (cf. 4.2.3.).
These conclusions are discussed in chapter 8.
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CHAPTHt 6. ANALYSIS OF Q<-4ffiraYI/jUANINE--DNA-MElHYLTOANSFHRASE 
ACITVnY IN QBD-K1. CHCHK1R. V79-379A AND V79-379AR 
CELLS.
6.1. Introduction.
The bacterial adaptive response essentially involves two 
repair enzymes (1.2.), whose activity can be induced by mutagen 
treatment at sub-lethal concentrations. There is conflicting 
evidence for the presence of these enzymes in mammalian cells 
(1.4.1. and 1.4.2.). Interests, in the main, have been focused on 
the O8 -methylguanine-DNA-methy 1 transferase (06MGMT) enzyme since 
this de-methylates the most important pre-mutagenic lesion
06-methyl guanine (06MG) leaving the natural base guanine (Beranek 
et al,, 1983; Newbold et al,, 1980). CHO and V79 cells have been 
reported to have a Her" phenotype i.e. methyl exision repair 
deficient (Foote et al,, 1983; Foote and Mitra, 1984; Yarosh et 
al., 1983, 1984) and so are unable to remove the 06MG lesion. If 
this is so, the apparent reduction of induced mutation frequencies 
following adaptive pre-treatment, observed for CH0-K1 and V79-379A 
cells (4.2.2.), is mediated via a mechanism not involving 
Waldstein et al., (1982c) found constitutive levels of (^MGMT in 
both CHO and V79 cells suggesting a possible involvement of this 
enzyme. However, this evidence was disputed by a number of authors 
(Foote et al., 1983; Foote and Mitra 1984; Harris et al., 1983; 
Yarosh et al., 1983, 1984).
To elucidate this problem it was decided to determine 
whether CH0-K1 and V79-379A cell lines actually possess the 06MGMT 
enzyme, and if so is it mutagen inducible. This was carried out by 
incubation of cell free extracts of each cell line with alkylated 
DNA and assessing the disappearance of 06MG using a HFLC
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separation technique. The 0®MG removal ability of pre-treated 
parental cell extracts and that of the resistant cell variants, 
also shown to have low induced mutation frequencies (5.6.1.), were 
determined. The MNNG-sensitive clones CH0-K1S and V79-379AS were 
not assayed for their ability to de-me thy late OsMG since the 
population doubling times of both lines was drastically increased 
by adaptive pr-treatment, making experimentation lenghty and 
unreliable. A cell line known to be Mer* i.e. C3H10T1/2 (Grisham 
and Smith, 1984; Smith et al., 1981) was used as a positive 
control and also to validate the assay procedure.
145
6.2. Materials.
This section includes materials not mentioned in Chapter 2.
6.2.1. Mobile phase.
— Three mobile phase systems were used during the course of 
these studies;
Mobile phase A : 5% methanol (HPLC grade, FSH Ltd., Loughborough): 
95% H2O, 6.5m NH4H2PO4 (BDH ChemicalsLtd, Poole), 
pH=5.0.
Mobile phase B : 40% methanol : 60% H2O, 6.5M NH4H2PO4 , pH=5.0. 
Mobile phase C : 70% methanol : 30% H2O.
Distilled water, used for the preparation of all mobile 
phase systems, was made free of particulate matter by vacuum 
filtration through a Millipore filtration unit fitted with a 47mm 
x 0.45 pm pore membrane filter. De-gassing was achieved by bubbling 
a constant stream of Helium through the mobile phase.
6.2.2. Colmn and HPLC equipment.
Separation of methylated nucleic acid bases was carried 
out using a reversed-phase 250 mm x 4.9 mm i.d. ODS-hypersil (5 pm 
particle size) column, pre-packed by Hi-Chrom Ltd., Reading,
The Spectra-Physics auto-analyser system was used in 
these studies. This comprised an SP8100 chromatograph with 
autosampler connected to a SP8440 variable wavelength detector 
both interfaced to a SP4200 dual channel computing integrator. The 
SP8100, SP8440 and SP4200 are interfaced in parallel and 
controlled by a Basic program running on an ADDS terminal operated 
by a Viewpoint/60 keyboard.
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6.2.3. flnlimn test system.
It is recommended by the manufacturers, that the 
performance of columns is tested on arrival and periodically 
during column use. The column efficiency is normally defined in 
terms of the number of theoretical plates, N, and is expressed as 
plates per column or plates per metre. It is calculated from 
either of the following equation:
N = 5.54(t*/W1/2)2  Equation 6.1.
and is illustrated in Figure 6.1.
Column testing is necessary to monitor deteriorations in 
performance as the life of the column increases and to eliminate 
these as the cause of poor separations. The standard test mixture 
for ODS-hypersil columns was Benzanu.de, Acetophenone and 
Benzophenone as recommended by Shandon Ltd, the manufacturers of 
this type of packing material. Fig.6.2. shows a typical column 
test chromatogram carried out before each experimental series. 
Chromatographic conditions are those recommended by Shandon 
designed for optimal performance. In the example shown, N, for 
peak a, is 12,499 theoretical plates, 12,764 for peak b and 12,764 
for peak c. The maximum quoted theoretical plate value, for 
ODS-hypersil columns, is 15,000 plates per 25cm (60,000 plates/ 
metre Shandon Ltd.). The efficiency of the column was therefore 
approximately 85% of the theoretical value which was deemed 
sufficient for the present studies.
6.2.4. Standards for HPLC.





Figure 6.1. Hie determination of HPLC column efficiency expressed as 
theoretical plates (N).
to = elution time for an unretained solute.
t« = elution time for solute a.
W 1 / 2 = peak width at half peak height.
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Elution time (mins.)
Pi^ ui't 6 » 2 »
Chromatogram showing separation of the recomnended test 
mixture for ODS-hypersil columns.
Peak a = Benzamide 3.7 mg
Peak b = Acetophenone 0.6mg
Peak c = Benzophenone 0.7mg made to 100ml with mobile phase.
Mobile phase C = methanol:H20 (70:30)
Flow rate = 1ml min"1. Wavelength = 254 nm.
Chart speed = 0.5 can min"1. Temperature = ambient. 
Apparatus = Spectra-physics (6.2.2.). Loop volume = 20pl.
149
Aldrich (cytosine, guanine), Sigma (adenine, thymine,
7-methylguanine) and Fluka AG, Switzerland (1-methylguanine, 
3-methylguanine, 3-methyladenine). All compounds were dissolved in 
0.1M HC1, filtered through a 25 ran x 0.45 pm Millipore filter unit 
and then diluted with mobile phase to concentrations of 10 pgml’1.
The methylated base crucial to these studies, O6-methyl 
guanine (06MG) is not commercially available and was therefore 
synthesised at this University. This methylated base was used as a 
standard marker at a concentration of 5 pgml*1.
6.2.4.1. Synthesis of Q6-methylguanine (6-methoxy-2-aminopurine).
Synthesis of this compound was carried out using the method 
of Balsiger and Montgomery, (I960), which involved the single-step 





The synthesis was performed as follows:
i) Sodium metal (500mg) was dissolved in 20ml of dry methanol in 
a round-bottomed flask.
ii) 410mg of 2-amino-6-chloropurine HC1 (2.4mnoles)(Sigma.) were 
added and the mixture stirred continuously.
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iii) The flask was brought to reflux temperature (80°C) and left for 
18 hours attached to a vertical water condenser.
iv) Following reflux the mixture was cooled to room temperature 
and acidified with 1.2ml (20mmol) of glacial acetic acid. 
Volatile material was removed under vacuum.
v) The residue was recrystallised from a small quantity of water 
and dried in a vacuum dessicator after recovery by 
filtration.
vi) The dried product (06MG) (M.Wt = 165.1)was weighed and the 
yield calculated
2.4mmol of 6-chloroguanine yielded 376mg product i.e.
376/165.1 = 2.28 nmols.
Therefore yield = 2.28/2.4 x 100 = 95X
vii) The structure and purity of the product were verified by NMR 
spectroscopy.
6.2.4.2. *H and 13C NMR spectra of Og-methvl guanine.
The structure of 06-methylguanine produced by the reaction 
in 6.2.4.1. was confirmed by NMR spectroscopy. Both reaction 
compounds were dissolved in DMSO-de (IMS internal standard) and 
analysed in a JBOL JNM-GX270 FT-NMR spectrometer operating at 270 
MHz (XH) or 67.8 MHz (13C). The XH NMR spectra for 6-chloroguanine 
and the synthesised 06MG are illustrated in Figure 6.3. For the 
purposes of this thesis it is not considered necessary to give a 
detailed account of the underlying theoretical basis of this type 
of spectroscopy; for this the reader is refered to Williams and 
Fleming, (1980), and related texts. However, explanation of the 
spectra presented in Figure 6.3. is facilitated by a brief and 
concise description of the principles involved in NMR
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spectroscopy.
Nuclear Magnetic Resonance (NMR) is observable because 
certain nuclei e.g. 1H and 13C behave like bar magnets • If a 
solution of the compound, containing 1H or 13C, is placed in a 
constant magnetic field the nuclei will either align themselves 
with the field, in a low-energy orientation, or against the field 
in a high-energy orientation. At equilibrium there will be a 
greater proportion of nuclei in the low-energy orientation. 
Application of an excitory radio-frequency radiation to the 
solution will cause the nuclei to change their energy state. The 
difference in energy between the two orientations is given by 
AE, which is proportional to the resonance radiofrequency. The 
NMR signal is generated by the net absorption of radiofrequency 
due to the imbalance in distribution of the nuclei between the two 
energy states. This absorption of a radiofrequency is detected by 
a receiver and then relayed to a chart recorder.
Nuclei, within a molecule, usually have unique magnetic 
environments. Each has a slightly different resonance frequency 
which is characterised by a chemical shift. Using 
tetramethylsilane ((CH3)4Si) as the internal reference compound, 
the chemical shift of a sample proton can be defined in terms of 6 
6 = Vs -  Vims / operating frequency x  1 0 s p.p.m.
where Vs = resonance radiofrequency of the sample, 
and Vtms = resonance radiofrequency of the internal standard IMS.
The spectrophotometer used for this analysis is equipped 
with an integration facility in which the spectrum is re-scanned 
in the mode such that the chart pen rises, on passing a signal in 
the spectrum, by an amount proportioned, to the number of protons 
producing the signal. Knowing that the number of protons of
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6-chloroguanine is 4, the relative heights of each step of the 
integration trace of spectrun 1 (Fig.6.3.), passing from right to 
left, indicates two, one and one protons at 6 values of 6.8, 8.2 
and 13 p.p.m. respectively.
Since the only difference, in proton NMR terms, between the 
starting compound and product is the presence of a methoxyl group, 
spectrum 2 should possess the same peak and integration patterns as 
spectrum 1 with the addition of a peak with a relative integration 
value of 3 i.e. 3 protons. This is indeed the case with the peak 
corresponding to the methoxyl group positioned at 6 value = 4. The 
peak at 13 p.p.m. was not included in spectrum 2 (Figure.6.3.). It 
can be concluded, therefore, that a methoxyl group has been 
substituted at the 6 position of the starting compound by replacing 
the chlorine atom. Spectrum 2 also shows small peaks to the left 
of the main peaks at 6 values 6.6 and 8.1 p.p.m. These correspond 
to the presence of a quantity of unreacted starting compound. 
Measurement of these peaks and comparison with the major peaks at 
6 values of 6.3 and 7.9 p.p.m. gives an estimation of product 
purity. When the peaks between 6 and 7 p.p.m. of spectrum 2 are 
measured, the following is observed:
Starting compound peak height= 27mm. Product peak height = 180mm. 
Therefore the purity of the synthesised O6-methylguanine 
is 180/27 x 100 = 85%.
The 13C-NMR spectra of 6-chloropurine and O6-methylguanine 
are shown in Figure 6.4. Spectrum 1 expresses peaks corresponding 
to the aromatic carbon atoms in 6-chloroguanine. Spectrum 2 also
I
contains these peaks but this time also a peak at 6 value = 53.
This corresponds to the methoxyl group of O6-methylguanine and is 




Figure 6.3. Proton NMR spectra of 6-chloroguanine and
06-methylguanine. Spectrun 2 shows the presence 
of a methyl group i.e. 6 value = 4. (6.2.4.2.).
1150








Figure 6.4. 13C-NMR spectra of 6-chloroguanine (1) and the product of 
equation 6.2. (i.e. the synthesised O6methylguanine) (2)
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= 45-60ppm (Williams and Fleming, 1980).
These data, in conjunction with the proton-NMR data, are 
conclusive evidence that the compound produced by the reaction 
given in 6.2.4.1. is indeed O6-methylguanine.
6.3. Separation of methylated DMA bases by high-performance liquid 
chromatography.
6.3.1. Separation of a mixture of 8 DNA bases.
Using the HPLC system outlined in 6.2.1. and 6.2.2. a 
mixture of 8 DNA bases, (guanine, cytosine, adenine, thymine, 
1-methyladenine, 3-methylguanine, 7-methylguanine and 
O6-methylguanine) were chromatographically separated. Since the 
injection loop volume was 20 pi, 10 pgml*1 or 1 pgml-1 solution 
injections would load either 200ng or 20ng of base onto the 
column. Fig.6.5. shows the separation of the above bases using 
moblie phase A (6.2.1.) at a flow rate of 1 mlrnin-1. Each peak 
indicates the retention time as calculated by the SP4200 computing 
integrator. The position of individual bases was determined by 
preparing a series of eight DNA base solutions, omitting a 
different base in each, of the eight present in the standard base 
mixture above, then identifying the absent peak from the standard 
chromatogram. Table 6.1. shows the mean retention time of each 
base determined from four replicate chromatographic separations.
The elution order of these bases agrees with the findings 
of Valencia et al., (1985) who used a reversed phase system, 
employing an identical mobile phase, to separate 13 nucleic acid 
bases. The retention times, however, are not comparable since 
these workers used a 300mm column packed with pBondpak phenyl 
(Ci8) with mid-run flow-rate alterations. This system failed to
OS
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Figure 6.5. Chromatogram showing the separation of 8 DNA bases using
an ODS-hypersil column. In the running order, from left to 
right, the peaks represent cytosine, guanine, thymine, 
3-methylguanine, 1-methylguanine, 7-methylguanine, adenine and 
O6-methylguanine. Mobile phase A. Flow rate = 1 ml min"1. 
Wavelength = 254nm. Chart speed = 0.5 cm min"1. Temperature = 
ambient. Apparatus = Spectra-Physics (6.2.2.). Loop volume =
20 pi. 156
Table 6.1. The retention times of eight DNA bases separated by reversed-phase HPLC.
Base Retention Time Rt (mins.) Average Rt(mins).
Cytosine 6.5 6.58 6.12 6.29 6.37
Guanine 6.95 6.85 7.14 7.14 7.02
Thymine 9.64 9.61 10.18 10.15 9.90
3-methyl guanine 10.82 10.81 10.79 10.79 10.80
1-methylguanine 13.61 13.61 13.48 12.84 13.40
7-methyladenine 14.41 14.37 14.68 13.48 14.24
Adenine 15.56 15.59 15.21 15.17 15.38
O*-methylguanine 20.39 20.39 19.75 19.91 20.11
Column = 250am x 4.9 am i.d. CDS-Hypersil (5 pm particle size). Injector 
loop volume = 20 pi. Temperature = ambient. Mobile phase = A (6.2.1.). 
Flow rate = 1 ml min’1. Wavelength = 254 nm. Chart speed = 0.5 cm min’1.
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separate adenine and 7-methylguanine whilst showing distinct 
separation of cytosine and guanine. The 006-hypersil column used 
in these studies, showed the opposite (Fig.6.5.). It was not 
possible to resolve 3-methyladenine using this system.
A number of studies have shown adequate separation of bases 
using strong cation-exchange (SCX) rather than reversed phase 
columns (Ratko and Fezzuto, 1985; Saffirman et al., 1984; Warren, 
1984), but preliminary studies, using a Whatman Partisil 10 SCX 
column, met with little success. Therefore the reversed-phase 
system, described above, was used in this study.
6.3.2. Optimisation of O8-methylgianine detection.
Since O*-methylguanine is the most important base and had 
the longest retention time, it was decided to optimise the 
detection of this base. Decreased retention time, by means of an 
increased organic modifier i.e. methanol, results in a poor 
separation of the remaining bases but an improvement in the 
O6-methylguanine peak sharpness. The concentration of methanol was 
increased to 40% (mobile phase B) resulting in a retention time 
for 06MG of approximately 6 mins (Fig.6.6.) compared to 20 mins 
using Mobile phase A (Fig.6.5.). Furthermore the sharpness of the 
O6-methylguanine peak was increased to such an extent that 
the machine attenuation was doubled to bring the peak into 
chart recorder range. The attenuation function of the computing 
integrator differs from the sensitivity function by producing a 
visually *on-scale* peak, whilst integrating the area below the 
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Figure 6.6. Identification of 06MG (Rt=5.96) in a mixture of 8 DNA 
bases using N OBS-hypersil column.
Mobile phase B. Flow rate = 1 ml min"1. Wavelength = 254nm.
Chart speed = 0.5 cm min’1. Temperature = ambient.
Apparatus = Spectra-Physics (6.2.2.). Loop volume = 20 pi.
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6.3.3. Calibration curve for 06-methvlguanine.
A useful feature of the SP4200 computing integrator is the 
ability to integrate the area under each chromatogram peak. The 
areas of fused or riding peaks were calculated by machine 
estimation of the baseline. Using this feature it was possible to 
produce an accurate calibration curve of machine integration units 
plotted against known concentrations of 06MG and was prepared as 
shown in Table 6.2. below, this allowed quantification of this 
base in enzyme assay reaction mixtures Figure 6.7. shows this 
relationship to be linear over the concentration range tested.
Table 6.2. Preparation of standard solutions for the preparation 
of an 06MG calibration curve.
0«MG stock 0.25 0.50 0.75 1.00 1.25
solution (5 pgml-1) (ml).
Mobile phase B (ml). 4.75 4.50 4.25 4.00 3.75
Cane", of C^MG 0.25 0.50 0.75 1.00 1.25
(pgml"1).
0*MG (ng) loaded 5 10 15 20 25
onto column (i.e.
20 pi injection).
6.4. Assay system for the determination of
O*-methvlguanine-EKA-methyltransferase (Q*MGMT) activity.
6.4.1. Cell-free extract preparation.
The method of Domoradzki et al., (1984) was used to prepare 
cell-free extracts of cell lines. This is outlined below:
i) 1.0 - 1.5 x 10* cells were suspended in medium, centrifuged at 
lOOOrpm for 5min then washed with buffer containing 50mM Tris-HCl 
(Sigma), ImM dithiothreitol (Sigma) and O.lmM EDTA, pH=7.5 and 
re-centrifuged at lOOOrpm for 5min. ii) The wash was discarded and 


























.7. Calibration curve of 06MG against chromatogram peak area. 
QDS-hypersil column. Mobile phase B. Flow rate = 1 ml min*1. 
Wavelength = 254. Temperature = ambient. Apparatus = 
Spectra-Physics. Chart speed 0.5 cm min*1. Loop voluae 20 pi. 
(x) = standard points, ( + ) = computer fitted line - least 
squares estimate.
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iii) Cell pellets were re-suspended in 1ml of buffer (see (i)) and 
sonicated in an ultrasonic bath at a frequency of 51 kHz (Lucas 
Dawe Ultrasonics, Shelton USA.), for two periods of 30 seconds, 
each separated by a 1 minute interval. The preparation was then 
centrifuged at 2000rpm for 10 mins to remove cellular debris. The 
supernatant was removed and designated as the cell extract, 
v) Protein concentration in this extract was calculated by the 
Bradford protein estimation (6.4.4.) and adjusted to 20-30 mgml"1 
with buffer (see (i)).
6.4.2. Preparation of alkylated DNA substrate.
DNA was alkylated as described by Pegg et al., (1981). Calf 
thymus DNA was suspended at 5 mgml'1 in 80mM sodium phosphate (BDH 
chemicals), pH=8.0 and incubated with ImM MNNGr for 30 minutes at 
37°C. The preparation was dialysed overnight against two changes 
of phosphate buffer at 4°C.
6.4.3. Enzyme assay conditions.
The reaction was based on the assay used by Boiteux and 
Laval, (1985) and was comprised of the following:
200 pi cell extract containing between 2 and 5 mg protein (6.4.1.) 
200 pi alkylated 5 mgml'1 calf thymus DNA suspension i.e. lmg IMA 
(6.4.2.)
100 pi incubation buffer (70mM Hepes (Sigma), ImM EDTA and ImM 
dithiothreitol, pH=7.6).
This mixture was incubated at 37°C for 0, 30 or 60 minutes 
in an Eppendorf microfuge tube (Sterilin) and the reaction stopped 
by rapidly cooling to 0°C on ice. IMA hydrolysis was achieved by
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addition of 20 til 1M HC1 and then heating the tubes at 80°C for 
30 minutes. The samples were neutralised by addition of 20 pi 
1M NaOH and the precipitate removed by centrifugation at 12,000g 
for 5 min. in a MSE Microcentaur microfuge (2.1.) The supernatant 
was filtered through a 25mm Swinnex unit fitted with a 0.2 pm 
Sartorius membrane (2.5.1.) and loaded onto the HPLC system 
for base quantification (6.5.).
6.4.4. Protein estimation.
Protein estimation was carried out by the method of 
Bradford, (1976) using a protein dye binding assay system:
Standard protein - 1 mgml"1 Bovine Seran Albunin (BSA) 
reagent (Aldrich) in distilled water.
Protein reagent - lOOmg of Cocmassie Brilliant Blue G-250 (BDH)
was dissolved in 50ml of 95% ethanol. 100ml of 
85% phosphoric acid w/v (FSH) was added and 
the solution made to 1 litre with distilled 
water i.e. 0.01% v/v Cocmassie Blue, 4.75% w/v 
EtCH and 8.5% phosphoric acid.
Standard protein - Duplicate standard curves were prepared as 
curve shown in Table 6.3. below:
Table 6.3. Preparation of standard solutions for the construction 
of a protein calibration curve.
Standard solution (pi) 0 10 20 40 60 80 100
Water (pi) 100 90 80 60 40 20 0
Protein (total pg) 0 10 20 40 60 80 100
To each tube 5ml of protein reagent were added, vortex
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mixed and and then left for 5 minutes at room temperature. The 
optical density at 595nm was read and a standard curve 
constructed. The spectrophotometer was set to zero by using a 
blank containing water. Fig.6.8. shows a typical protein standard 
curve of optical density at 595nm plotted against pg protein (BSA) 
and is seen to be linear with increasing dose over the range 10 to 
80 pg protein, above which the relationship becomes non-linear.
Protein estimation of cell-free extracts used lOOpl plus 
5ml protein reagent. If the optical density was greater than the 
range of the standard curve the sample was diluted with buffer 
(6.4.1.(i)) and re-estimated. A standard curve was constructed 
before each protein estimation since the protein reagent is known 
to deteriorate with age (Bradford, 1976).
6.4.5. Treatment of results.
Cell-free extract mediated de-methylation of the alkylated 
DNA substrate was assessed by comparison of the total amount of 
0 8MGr, at incubation time zero, with the total amount of 0 6MQ after
30 and/or 60 minutes incubation at 37°C (6.4.3. )• An 0®MG
calibration curve was constructed immediately before sample 
analysis and the amount, in nanogrammes, was calculated then 
converted to proles by multiplying by a factor of 6 (M.Wt. of 
0*MB = 165.1, hence lng = 6pmoles).
Results are expressed as follows:
pinoles 06MG de-methy la ted/mg protein =
pmoles 06MG de-methy la ted/mg protein at t=zero










0 10 20 30 40 50 60 70 80 90 100
pg protein (BSA)
Figure 6.8. Protein standard curve estimated by the method of
Bradford, (1976). Optical density at 595nm is plotted 
against pg BSA standard. '
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6.5. De-methylaticn of Q*MS in an exogenous alkvlftted DMA substrate.
6.5.1. Assessment of the ability of C3H 10T1/2 cells to
de-methy late 06MG of an exogenous alkylated DNA substrate. 
C3H 10T1/2 cells have been shown to possess the ability to 
de-methy late 06MG adducts contained within MNNG-treated DNA 
(Grisham and Smith, 1984; Smith et al., 1981). This cell line was 
therefore used as a positive control for the validation of the 
assay system. C3H IOTV2 cells are a fibroblast line derived from 
the embryonic ventral prostrate glands of inbred C3H mice 
(Reznikoff et al,, 1973). They have a plating efficiency of 12 to 
20%, an average generation time of 15.5 hours and are routinely 
grown in 75cm2 T/C flasks (2.1.). In previous studies Eagles Basal 
medium (BME) was used for the culture of this cell line (Greenberg 
et al., 1978; Reznikoff et al., 1973; Smith et al., 1981), but the 
use of Hams F10 containing 10% heat-inactivated PCS supported 
adequate cellular growth, with a doubling time of 15 hours.
The de-roe thy lation ability of this cell line was assessed 
as follows:
Two days prior to the experiment twelve 75cm2 flasks, each 
containing 15ml medium, were inoculated with 1x10s C3H IOTV2 
cells, gassed with 5% OO2 in air and incubated at 37.5°C. After 18 
hours growth the cells were dispersed with trypsin (2.3.3.), a 
cell extract prepared as described in 6.4.1. and the protein 
content estimated (6.4.4.) and adjusted to 20-25 mgml*1. As an 
approximation, for experimental guidance, 1x10s cells were 
equivalent to 20mg protein.
Incubation of each cell extract with alkylated DNA 
substrate, and its subsequent hydrolysis, was performed as 
outlined in 6.4.3. • The supernatants of extracts incubated at t=0,
167
30 and 60 minutes were analysed for 06MG content by the HPLC 
system outlined in 6.3.2. Fig.6.9. shows a chromatogram series, 
from a single experiment, of total 06MS content after each 
incubation time. Table 6.4. presents the results obtained from 
four independent experiments. The ability of C3H 10Ti/2 cell 
extracts to de-methy late 06MG from alkylated DNA is expressed as 
pmoles 06MGr removed per mg cell extract protein. After 30 and 60 
minutes incubation an average of 8.3 and 23.3 pmoles per mg 
protein, were de-methy la ted by the extracts. Smith et al., (1981) 
reported the capacity of this cell line to de-roe thy late 06MQ and 
so it was decided that the C3H 10T1/2 cell line could act as a 
satisfactory positive control for these studies.
6.5.2. Assessment of the ability of CHO-K1. CH0-K1R. V79-379A 
and V79-379AR cells to de-roe thy late OgMG.
The experimental protocol for the above cell lines was 
identical to that used for the C3H IOTV2 cell line as described 
in 6.5.1. The de-methylation of 06MGr from alkylated DNA by each 
cell line is shown in Table 6.5. From these results it can be seen 
that there is no significant de-methylation of 06MG by cell 
extracts of any of these cell lines. The control consisted of 5mg 
BSA substituted for the cell extract. It seems probable, therefore 
that neither CHO-K1 nor V79-379A cells possess any 06MG 
de-roe thy lat ing ability i.e. no methyl transferase enzyme, even at a 
constituitive level. The MNNG-resistant cells CH0-K1R and 
V79-379AR, which have been shown to have a lower MNNG-induced 
mutation frequency than their respective parental cells (5.6.1.), 
also exhibited the lack of ability to de-methy late the alkylated 
substrate. The partial de-methylating ability of each cell line
Figure 6.9. Chromatogram series illustrating the progressive disappearance 
of the 0®MG peak as a function of incubation time with a 
cell-free extract of C3H 10T1/2 cells.
ODS-hypersil column. Mobile phase B. Flow rate = 1 ml min*1. 
Wavelength = 254na. Chart speed = 0.5 cm min-1. Temperature = 
ambient. Apparatus = Spectra-Physics (6.2.2.). Loop volume = 20pl.







0 6MGr peak area 
(machine units).
ng pmoles Cell extract 
total mg/ 
incubation.




C3H IOTV2 0 1 191565 27.4 164 4.8 0
2 195736 28.0 168 5.1 0 0
3 203712 29.2 175 4.9 0
4 216346 30.9 185 4.8 0
30 1 153626 21.9 131 4.8 6.9
2 154712 22.1 133 5.1 6.8 8.3±0.86
3 153630 21.9 131 4.9 8.9
4 157220 22.5 135 4.8 10.4
60 1 68360 9.8 59 4.8 21.9
2 72854 10.4 62 5.1 20.8 23.3±1.19
3 63219 9.1 55 4.9 24.5
4 70184 10.0 60 4.8 26.0
* Calculated by Equation 6.3.
Table 6.5. De-methylation of 0*MB in alkylated DNA by cell-free extract of CHP-K1 and V79-379A cells
and their respective MNNG resistant clones CHO-K1R and V79-379AR.




0*MQ peak area 
(machine units).







CH0-K1 0 1 203242 29.2 174 5.0 0 0
2 211544 30.5 182 4.9 0
60 1 200489 28.8 172 5.0 0.4 0.4
2 219951 31.8 190 4.9 0
CH0-K1R 0 1 203815 29.2 175 4.8 0
2 213861 30.4 183 4.7 0
60 1 194700 27.9 167 4.8 1.7
2 193771 17.7 166 4.7 3.6 2.7
V79-379A 0 1 192832 27.6 165 4.2 0
2 216841 31.0 186 4.6 0
60 1 191643 27.4 165 4.2 0
2 187241 26.8 161 4.6 5.4 5.4
V79-379AR 0 1 197467 28.3 170 4.2 0
2 198447 28.4 170 5.0 0
60 1 193241 27.7 166 4.2 0.95
2 197389 28.3 170 5.0 0 0.95
Control 0 1 204952 29.3 176 5.0 0
(5mg BSA). 2 214831 30.7 184 5.0 0
60 1 191643 27.4 164 5.0 2.4
2 197210 28.2 169 5.0 3.0 2.7





was attributed to spontaneous substrate de-methylation since a 
control, which substituted BSA for the cell-free extract, also 
showed a small degree of de-methylating ability, after 60 minutes 
incubation i.e. 2.7 pmoles de-methy la ted/ mg protein for CH0-K1 
cells and 3.7 pmoles de-methy la ted/ mg protein for V79-379A cells 
(Table 6.5.).
6.5.3. The effect of adaptive pre-treatment on the ability of
CH0-K1. CHO-K1R. V79-379A and V79-379AR cells to
de-methy late Q6MG.
Two days prior to the start of the experiment, twelve 75cm2 
T/C flasks, each containing 15ml Hams F10 + 5% PCS were inoculated 
with lxlO6 cells. To each flask 0.01 pgml-1 MNNG was added 
(t=-48). The flasks were gassed with 5% 002 in air and incubated 
at 37.5°C. After 6 hours (t=-42), and every six hours until t=0, 
the medium in each flask was replaced with fresh, prewarmed Hams 
F10 + 5% PCS containing 0.01 pgml*1 MNNG. At t=0 all cells were 
harvested and assayed for their ability to de-methy late 08MG as 
outlined in 6.5.2. The evidence of 3.5.2. and the results of the 
above experiments, presented in Tables 6.6. and 6.7., strongly 
suggest the absence or inactivity of the 06MGMT enzyme in the cell 
lines studied since the de-methylation observed was not greater 
than that found for the protein control.
Table 6.6. De-methylation of 06MS in alkylated DNA by cell-free extracts of CHO-K1 and CHO-K1R cells
following adaptive ore-treatment.




06MG peak area 
(machine units).







CH0-K1 0 1 203242 29.2 174 5.0 0 0
2 211544 30.5 182 4.9 0
60 1 200489 28.8 172 5.0 0.4 0.4
a 2 219951 31.8 190 4.9 0
CHO-K1 0 1 213338 30.5 183 5.2 0
+ ADA 2 197015 28.2 169 5.1 0
60 1 183150 26.2 156 5.2 5.2
2 190565 27.3 164 5.1 0.98 3.1
CH0-K1R 0 1 203815 29.2 175 4.8 0
2 213861 30.4 183 4.7 0
60 1 194700 27.9 167 4.8 1.7
2 193771 17.7 166 4.7 3.6 2.7
CHO-K1R 0 1 197562 28.3 170 4.9 0
+ ADA 2 213861 30.6 183 4.7 0
60 1 192654 27.6 165 4.9 1.0
2 193718 27.7 166 4.7 3.6 2.3
Control 0 1 204952 29.3 176 5.0 0
(5mg BSA) • 2 214831 30.7 184 5.0 0
60 1 191643 27.4 164 5.0 2.4
2 197210 28.2 169 5.0 3.0 2.7
•Calculated by equation 6.3. ADA = adaptive pre-treatment (Protocol 2).
Table 6.7. De-methylation of C^MB in Alleviated DNA by cell-free extracts of V79-379A and V79-379AR
cells following adaptive pre-treatment.




0#MG peak area 
(machine units).







V79-379A 0 1 192832 27.6 165 4.2 0
2 216841 31.0 186 4.6 0 0
60 1 191643 27.4 165 4.2 0
2 187241 26.8 161 4.6 5.4 5.4
V79-379A 0 1 206133 29.5 177 4.3 0
+ ADA 2 198324 28.4 170 5.1 0
60 1 193128 27.6 166 4.3 2.5
2 197770 28.3 170 5.1 0 2.5
V79-379AR 0 1 197467 28.3 170 4.2 0
2 198447 28.4 170 5.0 0
60 1 193241 27.7 166 4.2 0.95
2 197389 28.3 170 5.0 0 0.95
V79-379AR 0 1 218734 31.3 188 5.1 0
+ ADA 2 204562 28.3 169 5.0 0
60 1 198234 28.4 170 5.1 3.5
2 196685 28.1 169 5.0 0 3.5
Control 0 1 204952 29.3 176 5.0 0
(5mg BSA) 2 214831 30.7 184 5.0 0
60 1 191643 27.4 164 5.0 2.4
2 197210 28.2 169 5.0 3.0 2.7
•Calculated by Equation 6.3. ADA = adaptive pre-treatment (Protocol 2).
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6.6. Conclusions.
The following conclusions can be drawn from the results
presented in this chapter.
1) Methylated and normal DNA bases can be separated and identified 
by HPLC using a reversed-phase ODS-hypersil column (6.3.).
2) The total content of 06MG in an acid hydrolysed DNA sample can 
be calculated using a calibration curve of peak area plotted 
against nanogramme quantities of 06MG standard. The HPLC 
technique is capable of quantitative determination of 06M3 over 
the range 5-20 ng.
3) Mouse fibroblast cells C3H 10T1/2 are able to de-methy late 08MG 
contained within an exogenous methylated DNA substrate.
Cell-free extracts of C3H IOTV2 removed 8.3 pinoles 06MG per mg 
protein after 30 minutes incubation and 23.3 pmoles per mg 
protein after 60 minutes (Table 6.4.).
4) Cell-free extracts of CHO-K1, CHOK1R, V79-379A and V79-379AR 
cells did not change the amount of 0*MQ in methylated DNA after 
60 minute incubation. The partial de-methylating ability of each 
cell line was attributed to spontaneous substrate de-methylation 
since a control, which substituted BSA for the cell-free 
extract, also showed a small degree of de-methylation ability 
i.e. 2.7 pinoles de-methy la ted/ mg protein/ hour (Table 6.5.)
5) Adaptive pre-treatment with non-toxic doses of MNNG did not 
alter the de-methylation ability of the four hamster cell lines 
studied (Tables 6.6. and 6.7.).
6) It can be concluded, therefore that CHO-K1, V79-379A and the 
derived MNNG-resistant clones do not possess an active 06MGMT 
enzyme, even at a low, constitutive level.
These conclusions will be discussed in Chapter 8.
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CHAPTER 7. THE EFFECT OF ADAPTIVE PRE-TREATMENT CN THE
MNNG-INDUCED SISHR CHRDHATID EXCHANGE PRHOUFNCIES IN 
fHTMRSE HAHSTER rKIJ.S.
7.1. Introduction.
Sister chromatid exchanges (SCE), originally demonstrated 
by Taylor, (1958), reflect the symmetrical, reciprocal interchange 
of DNA molecules between sister chromatids at homologous loci. Hie 
introduction of high-resolution brctnodeoxyuridine (BrdU) dye 
techniques has greatly simplified the visualisation of SCE in 
metaphase chromosome preparations (Latt, 1975; Perry and Wolff, 
1974). These techniques have revealed that SCE occurs at the time 
of DNA replication and involves an exchange of DNA duplexes 
(Evans, 1977). DNA damaging agents have been shown to greatly 
increase the frequency of SCE over the normally low, spontaneous 
levels evident in untreated cells, and consequently are considered 
to be a useful indicator of the mutagenicity of these agents 
(Evans, 1977). Although little is known about the biochemistry of 
the formation of SCE, it has been suggested that they occur as a 
result of a cellular DNA repair response to DNA lesions, and are 
probably some kind of recombination process (Latt et al., 1975; 
Wolff et al., 1975). Since several classes of agent are capable of 
inducing SCE, the lesions responsible are probably of many 
different types (Evans, 1977; Heflich et al., 1982; Morris et al., 
1984). Recent reports indicate a correlation between the induction 
of SCE and mutational events, although no universal conclusions 
have been drawn about this relationship since each test agent has 
responded differently, in terms of a mutation to SCE ratio 
(Carrano et al., 1978; Heflich et al., 1982; Morris et al., 1984;
Natarajan et ai., 1984).
Samson and Schwartz, (1980) first reported a decrease in 
MNNG-induced SCE frequencies following MNNG or MNU adaptive 
pre-treatment. SCE were reduced in both CHO and in the SV-40 
transformed human cell line GM637. Similar results were found by 
Kaina, (1983b) who reported the protective effect of MNNG 
pre-treatment on the induced SCE frequency of V79-C10 cells, after 
subsequent MNNG exposure.HeLa S3, V79 and CHO cells transfected 
with an plasmid containing an active E.coli 06MGMT gene, show 
lower induced SCE frequencies than their respective, 
non-transfected parental line, suggesting that one of the lesions 
responsible for SCE is 06MG (Bignami et ai*, 1987; Ishizaki et 
ai*, 1986; White et ai., 1986). Induction of this enzyme, under 
adaptive conditions, may explain the reduction of SCE following 
pre-treatment* Since CHO and V79 have been shown to lack the 
OeMGMT enzyme (Foote et ai*, 1983; Foote and Mitra, 1984; Chapter 
6*5*) it would seem unlikely that any decrease of induced SCE 
frequency, following adaptive pre-treatment, can be attributed to 
induction of this enzyme.
The following chapter outlines the techniques involved in 
SCE visualisation and reports the MNNG-induced SCE of CHO-K1 and 
V79-379A cells either with or without adaptive pre-treatment. 
Resistant lines CH0-K1R and V79-379AR were also analysed to 
establish whether the process giving rise to cytotoxic resistance 
had any influence on the MNNG-induced SCE process *_1he sensitive 
cell clones, CH0-K1S and V79-379AS, were not assessed for MNNG 
induced SCE because they exhibited such a drastic increase in 
population doubling time, following adaptive pre-treatment 
(5.5.2*), that incubation of cells with BrdU, for two rounds of




Materials used in the assay of SCE, not previously
listed in chapter 2, are shown below.
1) 5-bromodeoxyuridine (BrdU) Sigma. M.Wt = 307.4. The solid and
5mM (1.54 rngml-1) stock solution in PBS(A) were stored, protected from 
light, at -20°C.
2) Hoechst 33258 (2- (-2- (4-hydroxyphenyl) -6-benzimidazolyl) -6 
- (l-methyl-4-piperazyl) -benzami dazole 3HC1), Hoechst GMbH,
Frankfurt, W.Germany. Solid and stock solution in DDH2O (500 
pgml"1) were stored at 4°C protected from light.
3) Polyurethane cement, Woolworth pic, Bath.
4) Broad-spectrum UV-light source - General Electric 15-W blacklight 
(F15T8BLB).
5) Sorensen’s buffer - 6.7mM potassium dihydrogen phosphate and 6.7mM 
disodium hydrogen phosphate, pH=6.8.
6) 2 x SSC - saline sodium citrate (0.3M sodium chloride, 0.03M 
tri-sodiun citrate (Sigma), pH=7.0).
7) Glacial acetic acid - Fisons (FSH) Ltd.
8) Microscope slides - 76 x 26mm, 1mm thick, pre-washed 
microscope slides (KTH 370) (Chance Proper Ltd., Smethwick,
England)•
9) Colchicine - mitotic spindle inhibitor, (BDH chemicals Ltd), 
was stored as a dry powder at roan temperature. Stock solution 
of 0.4 rngml"1 (ImM) in DEH2O was stored frozen at -20°C.
7.3. Detection of Sister Chromatid (SCE).
SCE detection requires the differential staining of sister
chromatids. This is usually achieved by incorporation of the
thymidine analogue 5-brcmodeoxyuridine (BrdU) into the chromatids
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during replication. SCE analysis takes advantage of the 
semi-conservative nature of DNA replication and if cells are 
exposed to BrdU for two cell cycles, metaphase chromosomes come to 
possess one chromatid unifilarly substituted with BrdU and its 
sister, bifilarly substituted. The chromatids can be 
differentiated by treatment with the dye Hoechst 33258, which 
fluoresces more strongly when bound to unifilarly substituted 
chromatids than when bound to bifilarly substituted chromatids 
(Latt, 1975). Since the Hoechst dye is highly photo-instable a 
photographic record must be made of the fluorescing metaphase 
within one minute of preparation. A more permanent differentiation 
procedure was devised by Perry and Wolff, (1974) who combined 
Hoechst dye incorporation with Giemsa staining (Fluorescence plus 
Giemsa or FPG technique), which allows examination of sister 
chromatids by conventional light microscopy.
7.3.1. Cell Treatment Protocol.
Ihis protocol was designed such that the cells were exposed 
to BrdU for two rounds of replication to ensure that virtually all 
metaphase cells examined were at the second mitosis following BrdU 
addition.
Cultures were started by inoculating 4x10s cells into 25cm2 
T/C flasks each containing 5ml Hams F10 + 5% PCS lacking thymidine 
(2.3.5.), gassed with 5% 002 in air and incubated at 37.5°C. 
(Thymidine present in the media may compete with BrdU for 
incorporation into DNA during its synthesis, resulting in a lower 
SCE rate (Morgan and Crossen, 1977)). After 20 hours incubation the 
culture media was discarded and replaced with 5ml fresh Hams F10 
+ 5% PCS lacking thymidine to which 10 pM BrdU had been added.
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Test or control treatments were also introduced at this stage. 
Following 30 hours incubation* 5 pM colchicine was added and two 
hours later the cells were harvested. Each culture flask was 
washed with 2ml of trypsin solution (2.3.3.) and then incubated 
with 3 ml trypsin at 37°C for 5 minutes. The resulting cell 
suspensions were tipped into plastic T/C serum tubes (2.1.) and 
5ml of warm DDH2O added to each. Thorough mixing of the tubes was 
followed by a 15 minute incubation in a water bath set at 37.5°C. 
The cells, swollen by the hypotonic treatment, were centrifuged in 
a bench centrifuge for 5 minutes at 1000 rpm, and then resuspended 
in about 0.2ml supernatant. 5ml of fresh fixative (3:1, 
methanol:glacial acetic acid. Prepared and used within 1 hour), 
was rapidly added. After centrifugation, the fixative was 
discarded with a Pasteur pipette, care being taken not to disturb 
the cell pellet, and replaced with 5ml fresh fixative. After 
thorough mixing, the tube was re-centrifuged, the fixative 
discarded and the cell pellet re-suspended in approximately 1ml of 
fresh fixative. Tubes were left at -20°C for 1 hour before 
metaphase preparation.
A metaphase chromosome preparation was made by running 3-5 
drops of the cold cell suspension down a clean microscope slide 
held at 45°. The slide was allowed to air-dry in a vertical 
position and then checked for adequate metaphase density under 
low-power phase optics. If the density of metaphase ceils was too 
low additional drops of the suspension were added and again left 
to air-dry. If the metaphase spreads were not satisfactory i.e. 
did not show separate, well-defined chromosomes in one plane of 
focus, the cells were subjected to further changes of fixative and 
re-spread. If this was not satisfactory the spreads were discarded
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and the experiment repeated.
7.3.2. Fluorescence plus Giemsa Staining (FFG).
The FTO method of Perry and Wolff, (1974) was used in these 
studies. Freshly made slides tend to show G-banding rather than 
the characteristic 'harlequin’ staining of SCE preparations. 
Therefore metaphase spreads were 'aged' for at least 1 week, in a 
dust-free environment at room temperature. After ageing, slides 
were stained in Hoechst 33258 0.5 jigml"1 (1:1000 dilution of stock 
with Sorensen's buffer pH=6.8), for 15 minutes. After rinsing with 
tap water and blotting dry, the preparations were mounted with 
Sorensen's buffer, a coverslip placed over the slide and sealed 
with polyurethane cement. The slides were then exposed to 
broad-spectrum UV-light for 2 hours. This allowed a photochemical 
reaction to occur whereby chromatids come to fluoresce 
differentially. Careful removal of the coverslips i.e. lifted 
straight off rather than slid off, was followed by immersion in 2 
x SSC at 60°C and incubated for 1 hour, before finally staining 
the slides in 5% Giemsa in Sorensen's buffer pH=6.8 for 30 
minutes. Slides were then rinsed in DDH2O and air-dried.
Microscope evaluation of SCE was now possible.
7.3.3. Scoring of SCE.
Following FTO staining all slides were coded with a diamond 
tipped glass marker and scored randomly i.e. 'blind'. Each slide 
was scanned methodically in breadthwise sweeps under low power 
(x256) and every apparently unbroken metaphase cell examined under 
high-power (xl600) oil immersion, bright-field microscopy. Spreads 
that were completely harlequin stained and which contained between
1 8 2
19 and 22 centromeres were analysed for SCE. A SCE was only 
counted when it was clearly evident in both chromatids at the same 
point. Care was taken not to count one SCE where there were two 
exchange points. Each exchange point, rather than the area between 
the exchange point, should be scored as an SCE; otherwise the 
total number of SCE will be under estimated. The chromosome 
illustrated in Plate 7.1. below shows 3 SCE, as indicated by the 
arrows.
Plate 7.1. A single chromosome from a metaphase preparation of a 
CH0-K1 cell exhibiting three sister chromatid 
exchanges (arrowed).
7.3.4. Treatment of results.
Conventionally, the frequency of SCE is expressed as ’SCE 
per cell* (Carrano et al., 1978; Natarajan et al., 1984; Schwartz, 
1986; Thompson e t al., 1982) or as ’SCE per chromosome’ (Bodell, 
1986; Morris et al., 1984; Samson and Linn, 1987). Both parameters 
have been reported but the latter is probably the most meaningful 
since ’SCE per cell* is influenced by the variation in chromosome
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number, cannon to many cell lines, and by loss of chromosomes 
during preparation. In this chapter data are presented both as 
'SCE per chromosome' and 'SCE per cell'.
7.4. Dose-response relationship of MNNG-induced SCE.
The construction of an SCE/mutagen dose-response 
curves served two useful purposes; a) to create a 'standard 
MNNG-induced SCE curve’ for comparison with curves produced by 
cells subjected to adaptive pre-treatment and b) to evaluate the 
efficiency of the technique by comparison to SCE yield obtained by 
other workers.
7.4.1. MNNG-induced SCE in CHO-K1 and V79-379A cells.
The details of cell treatment, staining and scoring of SCE 
are outlined in 7.3. Duplicate flasks were set up for both control 
(vehicle) and mutagen treated cells. A range of 0.1 - 0.3 pgml"1 
MNNG was used and for each dose a total of 19-21 harlequin-stained 
metaphase cells were scored for SCE. The data obtained from three 
independent experiments is presented in Tables 7.1. and 7.2. for 
CHO-K1 and V79-379A cells respectively, and are represented 
graphically in Figs. 7.1. and 7.2. plotted as SCE per chromosome 
against MNNG concentration. The S.E. in these, and subsequent 
Tables in this chapter, were calculated using the individual data 
points, thus taking sample size into account. In Plate 7.2. a cell 
from the vehicle control culture and a cell exposed to 0.1 jigml*1 





Figure 7.1. The MNNG-induced SCE frequencies in CHO-K1 cells 
grown in Hams F10 + 5% PCS lacking thymidine. The 
background SCE frequencies have been subtracted 










Figure 7.2. The MNNG-induced SCE frequencies in V79-379A 
cells grown in Hams F10 ♦ 5% PCS lacking 
thymidine. The background SCE frequencies have 
been subtracted at each dose level. (n=3 ± S.E.)















Mean SCE per 
chrom.IS.E
Induced SCE Mean induced 
per chromosome SCE per
chrom.IS.E.
0 7 136 59 8.43 0.43
7 137 60 8.67 911 0.44 0.4410.1 0 0
98 43 8.60 0.44
0.1 7 142 220 31.43 1.55 1.11
7 139 238 34.00 3213 1.71 1.6610.1 1.27 1.1610.2
7 140 220 31.43 1.66 1.12
0.2 7 142 481 68.71 3.39 2.95
7 142 473 67.67 7016 3.33 3.4510.4 2.89 3.0110.2
101 366 73.20 3.62 3.18
0.3 7 136 638 91.14 4.73 4.29
7 142 631 90.14 9214 4.64 4.6810.4 4.10 4.2410.1
7 137 635 93.29 4.77 4% 33




Table 7.2. The MNNG-induced SCE frequencies in V79-379A cells grown in Hans F10 + 5% PCS lacking thymidine.
MNNG Total cells Nunber of Number SCE per Mean SCE per SCE per SCE per Induced SCE Mean induced
Mgel'1 scored. chromsomes*. of SCE. cell celljtS.E. chromosome chrom.IS.E. per chromosome per chrom. 
±S.E.
0 7 139 83 11.86 0.60
0 7 141 70 10.00 11 ±2 0.50 0.54±0.11 0 0
0 7 139 72 10.29 0.52
0.1 7 141 305 43.57 2.16 1.62
0.1 7 137 297 42.43 42±4 2.17 2.09±0.20 1.63 1.55t0.1
0.1 7 140 272 38.85 1.94 1.40
0.2 7 140 620 88.57 4.43 3.89
0.2 7 141 618 88.29 88±1 4.38 4.38tO.13 3.84 3.85tO.2
0.2 7 139 607 86.71 4.37 3.83
0.3 7 140 758 108.29 5.41 4.87
0.3 7 139 716 102.29 106 ±9 5.15 £. 31tO.12 4.61 4.76t0.2
0.3 7 139 743 106.14 5.35 4.81
Modal chromosome number = 20±1
Plate 7.2. Metaphase spreads of CHO-K1 cells grown in Hams F10 +
5% PCS lacking thymidine in the presence of 10 pM BrdU, stained 
by the FPG technique. (1) = control, treated with vehicle, showing 
12 SCE, and (2) treated with 0.1 ngm! * 1 MNNG showing 34 SCE.
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7.4.2. MNNG-induced SCE in CH0-K1R and V79-379AR cells.
Dose-response curves for both CHO-K1R and V79-379A/R cells 
were constructed following the protocol outlined in 7.4.1. for 
CH0-K1 and V79-379A cells. The results are presented graphically 
on Fig. 7.3.a and b, for CHO-K1R and V79-379AR cells respectively. 
Tables 7.1. and 7.2. illustrate the data obtained for a series of 
SCE experiments by presenting data for the MNNG-induced SCE 
frequencies for CHQ-K1 and V79-379A cells. The most obvious 
difference between resistant and parental cells is the presence of 
a double chromosome set i.e. they are polyploid. This is 
illustrated in Plates 7.3. and 7.4. CH0-K1 and V79-379A cells have 
modal chromosome numbers of 20±2 chromosomes per cell, the 
MNNG-resistant clones have 39±2 chromosomes per cell.
Although the resistant cells have exactly double the number 
of chromosomes of their parental cells, this is not matched in 
terms of SCE induction. The induced SCE per chromosome of CHO-K1 
and CHO-K1R are similar at a dose level of 0.1 pgml-1 MNNG. Doses 
of 0.2 and 0.3 pgml*1 MNNG are very different, with an 
approximately two-fold lower level of induced SCE in CHD-K1R cells 
than CH0-K1 cells at the 0.3 pgml-1 level. This is also true of 
V79-379A and V79-379AR. It has been suggested that the presence of 
an active C^MGMT gene will elicit lower induced-SCE than cells 
deficient of this gene (Bignami et ai», 1987; Ishizaki et al., 
1987; White et al., 1986). However, the results from 6.5.2, where 
the demethylation ability of both CHO-K1R and V79-379AR were 
assessed, suggest the absence or inactivity of this gene.
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Figure 7.3. The MNNG induced SCE frequencies in CHO-K1R cells, (a), and V79-379AR cells, (b), grown in 
Hans F10 + 5% PCS lacking thymidine. Open and closed symbols represent pre-treated (n=2 ± 
S.E.) and control cells (n=3 ± S.E.) respectively. 19
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Plate 7.3. Metaphase spreads of a CHO-K1 cell, (1), and a CH3-K1R 
cell, (2), grown in Hams F10 + 5% FCS and stained with 5% Giemsa. 





Plate 7.4. Metaphase spreads of a V79-379A cell, (1), and a 
V79-379AR cell, (2), grown in Hams F10 ♦ 5% PCS and stained with 
5% Giemsa. Chromosome numbers of 19 and 3 7 are illustrated, 
respectively.
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7.4.3. The effect of adaptive ore-treatment on the MNNG-induced
SCE frequencies in CH0-K1. CHO-K1R. V79-379A and V79-379AR
cells.
Two days prior to each experiment cultures of each cell 
line were initiated by inoculating 5x10s cells into 150ml culture 
bottles containing 15ml Hams F10 + 5% PCS, gassed with 5% 002 in 
air and incubated at 37.5°C. After 48 hours growth cells were 
dispersed with trypsin (2.6.2.) and the cell density determined 
(2.6.3.). For each cell line duplicate 25cm2 flasks were 
inoculated with 4x105 cells containing 5ml Hams F10 + 5% PCS plus 
0.01 jigml"1 MNNG (t=-48). The flasks were gassed with 5% CO2 in 
air and incubated at 37.5°C for 6 hours. After this time (t=-42) 
the media was discarded and replaced with 5ml of fresh, pre-warmed 
Hams F10 + 5% PCS containing 0.01 jigml*1 MNNG. This procedure was 
repeated every 6 hours until t=0 was reached (Fig.7.7.). At t=0 
cells were harvested and 4x105 cells inoculated into a number of 
25cm2 T/C flasks each containing 5ml of Hams F10 + 5% PCS lacking 
thymidine (2.3.5.(ii)) i.e duplicate flasks for control and each 
mutagen dose level. After a two hour incubation period 10pM BrdU 
was added. Test or control treatments were also introduced to the 
flasks at this stage. Following a further 30 hour incubation 5pM 
colchicine was added and 2 hours later the cells were harvested by 
the procedure outlined in 7.3.1. Spreads of each cell line at each 
mutagen dose level were prepared and stained as previously 
detailed in 7.3.1. and 7.3.2. and SCE were scored (7.3.3.)» The 
results obtained are presented graphically in Figs.7.4., 7.5. and
7.6. Tables 7.3. and 7.4. show the results obtained for CHO-K1 and 
V79-379A numerically.
Both CHO-K1 and V79-379A cell lines exhibit reduced SCE
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frequencies following adaptive pre-treatment but only at MNNG 
challenge doses of 0.2 and 0.3 pgnil"1. Background levels of SCE 
are considerably higher in pre-treated cells than untreated 
controls with values of 2.21 vs 0.44 SCE per chromosome for CHO-K1 
and 1.97 vs 0.54 SCE per chromosome for V79-379A cells. Figures
7.4. and 7.5. show the effect of pre-treatment on both cell lines* 
the results expressed as induced SCE per chromosome following 
subtraction of the relevant background (vehicle control) count 
(Thompson et al., 1982).
CHQ-K1R and V79-379AR cells show little difference between 
the MNNG-induced SCE frequencies of pre-treated and untreated 











Figure 7.4. The effect of adaptive pre-treatment, by Protocol 
2, on the MNNG-induced SCE frequencies in CHO-K1 
cells grown in Hams F10 ♦ 5% PCS lacking 
thymidine. Qpen and closed symbols represent 
pre-treated cells (n=2 ± S.E.) and control cells 



















Figure 7.S. The effect of adaptive pre-treatment* by Protocol 
2* on the MNNG-induced SCE frequencies in 
V79-379A cells grown in Hams F10 + 5% PCS lacking 
thymidine. Open and closed symbols represent 
pre-treated cells (n=2 ± S.E.) and control cells 
(n=3 ± S.E.) respectively.
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Figure 7.6. The 'effect of adaptive pre-treatment, by Protocol 2, on the MNNG-induced SCE frequencies in 
CH0-K1R cells, (a) and V79-379AR cells, (b), grown in Hams F10 + 5% PCS lacking thymidine. 




Table 7.3. The effect of adaptive pre-treatment, by Protocol 2, on the MNNG-induced SCE frequencies in CH0-K1 cells grown
in Haas F10 + 5% PCS laking thymidine.
MNNG Total cells Expt. Nunber of Number of SCE per SCE per Mean SCE Induced SCE Mean induced
Ugml-1 scored. N°. chromosomes. SCE. cell. chromosome per chrom. 
±S.E.
per chrom. SCE per chrom. 
1S.E.
0 7 1 414 312 44.6 2.21
7 2 137 301 43.0 2.19 2.23±0.31 0 0
7 2 282" 647 92.4 2.29
0.1 6 1 121 369 61.5 3.05 0.82
6 2 116 359 59.8 3.09 3.2910.11 0.86 1.1410.3
5 2 160" 635 127.0 3.96 1.73
0.2 6 1 122 460 76.7 3.77 1.54
3 2 60 225 75.0 3.75 3.4910.27 1.52 1.2610.27
5 2 196" 577 115.4 2.94 0.71
0.3 6 1 122 538 89.7 4.41 2.18
6 2 118 577 96.2 4.89 4.4910.21 2.66 2.2710.21
6 2 242" 1011 168.5 4.18 1.95
Polyploid cells (49% of cells scored in Expt.2.)
The effect of adaptive pre-treatment, by protocol 2, on the MNNG-induced frequencies in V79-379A cells
grown in Haas F10 + 5% PCS laking thymidine.
MNNG Total cells Expt. Nunber of Nunber of SCE per SCE per Mean SCE Induced SCE Mean induced
Mgal-1 scored. N°. chromosomes SCE. cell. chromosome per chrom. 
1S.E.
per chrom. SCE per chrom. 
1S.E.
0 6 1 124 228 38.0 1.83
6 2 119 240 40.0 2.02 1.9710.10 0 0
7 2 279* 674 82.0 2.06
0.1 6 1 121 431 71.8 3.56 1.59
6 2 118 449 74.8 3.81 3.6510.10 1.84 1.7510.10
6 2 239* 861 143.5 3.60 1.82
0.2 6 1 120 621 103.5 5.18 3.21
6 2 116 616 102.7 5.31 4.9410.31 3.34 2.9710.31
6 2 239* 1033 172.2 4.32 2.35
0.3 6 1 120 698 116.3 5.82 3.85
6 2 117 615 102.5 5.26 5.1910.39 3.29 3.2210.39
4 2 161* 722 180.5 4.48 2.51
Polyploid cells (34% of cells scored in Expt.2.)
Figure 7.5. Diagrammatical summary of the protocol used to assess the effect of adaptive
pre-treatment on the MNNG-induced SCE in CH0-K1, CHO-K1R, V79-379A and V79-379AR 
cells.
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pre-treatment.
a-d = adaptive dose - 0.01 jigml"1 MNNG.
c-d = challenge dose - 0, 0.1, 0.2 and 0.3 ngml'1 MNNG.
BrdU = 10|iM 5-bromodeoxyuridine.
00L = 5pM colchicine.








From the results presented in this chapter the following
conclusions may be drawn.
1) Sister chromatid exchanges (SCE) can be induced by MNNG in 
CHO-Kl, CH0-K1R, V79-379A and V79-379AR cells and visualised by 
differential staining of the chromatid arms (7.3.1. and 7.3.2.)
2) Both CHO-Kl and V79-379A were found to have a modal chromosome 
number of 20±2y whereas CHO-K1R and V79-379AR cells were 
polyploid with a modal number fo 39±2 (Plates 7.3. and 7.4.).
3) MNNG, in the concentration range 0.1 to 0.3 Mgml-1 induced SCE 
in a dose dependent fashion for CHO-Kl, CHO-K1R, V79-379A and 
V79-379AR cells (Figs.7.1., 7.2. and 7.3.), to a maximum
frequency of 4.76 SCE per chromosome.
4) The background (vehicle control) SCE frequencies were 0.44 SCE 
per chromosome for CHO-Kl, 0.67 SCE per chromosome for CHO-K1R, 
0.54 SCE per chromosome for V79-379A and 0.75 SCE per 
chromosome for V79-379AR cells.
5) Adaptive pre-treatment of CHO-K1 and V79-379A cells lowered the 
induced SCE frequencies at MNNG challenge levels of 0.2 and 0.3 
pgml"1 but not at 0.1 pgml”1 Figs.7.4. and 7.5.).
6) Adaptive pre-treatment increased the background SCE levels over 
control for CHO-Kl (0.45 to 2.23 SCE per chromosome) and 
V79-379A cells (0.54 to 1.97 SCE per chromosome) (Tables 7.3. 
and 7.4.)•
7) CHO-Kl and V79-379A cell populations exhibited a high 
percentage of polyploid cells i.e. 49% and 34% respectively, 
following adaptive pre-treatment (Tables 7.3. and 7.4.).
8) Neither the background nor the induced SCE frequencies of 
CHO-K1R and V79-379AR cells were altered by adaptive
pre-treatment.
These conclusions will be discussed in Chapter 8.
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CHAPTER 8.1 DISCUSSION.
Ihe adaptive response to alkylating agents is an inducible 
form of DNA repair acting on alkylation damage. When E.coli 
cultures are exposed to low concentrations of alkylating agents, 
such as N-methyl-N*-nitrosoguanidine (MNNG), they become resistant 
to the cytotoxic and mutagenic effects of high concentrations of 
these compounds. Two enzymes are associated with this response and 
are induced by adaptive pre-treatment i.e. 3-methyladenine-DNA 
-glycosylase II (3-MAG), which removes 3-methyladenine (3MA), 
7-methylguanine (7MG) and 3-methylguanine (3MG) from alkylated 
DNA, and 06-methylguanine-DNA-methyltransferase (06MGMT), which 
de-methylates 08-methylguanine (06M®fT). In E.coli, under adaptive 
conditions, the cellular levels of these enzymes increase 20 and 
100-200 fold, respectively. The repair of 06MG prevents this 
lesion causing G:C to A:T transition mutations whereas the removal 
of 3MA and 3MG prevents cell killing. The presence of these 
enzymes in mammalian cell systems has been reported by a number of 
authors (Cathcart and Goldthwait, 1981; see also Table 1.2.). 
Possession of such enzymes suggests that mammalian cells have the 
capability to express an adaptive response if induced by adaptive 
pre-treatment. Evidence for the existence of a response, analogous 
to that of E,colit has so far been conflicting (see Chapter 1). 
Much work has been carried out using in vitro cell culture systems 
from which two relevant questions have arisen; 1) are the 
discrepancies that have been found due to the different 
experimental protocols used and 2) are the contrasting results 
that have been reported, due to the different cell types used ?. 
Ihe overall aim of this project, therefore, was to attempt to 
answer these questions by choosing two cell lines, common to the
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previous studies, and then subjecting them to adaptive 
pre-treatments following two different protocols. Each protocol 
was chosen by the virtue of its proven capability to induce the 
adaptive response in one or both cell lines. Ihe choice of each 
assay system used in this project was also based on previous 
studies which employed one or more of these biological end-points. 
The effect of MNNG pre-treatment on each cell line was assessed by 
changes in MNNG-induced cytotoxicity and mutation to ouabain 
resistance, growth parameter changes, sister chromatid exchanges 
and by indirect enzyme analysis of cell-free extracts.
Single plated CHO-Kl cells, exposed to increasing levels of 
MNNG, exhibited a dose-dependent decrease in survival as shown in 
Fig.3.1. The assay employed was demonstrated to be reproducible 
for both CHO-Kl and V79-379A cell lines (Figs.3.2. and 3.3.). For 
each cell line, plating efficiencies for control cells were within 
the range 70 to 95X and were similar to the plating efficiencies 
found previously by other workers using Chinese hamster cell 
lines. (Bradley et al., 1981; Dewdney, 1982). Cell killing in both 
cell lines was seen to be bi-phasic when cell survival was 
plotted, on a log scale, as a function of MNNG dose. The curves 
show an immediate exponential reduction in cell survival with 
mutagen doses up to 0.05 tignl’1 MNNG. At mutagen concentrations 
between 0.05 jigml”1 and 0.3 pgrnl-1 MNNG there is a further 
exponential reduction in cell survival but the rate of reduction 
is slower. If both exponential portions of the curve cue 
extrapolated the inflection point of the curve can be derived from 
the intersection of the two lines. For CHO-Kl cells the curve 
inflection is observed at an MNNG concentration of 0.05 pgml’1 and
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a survival level of 4% and for V79-379A cells the values are 0.1 
Ugml"1 and 2% survival. A bi-phasic curve could indicate the 
presence of two sub-populations of cells, each differing in their 
sensitivity to MNNG. Hie intercept with the y-axis of the latter
i
extrapolation line, for the second exponential phase of the curve, 
gives an approximation of the percentage of the more resistant 
sub-population. From'Figs.3.2. and 3.3. the population of CHO-Kl 
cells was shown to be comprised of 6% resistant cells and the 
population of V79-379A cells contained 4% resistant cells.
Bi-phasic dose-survivor curves have been reported by a number of 
authors using a variety of Chinese hamster cell lines. Barranco 
and Humphrey, (1971), reported the existence of an MNNG-resistant 
sub-population of CHO cells that comprised 3% of the overall 
population. Wilson, (1985) reported that 5% of a population of 
V79-379A cells were resistant to MNNG. Bi-phasic survivor curves, 
similar to those shown in Figs.3.1. and 3.2. were reported by 
Goth-Goldstein and Hughes, (1987b), following treatment of CHO-9 
cells with either MNNG or MNU. For each mutagen, extrapolation of 
the second exponential portion of the survivor curve showed that 
4% of the overall population were more resistant to MNNG whilst 10% 
were resistant to MNU. When this cell line was treated with MMS 
and ENU, however, there was no indication of resistant 
sub-populations, since cell killing was a simple exponential 
decrease in survival with this mutagen, following a slight 
shoulder region. This may suggest the production of bi-phasic 
curves is dependent cm the type of mutagen used. However, this 
does not seem to be the case, since the MNNG-induced cell killing 
of C3H IOTV2 cells, another rodent fibroblast line, was shown to 
be a simple dose-dependent reduction in survival with MNNG dose,
2 0 6
rather than a bi-phasic response (Grisham and Smith, 1984).
Carver et al, t (1979), estimated the cytotoxic potency of a 
number of mutagens by comparing the relative Da7 values. The D37 
value is defined as the dose required to kill 63% of the cell 
population (37% survival) and is considered to be a valid measure 
of cytotoxic potency. From the dose-response data plotted for MNNG 
treated CHO-Kl cells, a D37 value of 0.021 pgml"1 was derived 
(Fig.3.2.). This is similar to values previously obtained for this 
cell line by Dewdney, (1982) (D37 = 0.035 pgml-1) and Wilson,
(1985) (D37 = 0.021 pgml”1). When compared to parental CHO cells, 
however, (Barranco and Humphrey, 1971, D37 = 0.07 pgml“1; Kao and 
Puck, 1968, D37 = 0.44 pgml"1) single plated CHO-Kl cells are 
found to be more sensitive to the toxic effects of MNNG. A similar 
relative sensitivity is seen when considering V79-379A cells. The 
dose-response data plotted for these cells gave a D37 value of
0.012 Mgml"1 (Fig.3.3.) which agrees with the findings of Wilson, 
(1985), who also used V79-379A cells (D37 = 0.011 pgml’1), but not 
with other workers with V79 cells. Chu and Mailing, (1968) 
reported a D37 value of 0.74 pgml"1 and Peterson et al., (1979) a 
D37 value of 1.03 pgml'1. The reason(s) for the sensitivity of 
CHO-Kl and V79-379A cells compared to their parental cells still 
remains to be elucidated. However, the degradation of solid MNNG 
during the course of the studies was discounted by Wilson, (1985) 
who compared the UV absorption spectra of MNNG, used throughout 
her studies, with a newly acquired MNNG batch, finding no 
difference in peak maxima.
The adaptive pre-treatment dose, used throughout these 
studies, was chosen on the basis of the minimal effect on plating 
efficiency (i.e. survival) of both CHO-Kl and V79-379A cell lines.
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MNNG concentrations in the range 0 - 0.02 pgml"1 were used to 
determine the point at which a measurable decrease in cell 
survival occured. Fig. 3.4. illustrates the effects of these 
concentrations on the survival of each cell line. From these 
results the adaptive pre-treatment dose was chosen as 0.01 pgml-1 
MNNG, since it was the highest concentration tolerated by each 
cell line before cytotoxicity was evident i.e. 0.01 pgml*1 is 
non-toxic. This mutagen concentration exactly matches that used by 
Samson and Schwartz, (1980) and is similar to the MNNG 
pre-treatment doses of 0.011 pgrnl"1 used by Kaina, (1983b) and
0.0102 pgml-1 used by Frosina et al., (1984) on V79 cells. Figure
3.4. also indicates the presence of a small shoulder to the 
dose-survivor curves of both CHO-Kl and V79-379A cells which was 
not evident in Figs.3.2. and 3.3. Ihe shoulder region of a 
survivor curve produced by low doses of a chemical has been 
considered evidence of a cells capacity to accumulate or repair 
some damage before that damage becomes lethal (Elkind and Sutton, 
1959; Munson and Goodhead, 1977).
Ihe initial approach adopted for these studies involved the 
use of two adaptive protocols, one involving a single non-toxic 
pre-treatment dose (Protocol 1) and the other, multiple mutagen 
doses (Protocol 2) (Fig.3.5.). Kaina, (1982) subjected V79-C10 
cells to a single, non-toxic dose of either MNU or MNNG and 
challenged these cells six hours later with high doses of the same 
agent. These cells were shown to have increased survival, reduced 
mutation to 6-TG* and reduced chromosomal aberrations following 
this pre-treatment, when compared to untreated control cells. 
Samson and Schwartz (1980), using a multiple MNNG dose 
pre-treatment protocol (Protocol 2), reported an enhanced cell
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survival of CHO cells to subsequent MNNG challenge. These authors 
also reported a decrease in the MNNG-induced SCE frequency, in 
pre-treated cells, compared to control cells.
Application of each pre-treatment protocol to CHO-Kl and 
V79-379A cells was carried out and the effect of pre-treatment 
assessed, initially, in respect to changes in cell survival only. 
CHO-Kl cells seeded, pre-treated and challenged with MNNG after 6 
hours incubation showed no difference in survival when the D37 
values of control and pre-treated cells are compared (Fig.3.6.a)
i.e. 0.06 |igml~1 MNNG.
Treatment of V79-379A cell by Protocol 1 produced an 
enhanced survival of pre-treated cells (Da7-0.021 jigml"1 MNNG) 
over untreated control cells (D37=0.011 pgml-1 MNNG) (Fig.3.6.b). 
This result agrees with the findings of Kaina, (1982) who also 
found a 2-fold increase in cell survival using this pre-treatment 
protocol. The D37 value of the control cells is similar to that 
previously shown for V79-379A cells in 3.2.2. i.e. 0.012 pgml"1 
MNNG.
Pre-treatment by Protocol 2 of both CHO-Kl and V79-379A 
cells resulted in an enhanced cell survival to subsequent mutagen 
challenge (Figs.3.7. and 3.8.). Pre-treated CHO-Kl cells exhibited 
a 3-fold enhancement of survival over control, and V79-379A a 
6.8-fold enhancement.
The observed enhancement of survival of V79-379A cells 
following pre-treatment by Protocol 1, and of both cell lines by 
Protocol 2, may be explained in a number of ways:
a) Pre-treatment has altered in some way, the cellular mechanisms 
that deal with alkylation damage either by preventing alkylation 
damage or by repairing alkylation damage more efficiently
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consequently preventing cell killing. If the latter were true then 
one may suggest that an enzyme comparable to the 3-MAG induced 
during the E,coli adaptive response could be responsible. This 
theory cannot be ruled out but since activity was not assessed in 
these cells, during the present study, direct evidence is lacking.
b) The initial alkylations, caused by MNNG pre-treatment, could 
make the cells resistant to the second treatment by preventing 
the challenge dose from entering the cell or reaching the DNA 
target site. The results of Vistica, (1979) support this theory by 
showing that nitrogen mustard-sensitive mouse L5178Y 
lymphoblastoid cells had a reduced uptake of this mutagen, 
compared to the parental cells, which was due to an inactivation 
of a membrane transport system. In contrast, Schendel and Robins 
(1978) ruled out the possibility of diminished mutagen 
accessibility of adapted E.coli cells, by showing that the uptake 
kinetics of 14C-MNNG in both pre-treated and control cells was 
similar.
c) Since the action of MNNG is stimulated by cellular thiol levels 
(Lawley and Thatcher, 1970) a pre-treatment induced reduction of 
thiol levels could inhibit the cytotoxic action of MNNG. However 
Laval and Laval, (1984) found that the total thiol level within 
rat H4 cells was not modified following pre-treatment by a 
protocol similar to Protocol 2. Furthermore, Samson and Schwartz, 
(1980) showed that MNNG pre-treated CHO cells were resistant to 
challenge with the alkylating agents MMS and EMS, whose 
cytotoxicity is unaffected by thiol content.
d) Adaptive pre-treatment may have changed the cell cycle 
distribution and since the sensitivity of CHO cells, to MNNG, 
fluctuates throughout the cell cycle (Barranco and Humphrey,
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1971), this change may account for the increased resistance of 
adaptively pre-treated cells to subsequent mutagen challenge. 
CHQ-K1 cells were synchronised by the method of Zwanenburg, (1983) 
using a mitotic shake-off technique. This technique makes use of 
the fact that CH0-K1 cells, growing as a monolayer, round up and 
become less firmly attached to the growing surface when they enter 
mitosis. The mitotic cells were gently shaken off the monolayer 
and collected by centrifugation. One advantage of this method, 
over other techniques, is that there is no need for the addition 
of any chemicals to enrich the population with cells in a specific 
stage of the cell cycle. Zwanenburg, (1983) calculated that a 
suspension containing nearly 100% mitotic cells could be obtained 
in this way. Using this technique, to obtain a population of 
synchronous CHO-K1 cells, it was shown that synchrony was not 
induced by adaptive Protocol 2, since the MNNG dose-survivor curve 
for synchronised CHO-K1 cells did not match that of adaptively 
pre-treated unsynchronised CHO-K1 cells, but was similar to the 
MNNG dose-response curve of unsynchronised CH0-K1 cells 
(Fig.4.12.a).
e) The most likely explanation, however, in the absence of any 
enzymological evidence,, is that pre-treatment has selected for 
pre-existing mutagen resistant cells rather than inducing 
resistance in the whole population. The existence of a more 
resistant sub-population is suggested from the bi-phasic 
dose-survivor curve produced for both CH0-K1 and V79-379A cell 
lines, but selection of these cells, by Protocol 1, seems unlikely 
since pre-treatment occurred only several hours prior to 
challenge. Pre-treatment by Protocol 2, however, subjected the 
cell populations to adaptive mutagen doses for a much longer
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period) which allowed growth to occur and possible selection of 
pre-existing mutagen-resistant cells. If this theory is true, a 
pre-treatment-induced change in the proportion of each 
sub-population, may be an important factor in the interpretation 
of data obtained from adaptation experiments. Investigations into 
this aspect are discussed later in this chapter.
From the results above it was observed that Protocol 2 i.e. 
6-hourly mutagen doses over 48 hours, caused an enhancement of 
challenge-induced cell killing, in both cell lines. It was 
decided, therefore, to use this protocol in all subsequent 
adaptation experiments.
The second aspect of the E.coli adaptive response is 
mutagenic adaptation. This phenomenon has been studied in both CHO 
and V79 systems using a variety of mutagenic end-points. Most 
commonly used have been the forward mutation to 6-thioguanine 
resistance (6TG1) or ouabain resistance (OuaB) (Durrant et al., 
1981; Kaina, 1982, 1983a, b; Laval and Laval, 1984; Schwartz and 
Samson, 1983). Reverse mutations were used during the initial 
studies into the bacterial adaptive response and have also been 
assessed during studies into the adaptive response in V79 cells
i.e. HGPRT" to HGPRT+ (Fox and Carlton, 1984). However, as 
mentioned in Chapter 4, resistance to the steroid compound ouabain 
was used as a genetic marker for a number of experimentally 
attractive reasons; 1) its capability to detect base-pair 
substitution mutations, which are caused by 0®MG lesions, 2) ease 
of assay, 3) experimental reproducibility and 4) there are few 
cell density effects (Arlett et al., 1975). Expanding point 2, by 
comparison with the well used 6TG* system (HGPRT* to HGPRT"), the
ouabain resistance system is desirable since it has a mutant 
expression time of 47-49 hours whereas expression of 6TGR mutants 
requires a 7 day expression period with the necessity to perform 
one or two sub-cultures during this time. Although the 6TGR may be 
more sensitive than the Oua* due to its ability to detect 
frameshift as well as base-substitution mutations, the (XiaR 
genetic marker was chosen for these studies since a single type of 
mutation was sought. The enzyme involved in bacterial mutagenic 
adaptation, 06MGffT, de-methylates the potentially mutagenic lesion 
06MG to lower the number of detectable base-pair substitution 
mutations. In mammalian cells, induction of this enzyme during 
adaptive pre-treatment would lead to a decrease in these 
mutations, hence a system that detected only this type of mutation 
was used.
The mutation of CHO-K1 cells to OuaR was assessed using an 
in situ protocol. In this type of assay cells are plated, treated 
with a mutagen, and left undisturbed except for the addition of the 
selecting agent. The alternative respreading protocol, in which 
cells are mutagen treated as a monolayer, then plated out, should 
not be used to assess mutation to OuaR (Arlett, 1977). 
Trypsinisation, necessary for the dispersal of cells, has been 
reported to lead to the loss of newly arisen OuaR mutants in 
respreading assays (Arlett, 1977). The optimum conditions for the 
detection of OuaR CH0-K1 mutants, as validated by Dewdney, (1982), 
are similar to those of other CHO-K1 cells (Hsie et al., 1981). 
CHO-K1 cells treated with MNNG show a dose-dependent increase in 
mutation frequency (OuaR mutants per 106 surviving cell) up to 
3000 fold over the low, spontaneous level of 1x10*6 (Table.4.1.). 
The reproducibility of this assay was demonstrated for CHO-K1 and
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V79-379A cells (Figs.4.2. and 4.3.). Both cell lines exhibited a 
dose-dependent increase in mutation frequency when subjected to 
increasing concentrations of MNNG over the range 0.02 ngml"1 to 
0.3 pgml’1 MNNG.
Both CHO-K1 and V79-379A cell lines were found to have 
spontaneous mutation frequencies of approximately 1x10’ • which is 
in good agreement with previously reported figures i.e. Ahmed, 
(1977), 1.8xl0’6; Arlett et al., (1975), 4xl0’7; Lankas et al., 
(1977), 1.7xl0’6; Lever and Seegmuller, (1976), 1x10’6.
Adaptive pre-treatment by Protocol 2, of both cell lines, 
resulted in an apparent decrease in the MNNG-induced mutation 
frequencies. The results of these experiments are shown in Figs.
4.6. and 4.7. for pre-treated CHQ-K1 and V79-379A cells 
respectively. From these Figures it can be seen that when 
considering differences in mutation by comparing the induced 
mutants at each mutagen dose there is a substantial decrease in 
the frequencies following adaptive pre-treatment. If, however, one 
compares the effect as a function of the cell killing i.e. 
equicytotoxic doses, pre-treated and control cells are as equally 
mutable as each other for both cell lines (Fig.4.8.). Since there 
is a linear relationship between log cell survival and log 
mutation frequency (Carver et al., 1979; Munson and Goodhead,
1977) a ’real* decrease in mutation frequency, following 
adaptive pre-treatment, should result in fewer mutational events 
per killing event i.e a reduction in the slope value. However this 
is not the case. Schwartz and Samson, (1983) reported unaltered 
6TG* mutation frequencies after chronic pre-treatment of CHO 
cells. They presented the data as mutants per 105 clonable cells 
as a function of MNNG challenge dose. If they had expressed their
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results as a function of survival they would have noticed that for 
each challenge dose the cells were more mutable than their 
respective control implying that accumulation of mutants during 
the pre-treatment period had occured. Durrant et al., (1981) 
pre-treated V79 cells with a single dose of MNNG and compared the 
induced mutation frequencies of these cells with those of 
untreated cells and found that, on an equicytotoxic dose level, 
these cells were more mutable than the control cells. The authors 
interpreted this result as an accumulation of mutants in the 
surviving cells. A real reduction in the mutation frequencies, 
following adaptive pre-treatment, was presented by Laval and 
Laval, (1984) since analysis of mutation frequency vs survival 
showed a lower number of mutational events per killing event when 
rat H4 cells were pre-treated and challenged with MNNG. When these 
cells were pre-treated with MMS and then challenged with either 
MMS or MNNG the results showed no mutagenic adaptation, but 
instead indicated an accumulation of mutants i.e. the cells are 
more mutable following pre-treatment.
The theory that pre-treatment can cause the accumulation of 
mutations is supported by the fact that the spontaneous mutation 
frequency of pre-treated cells is much higher than that of control 
cells i.e. 30 fold (4.2.3.). This phenomenon was also noticed by 
Schwartz and Samson, (1983) who reported 40 6TG1 mutants per 10s 
survivors, in pre-treated cells, compared to 2 mutants per 10s 
survivors in control cells. Accumulation of mutants during the 
pre-treatment period is also indicated by the increase of 
background SCE reported in Chapter 7 for both CHO-K1 and V79-379A 
cells. Che possible explanation for the observed reduction in 
mutation, frequencies following pre-treatment, is the slowing of
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cellular growth, which could lead to an extended mutant expression 
period, ultimately producing fewer mutants. Laval and Laval, (1984) 
discounted this possibilty by determining the expression time of 
adapted and control cells, finding a maximum expression period of 
five days for each. Lankas et al., (1979) reported that slowly 
growing V79 cells produced less MNNG-induced Oua* mutants than 
other cells growing at the normal rate. During these experiments, 
cells were grown in medium containing either 2% or 10% FCS and 
since care was taken to allow both the fast, (10% FCS) and the 
slow (2% FCS) growing cells to achieve the same number of cell 
divisions before ouabain selection, this group concluded that it 
is the growth rate and not the number of cell divisions that is 
important in respect to the number of mutants produced.
Partial synchrony of the cells caused by adaptive 
pre-treatment, does not explain the apparent drop in mutation 
frequencies since synchronised CHO-K1 cells were shown to exhibit 
similar mutation frequencies to non-synchronised cells.
(Fig.4.12b).
CB0-K1 and V79-379A cells exhibit 'classical’ growth 
kinetics, growth being conventionally divided into three distinct 
phases i.e. lag phase, log or exponential phase and stationary 
phase. Growth of these cells is evaluated by calculating the 
population doubling time (T) which is a measure of the rate at 
which cells, in the exponential phase, can double their number. 
Measurement of this parameter is useful since it gives an 
indication as to the general state of growth of the cell 
population. Following adaptive pre-treatment CHO-K1 cells showed a 
population doubling time of 23.3 hours, which is 7.9 hours greater 
than that of control cells i.e. 14.4 hours (Table 4.3.). Tobey and
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Crissman, (1975) also showed CHO cells to have a 12 hour increase 
in population doubling time following mutagen administration. In 
contrast V79-379A cells showed only a very slight increase in 
population doubling time from 11.4 to 12.3 hours. Following 
adaptive pre-treatment, by Protocol 2, increased lag times for 
both CH0-K1 and V79-379A cells were found, and may be explained by 
the findings of Roberts and Ward, (1973) who suggested that 
increases of this parameter were due to a delay in cell cycle 
progression following mutagen pre-treatment. This manifests as an 
increased length of time taken for the cells to attach to the 
culture vessel before commencement of growth.
The decrease in cell growth of CH0-K1 cells, following 
adaptive pre-treatment, and to a much lesser extent V79-379A 
cells, may offer one explanation for the decreased mutation by 
effectively increasing the mutant expression period. However, this 
does not necessarily explain the enhancement of survival seen in 
each cell line since Lankas et al., (1979) reported no difference 
of MNNG-induced cytotoxicity between slow and fast growing cells. 
Once again the possibility that pre-treatment alters the 
proportion of pre-existing resistant cells, in the overall 
population, is suggested. This would result in an apparent 
increase in cell survival on mutagen challenge. A slowed growth 
rate of the sensitive sub-population may account for this 
enrichment. To clarify this theory, and to establish the 
contribution of each sub-population to the overall observed 
effects, it was necessary to isolate each sub-population and 
assess the effects of adaptive pre-treatment on the growth,
MNNG-induced cytotoxicity and mutation to Oua1 of each. Isolation 
of the individual populations was based on their differential
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sensitivity to MNNG cytotoxicity. MNNG-resistant colonies were 
easily isolated by ring cloning of colonies that survived a high 
dose of MNNG (0.3 pgml"1). The isolated cells were designated 
CHO-K1R and V79-379AR (5.3.1.). Isolating the sensitive 
sub-population was not as simple, since the only way to identify 
this sub-population was to kill it. However, a solution to this 
problem was found with the use of a replica plating technique. A 
common technique in bacterial work, this technique has been less 
easily applied to mammalian cell systems. Following the initial 
studies of Esko and Raetz, (1978), who used filter paper discs for 
replica plating, Raetz et al., (1982) reported an efficient and 
rapid method of replica plating using polyester mesh discs. This 
method was used to isolate MNNG-sensitive colonies of CHO-K1 and 
V79-379A cells and essentially involved the production of high 
quality replicas of a population of each cell line, subjecting 
them to a low dose of MNNG, identifying the colony (or colonies) 
that are absent (by comparison with an untreated replica) and then 
isolating this colony from the corresponding position on a master 
plate (Plates 5.1. and 5.2.). Isolation from this replica was 
achieved by ring cloning. The isolated cells were designated 
CHO-K1S and V79-379AS (5.3.2.). It must be emphasised, however, 
that the sucessful production of replicas could only be achieved 
if the discs were extremely clean. Any trace of the deeming 
chemicals, particularly the detergent used, resulted in partial or 
complete cell death.
Although resistant cells were isolated by their ability to 
survive a 0.3 pgml-1 dose of MNNG they were not completely 
resistant to the cytotoxic action of MNNG challenge. Thus, 
dose-survivor curves for both CH0-K1R and V79-379AR cells were
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produced. These cells were found to be 5.2 and 5.7 fold more 
resistant to the cytotoxic action of MNNG when compared, on a Da7 
basis, with their respective parental cells (Table 5.1.). Plating 
efficiencies of untreated CH0-K1R and V79-379AR cells ranged from 
75-90% which were similar to those found for the parental cells. 
Resistant cells isolated by other workers have shown between 3.3 
and 40 fold higher resistances to challenge by the selecting 
mutagen, when compared to their parental lines (Friedman and 
Huberman, 1980; Goldmacher et al., 1986; Goth-Goldstein and 
Hughes, 1987a; Ishida and Takahashi, 1987). CHO-K1R cells exhibit 
survival that is a simple exponential function of dose whereas 
V79-379AR cells have a bi-phasic curve suggesting that these cell 
retain an element of sensitive cells i.e. approximately 40%
(Figs.5.1. and 5.2.). CHO-K1R and V79-379AR cells exhibited 
population doubling times of 26.1 and 24.4 hours which are 11.7 
and 13 hours greater than their respective parental lines (Tables 
4.2 and 5.2.). It may be noted, at this point, that the population 
doubling time, derived for CHO-K1R cells, is similar to that 
obtained for CHO-Kl cells following adaptive pre-treatment i.e. 
23.3 hours (Table 4.3.).
Both CH0-K1R and V79-379AR cells exhibited MNNG-induced 
mutation frequencies to Oua1 that were lower, on a dose basis, 
than those of parental cells. This may be attributable to the 
slower growth rate observed in the resistant cells. When the 
results were analysed at equicytotoxic doses, however, these 
cells were seen to be as equally mutable as their respective 
parental lines. On a dose to dose and equi cytotoxic basis, the 
induced-mutation frequencies for each resistant line were 
comparable with those obtained for their respective parental cell
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lines after they had been subjected to adaptive pre-treatment.
This again suggests an enrichment of the population with the 
resistant sub-population, followed adaptive pre-treatment of 
parental cells.
Adaptive pre-treatment of CH0-K1R and V79-379AR cells did 
not alter any of the above parameters except for increasing the 
cytotoxic resistance of V79-379AR cells by a factor of 2 (i.e. D37 
values of 0.07 to 0.13 jigml"1). The bi-phasic nature of the 
V79-379AR dose-response curve was changed to a simple exponential 
decrease in cell survival by the adaptive pre-treatment, a fact 
that implies the incomplete elimination of the sensitive element 
of a V79-379A population during selection of the resistant 
sub-population. Adaptive pre-treatment has then completed this 
selection process.
Goth-Goldstein and Hughes, (1987a) described an 
MNNG-resistant CHO-9 clone (CHO-9-C13) which had survived a 3 
pgml"1 MNNG treatment. This was found to be 8-fold more resistant 
to MNNG challenge and had the same population doubling time as the 
parental CHO-9 cells. They also reported this clone to have a 
parental modal chromosome number of 21. Friedman and Huberman, 
(1980) isolated MNNG resistant V79 cells (VR-43) that had a 3.3 
fold greater resistance to MNNG challenge than the parental V79 
cells. VR-43 cells had a mean population doubling time of 16±2 
hours and a modal chromosomal number of 22 chromosomes which were 
the same as the parental values for these cells. These authors 
showed that MNNG treatment of VR-43 cells resulted in mutation 
frequencies to both OuaR and 6TG* that were lower, on a dose 
basis, than the parental line. However, when analysed at 
equi cytotoxic doses of MNNG the VR-43 cells were found to be more
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mutable than the V79 cells i.e. at doses yielding 37% survivors 
the VR-43 cells gave 2-fold higher mutation frequencies than the 
V79 cells. Goldmacher et al., (1986) found their isolated 
MNNG-resistant TK6 MT1 cell line to be hypermutable following MNNG 
challenge and have a doubling time approximately 5 hours greater 
than that of the parental line i.e. 21-24 hours 
compared to 17-18 hours.
The MNNG-sensitive cell clones CHO-K1S and V79-379AS 
exhibited cell killing identical to the parental lines up to a 
dose level of 0.05 pgml"1. Above this level the cells appear to be 
much more sensitive to MNNG than their respective parental lines 
(Figs.5.1. and 5.2.). Consequently a comparison between the D37 
values of parental and sensitive cells does not reflect the 
increased sensitivity of this cell line. Sensitivity was selected 
for during the isolation procedure where the more resistant 
sub-population was excluded by ring cloning. The second 
exponential phase of the parental survivor curve (resistant 
sub-population) is absent when survivor curves for these cell 
lines are constructed.
The growth parameters of CH0-K1S and V79-379AS were 
comparable to their parental values, but dramatically changed 
following adaptive pre-treatment. The population doubling time of 
CHO-K1S cells is increased by 94.1 hours from 14.4 to 108.5 hours 
and that of V79-379AS cells by 53.7 hours from 14.7 to 68.4 hours 
(Figs.5.6. and 5.7.). This observation explains the lack of 
success during the cytotoxicity and mutation experiments involving 
pre-treatment of these cells. Colony growth was not observed for 
either CHO-K1S or V79-379AS following adaptive pre-treatment and 
after 11 days incubation the experiments were abandoned.
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Assessment of the induction of Oua1 mutants by MNNG in both 
sensitive cell lines showed them to exhibit higher mutation 
frequencies for each mutagen dose but to be as equally mutable as 
their respective parental line on analysis at equicytotoxic doses.
Kaina (1987), reported that the Chinese hamster ovary clone ,
W27.1, was hypersensitive to MNNG at each dose level, when 
compared to the parental CHO-9 cells. This clone was isolated by 
replica plating on filter paper discs.
Sister chromatid exchanges are considered to be a useful indicator 
of the mutagenicity of alkylating agents and since the assessment of SCE 
was previously used as a mutagenic end-point during adaptation 
investigations, analysis of SCE was employed in the present 
studies. The sensitive cell lines CHD-K1S and V79-379AS were not 
assayed for induced SCE because they exhibited such a huge 
increase in doubling time, following adaptive pre-treatment, that 
incubation of cells with BrdU, for two rounds of DNA replication 
would have unreasonably lengthened the experiment. One other 
reason for not using these cell lines was the lack of cytotoxicity 
data concerning adaptively pre-treated cells, on which the dose 
range for SCE induction could be based. However, the parental and 
resistant cell lines were examined for MNNG-induced SCE. One 
surprising feature observed at the outset of this work, was that 
whilst CH0-K1 and V79-379A cells had a modal chromosome number of 
20±2, the resistant cell lines (CH0-K1R and V79-379AR) contained a 
polyploid genome with a chromosome number of 39±2. It is well 
establised that various chemical agents, including alkylating 
agents, can interfere with the processes that underlie the 
distribution of chromosomes in the daughter cells resulting in
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either aneuploid or polyploid cells (Bonatti et al., 1986;
Rainaldi et al.9 1987; Tsutsui et al,, 1986). Rainaldi et al,, 
(1987) suggested that chemically induced aneuploidy in their 
V79/AP4 cells may have arisen either by non-disjunction at 
division or by a total block in the formation of a functional 
metaphase spindle.
A dose-dependent induction of SCE in both CHO-K1 and 
V79-379A cells by MNNG Mas demonstrated and is shewn in Figs.7.1. 
and 7.2. These data are in good agreement with that reported by 
Perry and Evans, (1975) who examined the MNNG-induced SCE in CHO 
cells. The concentration range over which MNNG produced the 
responses seen in these Figures is also similar to that reported 
by Perry and Evans i.e. 0.004 pgml-1 to 0.2 pgml"1. These workers 
reported control (vehicle) SCE levels of 0.61 SCE per chromosome, 
a figure similar to the values found for CHO-K1 (0.44 SCE per 
chromosome) and V79-379A (0.54 SCE per chromosome). At dose levels 
of 0.2 pgml*1 MNNG CHO-K1 and V79-379A cells exhibited 3.4 and 
4.38 SCE per chromosome respectively compared to 5.31 SCE per 
chromosome for CHO cells (Perry and Evans, 1975) and 3.0 SCE per 
chromosome for V79 cells (Popescu et al., 1979).
Although the resistant cells have double the chromosome 
number of their respective parental cells this is not reflected in 
the numbers of MNNG-induced SCE. At each MNNG dose level studied 
the induced SCE per chromosome (with the relevant background count 
subtracted) were lower in the MNNG resistant clones (CHO-K1R and 
V79-379AR) when compared to the respective parental lines 
(Figs.7.1., 7.2. and 1,3,), The extra chromosomes may confer some 
resistance to SCE formation resulting in proportionally fewer 
SCE. If one considers the induction of SCE per cell, there were a
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greater number of exchanges in the resistant cells, at a low MNNG 
dose (0.1 pgml"1), than the parental cells but the numbers were 
equal at the higher dose levels (0.1 and 0.2 pgml”1)* It is 
conceivable that a cell, resistant or not, has a maximum level of 
possible SCE and the rate at which these are accumulated may vary 
from one cell line to another, but ultimately results in the same 
number of SCE per cell for a particular cell line. Alternatively 
the equallisation of SCE at higher doses may be a failing of the 
SCE visualisation technique, allowing only a limited number of SCE 
to be detected in any one cell. Krepinsky, (1979), however, scored 
a maximum of 300 EMS-induced SCE per cell in Blooms syndrome 
lymphocytes, which have a genome of approximately 46 chromosomes. 
Since the MNNG-resistant cells have 39±2 chromosomes per cell, it 
seems unlikely that a limitation of the visualisation technique 
would account for the lower SCE frequencies observed between 
parental cells and the derived MNNG-resistant clones..
Adaptive pre-treatment of both CH0-K1 and V79-379A cells 
resulted in lower MNNG-reduced SCE frequencies but only at 
challenge doses of 0.2 and 0.3 pgml’1 MNNG. Background levels of 
SCE are considerably higher in pre-treated cells than in untreated 
control cells with values of 2.21 vs 0.44 SCE per chromosome for 
CH0-K1 and 1.87 vs 0.54 SCE per chromosome for V79-379A cells.
This suggests that lesions (mutations) responsible for SCE 
induction have accumulated during the pre-treatment period and 
that only SCE above these background levels are induced by the 
challenge doses. Therefore Figures 7.4. and 7.5. show the effect 
of adaptive pre-treatment on both cell lines expressed as SCE per 
chromosome with the relevant background count subtracted.
These results are in agreement with those reported by
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Samson and Schwartz, (1980) who reported a resistance to SCE 
induction following adaptive pre-treatment. These authors also 
reported a 50% increase in background SCE levels for pre-treated 
cells. It was noticed, but not quantified, that populations of 
both CHO-K1 and V79-379A cells contained a small proportion of 
polyploid cells, which probably represents the resistant 
sub-population in each instance. Adaptive pre-treatment of these 
parental cells resulted in much greater percentages of polyploid 
cells i.e. CHD-K1 = 49% and V79-379A = 34% (Tables 7.3 and 7.4.). 
The presence of a greater proportion of polyploid cells, which may 
equate to the resistant cells CHO-K1R and V79-379AR, may explain 
the reduced SCE levels following pre-treatment, since the 
polyploid CH0-K1R and V79-379AR cells were shown to have SCE 
levels lower than the respective parental cells, at each dose 
level studied (Figs.7.1. 7.2. and 7.3.).
CHO-K1R and V79-379AR cells show little difference between 
the MNNG-induced SCE frequencies of pre-treated and untreated 
cells (Fig.7.6.). The background levels of SCE also remain 
unchanged following pre-treatment.
To elucidate whether the observed responses were due to 
pre-treatment induction of 06MGMT or pre-treatment selection of 
pre-existing resistant cells, it was necessary to determine the 
presence of this enzyme in both CH0-K1 and V79-379A cells. This 
was performed by assessing the ability of cell-free extracts of 
each cell line to de-me thy late an alkylated exogenous DNA 
substrate using a HPLC technique to separate the alkylated bases 
following acid hydrolysis of the substrate. To validate the 
de-me thylation assay a cell line was used which had previously
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been shown to possess the 06MGWT enzyme i.e. the mouse C3H IOTV2 
line (Grisham and Smith, 1984). Details are presented in Chapter
6. This cell line de-me thy la ted alkylated DNA at a rate of 23.3 
pinoles 06MG/mg protein/hour (Table 6.4.) (6.5.1.). Since a great 
deal of de-me thy lation work has been carried out using 
radiolabelled substrates (Dotnoradzki et al., 1985; Foote and 
Mitra, 1984; Ishida and Takahashi, 1987; Lefebvre and Laval, 1986; 
Yagi et al., 1984), it is difficult to directly compare the data 
presented in Chapter 6 with the published data. The de-me thy lation 
of 06MG, in an alkylated DNA substrate has been expressed as 
relative counts per minute (cpm) removed per mg protein, pmols 
removed per mg protein and fmols removed per mg protein. Foote and 
Mitra, (1984), using a 8-3H-labelled poly(dC, dG, m8dG) polymer, 
reported Hela 0CL3 cells to de-methylate the substrate to the 
order of 0.4 ptnol 06MG de-me thy lated per mg protein. Ishida and 
Takahashi, (1987), also using the HeLa cell line, reported 1.25 
pmol de-me thy la ted per mg protein. Both were estimated after a 4 
hour incubation of cell extract with substrate. Lefebvre and 
Laval, (1986) reported 0.091 pmol 06MG de-me thy lated per mg 
protein for extracts of rat H« cells, whereas Domoradzki et al.,
(1985) reported 0.24 pmol 06MG de-me thy lated per mg protein for 
extracts of normal hunan fibroblasts.
Smith et al., (1981) incubated C3H IOTV2 cells with 
14C-MNNG and, at specific times over a 34 hour period, harvested 
cells and estimated the amount of 06MG present in the cells' DNA 
by chromatographic separation of the individual bases on a 
Sephadex G-10 column. The results were expressed as the frequency 
of lesions, calculated as adducts per 106 guanine molecules, in 
the DNA recovered. They reported a 49% reduction of 06MG content
in these cells over a 34 hour period following MNNG 
administration. The results for C3H IOTV2 presented in Table 6.4. 
show a 66% reduction in the content of 0*MG over a period of 1 
hour. Although the de-mehtylation rate is more rapid than that 
reported by Smith et al., (1981), this assay system was 
nevertheless considered valid for the de-me thy lation studies 
undertaken for this thesis.
Using this assay technique it was shown that cell-free 
extracts of CHO-K1, CHO-K1R, V79-379A and V79-379AR cell lines did 
not de-me thy late alkylated DNA, above the control values, with or 
without adaptive pre-treatment (Tables 6.6. and 6.7.). The partial 
de-me thylating ability of each cell line can be attributed to 
spontaneous substrate de-me thy lation since a control, which used 
BSA instead of a cell-free extract, also showed a small degree of 
de-me thy lation ability i.e. 2.7 pinoles 06MG de-me thy lated/ mg 
protein/hour (Table 6.5.). The conclusion to be drawn from this 
series of experiments is that the hamster lines studied are devoid 
of demonstrable 06MGMT enzyme activity and that the cells are 
either totally deficient of the enzyme or the enzyme is inactive 
in these cell lines.
Two groups, Waldstein et al., (1982c) and Lefebvre and 
Laval, (1986) have reported the presence of 06MGMT in the CHO cell 
line, but only at low, constitutive levels. However induction of 
this enzyme following mutagen pre-treatment was not observed by 
either group. Walds tein et al., (1982a), however, reported a 2-3 
fold enhancement in 06MGMT activity of HeLa 0CL2 cells, following 
an adaptive pre-treatment protocol that involved a 6-hourly 
administration of 25 ngml"1 MNNG over a 24 hour period. In 
contrast, Foote and Mitra, (1984) failed to observe induction of
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this enzyme in either rat or CHO cells, using essentially the same 
pre-treatment protocol.
The existence of 06MGMT in Chinese hamster lines has been 
disputed by a number of authors (Foote et al., 1983; Foote and 
Mitra, 1984; Goth-Goldstein, 1980; Harris et al., 1983; Yarosh et 
al., 1984). One group i.e. Harris et al., (1983) pointed out that 
the concentration of protein used in Waldsteins* assay on crude 
extracts was too low, and that substantial differences in enzyme 
contents might be masked by this fact. Under such experimental 
conditions spontaneous depurination may be mistaken for actual 
06MG removal by these cells.
It may be concluded, from the evidence reported above and 
from previous reports, that Chinese hamster cell lines do not 
possess any demonstrable 06MGMT activity and that any 
adaptive-like effects observed, are almost certainly due to 
mechanisms other than 06MGMT induction.
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8.2. Concluding discussion.
The results of the present investigation have shown that 
CHO-K1 and V79-379A cells, following adaptive mutagen 
pre-treatment by a protocol that incorporates a chronic dose 
schedule, exhibit a bacterial-like adaptive response. However, on 
close scrutiny it was discovered that the reductions in MNNG 
challenge-induced cytotoxicity, mutation to Oua* and SCE 
frequency, that were observed after MNNG pre-treatment, were not a 
true adaptive response but were a protocol-mediated effect. It was 
found that pre-treatment by Protocol 2, increased the proportion 
of the more resistant sub-population via a growth suppression of 
the more sensitive sub-population, possibly combined with the 
induction of polyploid cells that were shown to be mutagen resistant.
Total absence, or inactivity, of the enzyme 06MGMT,in these 
cells suggests that the observed cytotoxicity, imitation and SCE 
responses are brought about by a mechanism other than that of 
increased enzymatic repair of alkylated IMA. The increased 
survival of pre-treated and then mutagen challenged cells, 
therefore, was attributed to the increased proportion of resistant 
cells. The observed reduction in mutation frequencies, in the 
pre-treated cells, was considered to be due to the lower number 
of mutants produced by the slower growing cells, i.e. the 
inability of these cells to reach the optimum mutant expression 
time.
The two questions asked at the outset of this investigation 
i.e. (1) are the discrepancies in the data, previously found by 
other workers, that have been reported, due to the different 
protocols used and (2) are the contrasting results due to the
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different cell types used, can be answered in the light of the 
present findings. Protocol structure seems to be very important 
when designing adaptation experiments since protocol 2 evoked an 
apparent response in both CH0-K1 and V79-379A cells, whereas 
Protocol 1 did so only in the V79-379A cell line. Using Protocol 2 
throughout the subsequent adaptation studies it was apparent that 
there were few inter-cell line differences when the effects of 
adaptive pre-treatment were assayed by a number of different 
biological end-points. It would seem therefore, that in order to 
make valid comparisons of the adaptive response between cell lines 
and between laboratories using different cell lines, a standard 
pre-treatment protocol must first be agreed upon if any meaningful 
work is to ensue.
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8.3. Suggestions for Future Work.
1) To confirm the theory that the reduced mutation, on a dose 
basis, observed in adapted CHO-K1 and V79-379A cells, is 
attributable to the slowed growth of these cells, compared to 
parental growth rates, an experiment should be performed in which 
the optimum mutant expression time of pre-treated cells is 
determined. This would elucidate whether, given the correct 
expression time, these cells could demonstrate the same number of 
mutants as the control cells.
2) Reduced mutation in pre-treated cells may arise by the actvity 
of an enzyme other than 06MGHT. Saffhill and Fox, (1980) reported 
that V79 cells were competent at de-methylating 04-methylthymidine 
within their DNA and suggested that since these cells do not 
possess O^ MO-fT that a different enzyme may be responsible for the 
observed reduction of mutation. The existence of this enzyme in 
CH0-K1 and V79-379A cells cannot be ruled out since the activity 
was not assayed. Each cell line could be cultured in the presence 
of 04-methyl-[6-3H]-thymidine allowing incorporation into the 
cellular DNA, and at various time intervals following this 
procedure, the de-me thylat i on of 04-methyl thymine could be shown 
by assessing the total amount of alkylations present in the DNA.
3) One other useful study would be to determine whether an enzyme 
activity similar to the 3-HAG activity found in bacteria, exists 
in these cell lines, and if so can it be induced by adaptive 
pre-treatment. The assay system used to determine the
de-me thy lation of 06MG in alkylated DNA was inadequate for this 
purpose since 3MG could not be differentiated from an 
acid-hydrolysed mixture of alkylated bases (not shown), even
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though separation was possible when a standard mixture of eight 
methylated bases was analysed.
4) One interesting result to emerge during the course of these 
studies was the fact that certain CHO-K1 and V79-379A cells have 
an inherent resistance to MNNG cytotoxicity. The appearance of 
resistant cells is a worrying factor when one considers cancer 
chemotherapy involving alkylating agents, since a hyper-resistant 
tumour, arising by either enzymatic or sensitive cell-suppression 
mechanisms, would be resistant to further chemotherapy by the same 
agent. It would be useful to elucidate the mechanism of MNNG 
resistance by studying the cell lines CH0-K1R and V79-379AR. The 
level of intercellular thiol has been suggested as the reason for 
the resistance and if true, could be relevant to the cytotoxic 
efficiency of drugs such as BCNU and OCNU, which require thiols to 
produce the active carboniun ion intermediate. Since cancer 
chemotherapy regimes are continued for long periods the likelyhood 
of the appearance of resistant cells is great. One possible 
mechanism of resistance, could be the reduced uptake of mutagen 
into the resistant cells, by a depleted membrane transport system, 
for instance. Studies into the relative uptake of 14C-MNNG could 
be performed and the efficiency of CHOK1R and V79-379AR cells 
could be compared with the uptake observed in the parental CH0-K1 
and V79-379A cells. Of greater relevance would be to study the 
relative uptake rates of anti-neoplastic drugs that are routinely 
used in cancer chemotherapy and to evaluate their cytotoxic 
potency to normal and resistant cells.
In conclusion it is suggested that future studies into the 
adaptive response should be performed using human cell lines, 
since the results of in vitro experiments will ultimately need to
be extrapolated back to the human situation.
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